category	-log10(pvalue)	zscore	ratio	molecules	direction
Pulmonary Fibrosis Idiopathic Signaling Pathway	4.24	0.99	0.614	ACTA1, ACTA2, ACTB, ACTC1, ACVR1, ACVR2A, ADAM10, ADAMTS1, AEBP2, AJUBA, AKT1, AKT2, AKT3, BAX, BMPR2, CAV1, CCN2, CCND1, CDH2, COL1A2, COL20A1, COL3A1, COL4A1, COL4A2, COL5A2, COL5A3, COL6A3, COL7A1, CTNNB1, EDN1, EGFR, EGR1, EIF4EBP1, EIF4EBP2, EPHB3, EZH2, F2, F2R, FGF18, FGF2, FGFR2, FGFRL1, FOXO1, FOXO4, FZD7, GNA13, HES1, HRAS, IL17RA, IL6, IL6ST, ITGAV, ITGB1, JARID2, JUN, KRAS, MAP2K1, MAP2K3, MAP2K6, MAPK12, MAPK14, MAPK3, MAPK8, MMP14, MRAS, MTF2, MTOR, NFKB1, NOTCH1, NOTCH3, NRAS, PDGFA, PDGFB, PDGFC, PDGFRA, PEX13, PIK3CB, PIK3R1, PIK3R3, PINK1, PRKN, PTK2, RALA, RELA, RHOA, ROCK1, RPS6KA2, RPS6KA5, RRAS, SMAD3, SMAD4, SRF, STAT3, STAT6, STK38, TGFA, TGFB1, TGFB2, TGFB3, TGFBR2, TP53, WNT9A, WWTR1, YAP1, YY1		positive
Germ Cell-Sertoli Cell Junction Signaling	3.41	0	0.632	ACTA1, ACTA2, ACTB, ACTC1, ACTN2, ACTN4, AFDN, AKT1, BCAR1, CDH2, CFL2, CTNNA1, CTNNB1, EPN2, FER, FNBP1, HRAS, ITGA3, ITGA6, ITGB1, KEAP1, KRAS, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAP3K1, MAP3K10, MAP3K2, MAP3K5, MAPK12, MAPK14, MAPK3, MAPK8, MRAS, NECTIN2, NECTIN3, NRAS, PAK4, PDPK1, PIK3CB, PIK3R1, PIK3R3, PTK2, RALA, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, RRAS, SORBS1, TGFB1, TGFB2, TGFB3, TGFBR2, TUBA1A, TUBB, TUBB2B, TUBB6, TUBG1, VCL, ZYX		no direction
Gα12/13 Signaling	3.19	-1.414	0.65	AKT1, AKT2, AKT3, ARHGEF1, CDH10, CDH15, CDH17, CDH2, CDH23, CDH5, CTNNB1, F2, F2R, F2RL1, GNA13, HRAS, IKBKB, IKBKG, JUN, KRAS, LPAR4, LPAR6, MAP2K1, MAP2K7, MAP3K1, MAP3K5, MAPK12, MAPK3, MAPK7, MAPK8, MEF2A, MEF2C, MEF2D, MRAS, MYL1, MYL4, MYL9, MYLPF, NFKB1, NFKBIA, NFKBIB, NRAS, PIK3CB, PIK3R1, PIK3R3, PTK2, RALA, RASA1, RELA, RHOA, ROCK1, RRAS		negative
Senescence Pathway	2.83	-2.294	0.578	ACVR1, ACVR2A, AKT1, AKT2, AKT3, ANAPC13, ANAPC2, ANAPC5, ATF3, BHLHE40, BMPR2, CACNA1C, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, Calm1 (includes others), CAPN1, CAPN2, CAPN3, CAPN7, CAPNS1, CCND1, CCND3, CCNE2, CDC16, CDC23, CDC25A, CDKN1A, CHP1, DLAT, DLD, DMTF1, E2F6, EIF4EBP1, ELF1, ETS1, ETS2, EZH2, FOXO4, GADD45A, GADD45G, HBP1, HIPK2, HRAS, IKBKB, IKBKG, IL6, IRF3, ITPR2, JUN, KRAS, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK12, MAPK14, MAPK3, MAPK7, MAPKAPK2, MAPKAPK3, MCU, MRAS, MTOR, NF1, NFAT5, NFATC1, NFATC2, NFKB1, NRAS, PDHA1, PDK1, PDK4, PIK3CB, PIK3R1, PIK3R3, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PPP3CA, PPP3CB, PPP3R1, RALA, RASSF5, RBL2, RING1, RNF2, RPS6KA5, RRAS, SMAD3, SMAD4, SQSTM1, STING1, TGFB1, TGFB2, TGFB3, TGFBR2, TP53, TRAF6, ZFP36L1		negative
Glioma Invasiveness Signaling	2.52	-1.4	0.703	CD44, F2R, FNBP1, HRAS, ITGAV, KRAS, MAPK3, MRAS, NRAS, PIK3CB, PIK3R1, PIK3R3, PTK2, RALA, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, RRAS, TIMP2, TIMP3		negative
Semaphorin Neuronal Repulsive Signaling Pathway	2.43	-1.342	0.623	AKT1, AKT2, AKT3, ARHGEF12, CD44, CFL2, ERBB2, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPT, MPRIP, MYL1, MYL4, MYL9, MYLPF, NRP1, NRP2, PAK4, Pde4d, PIK3CB, PIK3R1, PIK3R3, PLXNB1, PRKACA, PRKAR1A, PRKAR2B, PRKG1, RHOA, RND1, ROCK1, RRAS, SEMA3A, SEMA3F, SEMA4D, SEMA6A, SEMA6D, SMC3, TP53, VCAN		negative
Regulation Of The Epithelial Mesenchymal Transition By Growth Factors Pathway	2.33	-0.75	0.587	AKT1, AKT2, AKT3, CDH2, EGFR, EGR1, ERBB2, ETS1, FGF1, FGF12, FGF13, FGF16, FGF18, FGF2, FGF6, FGFR2, FGFRL1, FOXO1, HRAS, IKBKB, IKBKG, IL6, IL6R, JUN, KRAS, LTB, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAP3K1, MAPK12, MAPK14, MAPK3, MAPK8, MEST, MET, MRAS, MTOR, NFKB1, NGFR, NRAS, PARD6G, PDGFA, PDGFB, PDGFC, PDGFRA, PIK3CB, PIK3R1, PIK3R3, PTPN11, RALA, RELA, RHOA, RRAS, SMAD3, SMAD4, SNAI2, STAT3, TGFB1, TGFB2, TGFB3, TGFBR2, TNFRSF11B, TNFRSF1B, TNFSF12, TWIST1, WWTR1, YAP1, ZEB1, ZEB2		negative
Acute Phase Response Signaling	2.3	0	0.594	AKT1, AKT2, AKT3, C2, C3, CFB, F2, HNRNPK, HP, HRAS, IKBKB, IKBKG, IL1R1, IL1RAP, IL33, IL6, IL6R, IL6ST, IRAK1, ITIH4, JUN, KRAS, LBP, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAP3K1, MAP3K5, MAPK12, MAPK14, MAPK3, MAPK8, MRAS, MTOR, MYD88, NFKB1, NFKBIA, NFKBIB, NGFR, NRAS, OSMR, PDPK1, PIK3CB, PIK3R1, PIK3R3, PTPN11, RALA, RBP3, RBP4, RELA, RRAS, SERPINF1, SOCS2, SOCS3, SOCS7, STAT3, TF, TNFRSF11B, TNFRSF1B, TRAF2, TRAF6, TTR		no direction
Regulation of Cellular Mechanics by Calpain Protease	2.29	-0.943	0.667	ACTN2, ACTN4, CAPN1, CAPN2, CAPN3, CAPN7, CAPNS1, CAST, CCND1, CCND3, CCNE2, EGFR, EZR, HRAS, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, KRAS, MAPK3, MRAS, NRAS, PTK2, RALA, RRAS, TLN2, VCL		negative
FAT10 Cancer Signaling Pathway	2.27	-0.2	0.684	ACVR1, ACVR2A, AKT1, AKT2, AKT3, BMPR2, CTNNB1, IKBKB, IKBKG, IL6, NFKB1, NFKBIA, NFKBIB, NGFR, PCNA, RELA, SMAD3, SMAD4, STAT3, TGFB1, TGFB2, TGFB3, TGFBR2, TNFRSF11B, TNFRSF1B, TP53		negative
PI3K/AKT Signaling	2.24	0.59	0.586	AKT1, AKT2, AKT3, CCND1, CDKN1A, CSF2RB, CTNNB1, EIF4EBP1, EPM2A, FOXO1, GAB2, GDF15, GHR, GYS1, HRAS, HSP90AA1, IKBKB, IKBKG, IL12RB2, IL17RA, IL17RC, IL17RD, IL17RE, IL1R1, IL4R, IL6R, IL6ST, INPP5K, INPPL1, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, KRAS, MAP2K1, MAP3K5, MAPK3, MAPK8IP1, MCL1, MRAS, MTOR, NFKB1, NFKBIA, NFKBIB, NRAS, PDPK1, PIK3CB, PIK3R1, PIK3R3, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PTGS2, RALA, RELA, RRAS, THEM4, TP53, TSC1, TSC2, YWHAB, YWHAG, YWHAZ		positive
Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes	2.16	-0.801	0.629	BCL10, Calm1 (includes others), CD3G, CD80, CHP1, HRAS, IKBKB, IKBKG, JUN, KRAS, MAP2K1, MAP2K7, MAP3K1, MAPK12, MAPK3, MAPK8, MRAS, NFAT5, NFATC1, NFATC2, NFKB1, NFKBIA, NFKBIB, NRAS, PABPC4, PPP3CA, PPP3CB, PPP3R1, PRKCQ, RALA, RELA, RRAS, SMAD3, SMAD4, TGFB1, TGFB2, TGFB3, TGFBR2, TOB1		negative
Type II Diabetes Mellitus Signaling	2.12	0.493	0.594	ABCC8, ACSL1, ACSL3, ACSL5, ACSL6, ADIPOR1, ADIPOR2, AKT1, AKT2, AKT3, CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, IKBKB, IKBKG, INSR, IRS1, IRS2, ITPR2, MAP2K7, MAP3K1, MAP3K5, MAPK12, MAPK3, MAPK8, MTOR, NFKB1, NFKBIA, NFKBIB, NGFR, NSMAF, PDPK1, PIK3CB, PIK3R1, PIK3R3, PKM, PPARG, PRKAA1, PRKAB1, PRKAB2, PRKAG3, PRKCE, PRKCI, PRKCQ, RELA, SLC27A1, SLC2A4, SOCS2, SOCS3, SOCS7, TNFRSF11B, TNFRSF1B, TRAF2		positive
Integrin Signaling	2.07	0	0.574	ACTA1, ACTA2, ACTB, ACTC1, ACTN2, ACTN4, AKT1, AKT2, AKT3, ARHGAP5, ARPC1B, ARPC3, ARPC4, ASAP1, BCAR1, BCAR3, CAPN1, CAPN2, CAPN3, CAPN7, CAPNS1, CAV1, CRK, CTTN, FNBP1, HRAS, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, KRAS, MAP2K1, MAPK3, MAPK8, MPRIP, MRAS, MYL9, MYLK, MYLK3, NCK2, NEDD9, NRAS, PAK4, PARVA, PDGFB, PIK3CB, PIK3R1, PIK3R3, PIKFYVE, PTK2, RALA, RAPGEF1, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, ROCK1, RRAS, TLN2, TSPAN3, TSPAN7, TTN, VCL, Wasl, WIPF1, ZYX		no direction
Semaphorin Signaling in Neurons	2.03	0	0.688	ARHGEF12, CFL2, FNBP1, ITGB1, MAPK3, MET, NRP1, PAK4, PLXNB1, PTK2, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, ROCK1, SEMA3A, SEMA4D		no direction
NF-κB Activation by Viruses	1.93	0.928	0.644	AKT1, AKT2, AKT3, EIF2AK2, HRAS, IKBKB, IKBKG, ITGA3, ITGA6, ITGAV, ITGB1, KRAS, MAP3K1, MAPK3, MRAS, NFKB1, NFKBIA, NFKBIB, NRAS, PIK3CB, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, RALA, RELA, RRAS, TRAF2		positive
HGF Signaling	1.9	-0.845	0.603	AKT1, AKT2, AKT3, CCND1, CDKN1A, ELF1, ETS1, ETS2, HRAS, IL6, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, JUN, KRAS, MAP2K1, MAP2K7, MAP3K1, MAP3K10, MAP3K2, MAP3K5, MAPK12, MAPK3, MAPK8, MET, MRAS, NRAS, PIK3CB, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, PTGS2, PTK2, PTPN11, RALA, RAPGEF1, RRAS, STAT3		negative
Cardiac Hypertrophy Signaling (Enhanced)	1.87	-0.085	0.531	ACE, ACVR1, ACVR2A, ADCY5, ADCY8, ADRB2, AKAP13, AKT1, AKT2, AKT3, ATF6, ATP2A1, ATP2A3, BMPR2, CACNA1C, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, Calm1 (includes others), CAMK2D, CAMK2G, CHP1, CSF2RB, CTF1, CTNNB1, DVL3, EDN1, EIF2B2, EIF2B4, EIF4EBP1, FGF1, FGF12, FGF13, FGF16, FGF18, FGF2, FGF6, FGFR2, FGFRL1, FZD7, GHR, GNA13, GNAI2, GNB1, GNB2, GNG2, HDAC11, HDAC2, HDAC4, HDAC5, HDAC6, HDAC9, HRAS, HSPB3, HSPB7, IKBKB, IKBKG, IL12RB2, IL15, IL17F, IL17RA, IL17RC, IL17RD, IL17RE, IL1R1, IL33, IL4R, IL6, IL6R, IL6ST, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, ITPR2, JUN, KRAS, LTB, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAP3K1, MAP3K10, MAP3K2, MAP3K20, MAP3K5, MAPK12, MAPK14, MAPK3, MAPK7, MAPK8, MAPKAPK2, MAPKAPK3, MEF2A, MEF2C, MEF2D, MKNK1, MKNK2, MRAS, MTOR, NFAT5, NFATC1, NFATC2, NFKB1, NGFR, NRAS, PDE1C, PDE7A, PDE7B, PDE8A, PDIA3, PDK1, PIK3CB, PIK3R1, PIK3R3, PLCD4, PPP3CA, PPP3CB, PPP3R1, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, PRKG1, PTGS2, PTK2, RALA, RCAN1, RELA, RHOA, ROCK1, RPS6KA5, RRAS, RYR1, RYR3, SRF, STAT3, TGFB1, TGFB2, TGFB3, TGFBR2, TNFRSF11B, TNFRSF1B, TNFSF12, TSC2, WNT9A		negative
Hepatic Fibrosis Signaling Pathway	1.85	-0.647	0.537	ACTA2, ACVR1, ACVR2A, AKT1, AKT2, AKT3, ATF4, BMPR2, CACNA1C, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, Calm1 (includes others), CASP3, CCDC88A, CCL5, CCN2, CCND1, CNR1, COL1A2, COL3A1, COL5A3, CREB3L2, CSNK1A1, CSNK1E, CTNNB1, DVL3, EDN1, EZH2, FGF2, FNBP1, FOXO1, FOXO4, FTH1, FZD7, GLI3, GNAI2, HRAS, IKBKB, IKBKG, IL17RA, IL1R1, IL1RAP, IL33, IRAK1, IRAK2, IRS2, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, JUN, KLF9, KRAS, LRP1, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK12, MAPK14, MAPK3, MAPK8, MRAS, MTOR, MYD88, MYL1, MYL4, MYL9, MYLK, MYLK3, MYLPF, NFKB1, NFKBIA, NFKBIB, NGFR, NRAS, PDCD4, PDGFA, PDGFB, PDGFC, PDGFRA, PDK1, PIK3CB, PIK3R1, PIK3R3, PPARG, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, PTK2, RALA, RELA, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, ROCK1, RRAS, SDHD, SMAD3, SMAD4, SPP1, STAT3, TF, TFRC, TGFB1, TGFB2, TGFB3, TGFBR2, TLR4, TNFRSF11B, TNFRSF1B, TRAF6, TTN, VCAM1, VEGFD, WNT9A, YAP1		negative
RHOGDI Signaling	1.81	1.021	0.57	ACTA1, ACTA2, ACTB, ACTC1, ARHGAP5, ARHGAP6, ARHGDIA, ARHGEF1, ARHGEF12, ARHGEF17, ARHGEF9, ARPC1B, ARPC3, ARPC4, CD44, CDH10, CDH15, CDH17, CDH2, CDH23, CDH5, CFL2, DGKZ, DLC1, ESR1, EZR, FNBP1, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, MRAS, MYH1, MYH2, MYH3, MYH4, MYH8, MYH9, MYL1, MYL4, MYL9, MYLPF, PAK4, PIKFYVE, RDX, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, ROCK1, WASF2		positive
Caveolar-mediated Endocytosis Signaling	1.78	0	0.636	ACTA1, ACTA2, ACTB, ACTC1, B2M, CAV1, CAVIN1, COPA, COPB2, COPG2, EGFR, FLNA, FLNB, FLNC, FLOT1, HLA-A, INSR, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, ITSN1, MAP3K2, MR1, RAB5C		no direction
CLEAR Signaling Pathway	1.78	1.54	0.542	AKT1, AKT1S1, AKT2, AKT3, ATF4, ATP6AP1, ATP6AP2, ATP6V0A1, ATP6V0C, ATP6V0D1, ATP6V0E2, ATP6V1A, ATP6V1C1, ATP6V1E1, BMPR1B, BMPR2, CHP1, CREB3L2, CTSD, CTSF, DDIT4, EGFR, FGF2, FGFR2, FLCN, GAA, GBA, GHR, GLB1, GLMP, GNS, GUSB, HEXA, HPS5, HRAS, IKBKB, INSR, ITPR2, KRAS, LAMP1, LAMTOR2, LAMTOR5, MAP4K3, MAPK12, MAPK14, MAPK3, MAPK7, MCOLN1, MRAS, MTOR, NAGLU, NAGPA, NEU1, NGFR, NR1H4, NRAS, PDGFB, PDGFRA, PINK1, PPARA, PPARGC1A, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PPP3CA, PPP3CB, PPP3R1, PRKAA1, PRKAB1, PRKAB2, PRKAG3, PRKCE, PRKCI, PRKCQ, PRKN, PSAP, RALA, RPTOR, RRAGC, RRAGD, RRAS, SEC13, SEH1L, SLC36A1, STK4, STUB1, SUMF1, TFE3, TGFA, TGFB1, TGFB2, TGFBR2, TLR1, TLR4, TLR5, TLR6, TNFRSF11B, TNFRSF1B, TP53, TSC1, TSC2, VPS33A, VPS35, YWHAB, YWHAG, YWHAZ, ZKSCAN3		positive
Reelin Signaling in Neurons	1.74	-0.617	0.59	AFDN, AKT1, AKT2, AKT3, APOE, APP, ARHGEF1, ARHGEF10L, ARHGEF12, ARHGEF17, ARHGEF9, ARPC1B, ARPC3, ARPC4, CAMK2D, CAMK2G, CDH2, CNR1, CRK, GRIN1, GRIN2A, GRINA, ITGA3, ITGB1, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAP3K10, MAPK12, MAPK3, MAPK8, MAPK8IP1, MAPT, MTOR, NDEL1, NECTIN3, PAFAH1B2, PDK1, PDK4, PIK3CB, PIK3R1, PIK3R3, RAPGEF1, RHOA, VLDLR		negative
Regulation of Actin-based Motility by Rho	1.73	-0.898	0.607	ACTA1, ACTA2, ACTB, ACTC1, ARHGDIA, ARPC1B, ARPC3, ARPC4, BAIAP2, FNBP1, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, MPRIP, MYL1, MYL4, MYL9, MYLK, MYLPF, PAK4, PIKFYVE, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, ROCK1, Wasl, WIPF1		negative
Autophagy	1.73	-1.342	0.553	AKT1, AKT1S1, AKT2, AKT3, ARL8B, ATF4, ATG13, ATG2A, ATG9A, ATG9B, Calm1 (includes others), CHP1, CREB3L2, DAPK2, DDIT3, EPG5, FGF2, FOXO1, FUNDC1, INSR, IRS1, IRS2, JUN, LAMP1, LAMP2, MAP1LC3A, MAP1LC3B, MAP2K1, MAP2K7, MAPK12, MAPK3, MAPK8, MTOR, MYD88, NFKB1, NGFR, PDGFB, PIK3CB, PIK3R1, PIK3R3, PLEKHM1, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PPP3CA, PPP3CB, PPP3R1, PRKAA1, PRKAB1, PRKAB2, PRKACA, PRKAG3, PRKAR1A, PRKAR2B, PRKCQ, RALA, RB1CC1, RPTOR, SESN1, SLC1A5, SLC3A2, SLC7A5, SQSTM1, STX17, TGFA, TGFB1, TGFB2, TLR4, TNFRSF11B, TNFRSF1B, TP53, TRAF3, TRAF6, TSC1, TSC2, ULK1, VAMP8, VPS33A, VPS39, VPS41, WIPI1		negative
FGF Signaling	1.66	0.354	0.611	AKT1, AKT2, AKT3, ATF4, CREB3L2, CRK, FGF1, FGF12, FGF13, FGF16, FGF18, FGF2, FGF6, FGFR2, FGFRL1, HRAS, MAP2K1, MAP2K3, MAP2K6, MAP3K1, MAP3K5, MAPK12, MAPK14, MAPK3, MAPK8, MAPKAPK2, MET, PIK3CB, PIK3R1, PIK3R3, PTPN11, RPS6KA5, STAT3		positive
Calcium Signaling	1.66	-2.03	0.554	ACTA1, ACTA2, ACTC1, ATF4, ATP2A1, ATP2A3, ATP2B1, ATP2B3, ATP2B4, ATP2C1, CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, Calm1 (includes others), CALR, CAMK2D, CAMK2G, CASQ1, CHP1, CHRNB1, CHRNE, CREB3L2, GRIN1, GRIN2A, GRINA, HDAC11, HDAC2, HDAC4, HDAC5, HDAC6, HDAC9, ITPR2, MAPK3, MCU, MEF2A, MEF2C, MEF2D, MICU1, MYH1, MYH2, MYH3, MYH4, MYH8, MYH9, MYL1, MYL4, MYL9, NFAT5, NFATC1, NFATC2, PPP3CA, PPP3CB, PPP3R1, PRKACA, PRKAR1A, PRKAR2B, RCAN1, RYR1, RYR3, SLC8A3, SLC8B1, TNNC1, TNNI1, TNNI2, TNNI3, TNNT1, TNNT2, TNNT3, Tpm1, Tpm2, TPM3, TRPC1, TRPC3		negative
Signaling by Rho Family GTPases	1.66	-0.384	0.555	ACTA1, ACTA2, ACTB, ACTC1, ARHGEF1, ARHGEF12, ARHGEF17, ARHGEF9, ARPC1B, ARPC3, ARPC4, BAIAP2, CDC42EP3, CDH10, CDH15, CDH17, CDH2, CDH23, CDH5, CFL2, CLIP1, EZR, FNBP1, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, JUN, MAP2K1, MAP2K7, MAP3K10, MAP3K20, MAPK12, MAPK3, MAPK8, MRAS, MYL1, MYL4, MYL9, MYLK, MYLPF, NFKB1, PAK4, PIK3CB, PIK3R1, PIK3R3, PIKFYVE, PRKCI, PTK2, RDX, RELA, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, ROCK1, SEPTIN11, SEPTIN7, SEPTIN8, SEPTIN9, SLC9A1, WIPF1		negative
Calcium Transport I	1.65	-0.378	0.875	ANXA5, ATP2A1, ATP2A3, ATP2B1, ATP2B3, ATP2B4, ATP2C1		negative
Inhibition of ARE-Mediated mRNA Degradation Pathway	1.64	1.234	0.569	AGO2, AGO4, AKT1, AKT2, AKT3, CNOT2, CNOT3, CNOT6, CNOT7, CNOT8, CNOT9, DDX6, EXOSC7, LTB, MAPK12, MAPK14, MAPK3, MAPK7, MAPKAPK2, NGFR, PABPN1, PAPOLA, PARN, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PRKACA, PRKAR1A, PRKAR2B, PSMA1, PSMA2, PSMA4, PSMA7, PSMB1, PSMB2, PSMB7, PSMC2, PSMC3, PSMD1, PSMD11, PSMD12, PSMD14, PSMD4, PSMD5, PSMD6, PSME1, PSME4, TIA1, TNFRSF11B, TNFRSF1B, TNFSF12, YWHAB, YWHAG, YWHAZ, ZFP36L1, ZFP36L2		positive
HOTAIR Regulatory Pathway	1.63	-0.457	0.584	AEBP2, AGO2, AGO4, AKT1, AKT2, AKT3, AR, CD44, CDKN1A, COL1A2, COL3A1, CTNNB1, ERBB2, ESR1, EZH2, H3-3A/H3-3B, HDAC2, IRF1, JARID2, KDM1A, KMT2A, KMT2C, LAMTOR5, MET, MMP14, MTF2, NFKB1, NFKBIA, PIK3CB, PIK3R1, PIK3R3, RCOR1, RELA, RHOC, ROCK1, SNAI2, SPP1, SRF, STAT3, STK38, TGFB1, TLR4, TWIST1, WNT9A, YY1		negative
Ephrin Receptor Signaling	1.61	-0.302	0.562	ABI1, ADAM10, AKT1, AKT2, AKT3, ARPC1B, ARPC3, ARPC4, ATF4, BCAR1, CFL2, CREB3L2, CRK, EFNB1, EPHA3, EPHA7, EPHB2, EPHB3, EPHB6, FGF1, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, GRIN1, GRIN2A, GRINA, HRAS, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, ITSN1, KRAS, MAP2K1, MAPK3, MRAS, NCK2, NRAS, PAK4, PDGFA, PDGFB, PDGFC, PTK2, PTPN11, RALA, RAPGEF1, RASA1, RHOA, ROCK1, RRAS, SDC2, SDCBP, SORBS1, STAT3, VEGFD, Wasl, WIPF1		negative
PAK Signaling	1.59	-1.461	0.597	ARHGAP10, CASP3, CFL2, EPHA3, EPHB3, HRAS, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, KRAS, MAP2K1, MAPK12, MAPK3, MAPK8, MRAS, MYL1, MYL4, MYL9, MYLK, MYLPF, NCK2, NRAS, PAK4, PDGFA, PDGFB, PDGFC, PDGFRA, PIK3CB, PIK3R1, PIK3R3, PTK2, RALA, RRAS		negative
ILK Signaling	1.59	-1.116	0.556	ACTA1, ACTA2, ACTB, ACTC1, ACTN2, ACTN4, AKT1, AKT2, AKT3, ATF4, CASP3, CCND1, CFL2, CREB3L2, CTNNB1, DSP, FBLIM1, FERMT2, FLNA, FLNB, FLNC, FNBP1, IRS1, IRS2, ITGB1, JUN, MAP2K6, MAPK12, MAPK3, MAPK8, MTOR, MYH1, MYH2, MYH3, MYH4, MYH8, MYH9, MYL1, MYL4, MYL9, NCK2, NFKB1, PARVA, PDGFC, PDPK1, PIK3CB, PIK3R1, PIK3R3, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PTGS2, PTK2, RELA, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, RPS6KA5, SNAI2, VCL, VEGFD		negative
Axonal Guidance Signaling	1.58	0	0.529	ABLIM1, ABLIM2, ACE, ADAM10, ADAM19, ADAM9, ADAMTS1, ADAMTS10, ADAMTS12, ADAMTS20, ADAMTS4, ADAMTS5, ADAMTS9, AKT1, AKT2, AKT3, ARHGEF12, ARPC1B, ARPC3, ARPC4, BAIAP2, BCAR1, BDNF, BMP8A, CFL2, CHP1, COPS5, CRK, EFNB1, EIF3F, EPHA3, EPHA7, EPHB2, EPHB3, EPHB6, ERBB2, FZD7, GLI3, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, HRAS, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, ITSN1, KRAS, LNPEP, MAP2K1, MAPK3, MET, MKNK1, MMP14, MRAS, MYL1, MYL4, MYL9, MYLPF, NCK2, NFAT5, NFATC1, NFATC2, NGFR, NRAS, NRP1, NRP2, NTF3, NTNG1, PAK4, PAPPA, PAPPA2, PDGFA, PDGFB, PDGFC, PDIA3, PIK3CB, PIK3R1, PIK3R3, PLCD4, PLXNB1, PPP3CA, PPP3CB, PPP3R1, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, PSMD14, PTK2, PTPN11, RALA, RASA1, RASSF5, RHOA, RND1, ROCK1, RRAS, RTN4, SDC2, SDCBP, SEMA3A, SEMA3C, SEMA3D, SEMA3F, SEMA4C, SEMA4D, SEMA6A, SEMA6D, SRGAP3, STK36, SUFU, TUBA1A, TUBB, TUBB2B, TUBB6, TUBG1, VEGFD, Wasl, WIPF1, WNT9A		no direction
JAK/STAT Signaling	1.58	-0.557	0.617	AKT1, AKT2, AKT3, CDKN1A, CISH, HRAS, IL6, JUN, KRAS, MAP2K1, MAPK3, MRAS, MTOR, NFKB1, NRAS, PIAS1, PIAS2, PIK3CB, PIK3R1, PIK3R3, PTPN11, RALA, RELA, RRAS, SOCS2, SOCS3, SOCS7, STAT3, STAT6		negative
HMGB1 Signaling	1.58	-1.508	0.575	AKT1, AKT2, AKT3, FNBP1, HAT1, HRAS, IL15, IL17F, IL1R1, IL33, IL6, JUN, KRAS, LTB, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK12, MAPK14, MAPK3, MAPK8, MRAS, NFKB1, NGFR, NRAS, PIK3CB, PIK3R1, PIK3R3, PLAT, RALA, RELA, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, RRAS, TGFB1, TGFB2, TGFB3, TLR4, TNFRSF11B, TNFRSF1B, TNFSF12, VCAM1		negative
Protein Ubiquitination Pathway	1.56	0	0.541	ANAPC2, ANAPC5, B2M, CDC23, CRYAB, CUL1, CUL2, DNAJB1, DNAJB2, DNAJB5, DNAJC12, DNAJC19, DNAJC2, DNAJC21, DNAJC28, DNAJC4, DNAJC7, DNAJC9, FBXW7, HLA-A, HSP90AA1, HSPA13, HSPA2, HSPA4L, HSPB3, HSPB6, HSPB7, HSPB8, HSPE1, HSPH1, MED20, MR1, NEDD4L, PRKN, PSMA1, PSMA2, PSMA4, PSMA7, PSMB1, PSMB2, PSMB7, PSMC2, PSMC3, PSMD1, PSMD11, PSMD12, PSMD14, PSMD4, PSMD5, PSMD6, PSME1, SMURF2, STUB1, TAP1, TRAF6, TRAP1, Ubb, UBC, UBE2A, UBE2B, UBE2D1, UBE2D2, UBE2E1, UBE2E2, UBE2H, UBE2J1, UBE2L3, UBE2M, UBE2N, UBE2Q2, UBE2V2, UBE3A, UBR1, UBR2, UCHL1, UCHL5, USP11, USP14, USP16, USP18, USP19, USP24, USP25, USP28, USP29, USP3, USP30, USP34, USP38, USP45, USP47, USP53, USP9X		no direction
Actin Nucleation by ARP-WASP Complex	1.56	-1.706	0.612	ARPC1B, ARPC3, ARPC4, BAIAP2, FNBP1, HRAS, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, KRAS, MRAS, NCK2, NRAS, RALA, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, ROCK1, RRAS, WIPF1		negative
Dilated Cardiomyopathy Signaling Pathway	1.56	0.926	0.57	ABCC9, ACTA1, ACTA2, ACTB, ACTC1, ADCY5, ADCY8, AKT1, AKT2, AKT3, BAG3, BAX, CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, CAMK2D, CAMK2G, DMD, ITPR2, KDM1A, KDM5A, LAMA4, LMNA, MAPK12, MAPK14, MAPK3, MTOR, MYH1, MYH2, MYH3, MYH4, MYH8, MYH9, MYL1, MYL4, MYL9, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PTPN11, TNNC1, TNNI1, TNNI2, TNNI3, TNNT1, TNNT2, TNNT3, TTN		positive
Cancer Drug Resistance By Drug Efflux	1.53	0	0.632	ABCB1, ABCG2, AKT1, AKT2, AKT3, FOXO1, FOXO4, HRAS, KRAS, MAP2K1, MAPK3, mir-133, MRAS, NFKB1, NRAS, PDK1, PIK3CB, PIK3R1, PIK3R3, PTGS2, RALA, RRAS, TP53, YBX1		no direction
Actin Cytoskeleton Signaling	1.49	-0.272	0.546	ACTA1, ACTA2, ACTB, ACTC1, ACTN2, ACTN4, ARHGAP24, ARHGEF1, ARHGEF12, ARPC1B, ARPC3, ARPC4, BAIAP2, BCAR1, BRK1, CD14, CFL2, CRK, CYFIP2, EZR, F2, F2R, FGF1, FGF12, FGF13, FGF16, FGF18, FGF2, FGF6, FLNA, GNA13, HRAS, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, KRAS, LBP, MAP2K1, MAPK3, MPRIP, MRAS, MYH1, MYH2, MYH3, MYH4, MYH8, MYH9, MYL1, MYL4, MYL9, MYLK, MYLK3, MYLPF, NRAS, PAK4, PDGFA, PDGFB, PDGFC, PIK3CB, PIK3R1, PIK3R3, PTK2, RALA, RDX, RHOA, ROCK1, RRAS, SLC9A1, TLN2, TRIO, TTN, VCL, WASF2		negative
IL-23 Signaling Pathway	1.47	0.775	0.682	AKT1, AKT2, AKT3, IL12RB2, IL17F, NFKB1, NFKBIA, PIK3CB, PIK3R1, PIK3R3, RELA, RORA, RUNX1, SOCS3, STAT3		positive
LXR/RXR Activation	1.47	0.928	0.59	ABCA1, ABCG1, APOE, C3, CD14, FDFT1, HADH, IL1R1, IL1RAP, IL33, IL6, IRF3, ITIH4, LBP, LDLR, LPL, MLXIPL, MYLIP, NFKB1, NGFR, NR1H2, NR1H3, NR1H4, PLTP, PTGS2, RBP4, RELA, RXRG, SCD, SERPINF1, SREBF1, TF, TLR4, TNFRSF11B, TNFRSF1B, TTR		positive
D-myo-inositol (1,4,5)-trisphosphate Degradation	1.46	-0.707	0.8	BPNT1, BPNT2, IMPA1, INPP1, INPP5A, INPP5E, INPP5K, INPPL1		negative
GM-CSF Signaling	1.46	-1.46	0.614	AKT1, AKT2, AKT3, CAMK2D, CAMK2G, CCND1, CISH, CSF2RB, ETS1, HRAS, KRAS, MAP2K1, MAPK3, MRAS, NRAS, PIK3CB, PIK3R1, PIK3R3, PIM1, PPP3CA, PPP3CB, PPP3R1, PTPN11, RALA, RRAS, RUNX1, STAT3		negative
CSDE1 Signaling Pathway	1.41	-1.528	0.629	AGO2, AGO4, AKT1, AKT2, AKT3, APAF1, CCND3, CNOT6, CSDE1, CTNNB1, CTTN, DDX6, HNRNPC, LSM14A, PABPC4, PABPN1, PAIP1, SNAI2, SYNCRIP, TGFB1, TNC, TRIO		negative
Phosphatidylglycerol Biosynthesis II (Non-plastidic)	1.4	2.887	0.706	ABHD5, AGPAT2, AGPAT3, AGPAT4, CDS2, CRLS1, GPAT3, LPGAT1, MBOAT1, MBOAT7, PGS1, PTPMT1		positive
PEDF Signaling	1.39	0	0.593	AKT1, AKT2, AKT3, BDNF, FAS, HRAS, IKBKB, IKBKG, KRAS, MAPK12, MAPK14, MAPK3, MRAS, NFKB1, NFKBIA, NFKBIB, NRAS, PIK3CB, PIK3R1, PIK3R3, PNPLA2, PPARG, RALA, RELA, RHOA, ROCK1, RRAS, SERPINF1, SRF, TP53, WASF2, ZEB1		no direction
TGF-β Signaling	1.36	-1.3	0.586	ACVR1, ACVR2A, BMPR1B, BMPR2, HRAS, INHBB, JUN, KRAS, MAP2K1, MAP2K3, MAP2K6, MAPK12, MAPK14, MAPK3, MAPK8, MRAS, NRAS, PITX2, PMEPA1, RALA, RRAS, SKI, SMAD3, SMAD4, SMURF2, TFE3, TGFB1, TGFB2, TGFB3, TGFBR2, TRAF6, VDR, ZFYVE9, ZNF423		negative
Regulation of the Epithelial-Mesenchymal Transition Pathway	1.35	0	0.553	AKT1, AKT2, AKT3, APH1B, CDH2, CTNNB1, DVL3, EGFR, EGR1, ETS1, FGF1, FGF12, FGF13, FGF16, FGF18, FGF2, FGF6, FGFR2, FGFRL1, FZD7, HRAS, KRAS, MAML1, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK3, MET, MRAS, NCSTN, NFKB1, NOTCH1, NOTCH3, NRAS, PARD6G, PIK3CB, PIK3R1, PIK3R3, PSEN1, PTPN11, RALA, RELA, RHOA, RRAS, SMAD3, SMAD4, SNAI2, STAT3, TGFB1, TGFB2, TGFB3, TGFBR2, TWIST1, WNT9A, ZEB1, ZEB2		no direction
CD40 Signaling	1.35	0	0.61	IKBKB, IKBKG, JUN, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK12, MAPK14, MAPK3, MAPK8, MAPKAPK2, NFKB1, NFKBIA, NFKBIB, PIK3CB, PIK3R1, PIK3R3, PTGS2, RELA, STAT3, TNFAIP3, TRAF2, TRAF3, TRAF6		no direction
Apelin Cardiac Fibroblast Signaling Pathway	1.34	1.732	0.684	AKT1, AKT2, AKT3, APLN, CCN2, IL6, PRKAA1, PRKAB1, PRKAB2, PRKAG3, TGFB1, TGFB2, TGFB3		positive
tRNA Charging	1.34	-2.496	0.684	DARS1, EPRS1, FARS2, HARS2, IARS1, IARS2, LARS1, NARS1, NARS2, RARS1, TARS1, TARS3, YARS1		negative
Cardiac Hypertrophy Signaling	1.33	-2.357	0.537	ADCY5, ADCY8, ADRB2, ADSS2, AKT1, CACNA1C, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, Calm1 (includes others), CHP1, EIF2B2, EIF2B4, FNBP1, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, HRAS, IL6, IL6R, IRS1, JUN, KRAS, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAP3K1, MAP3K10, MAP3K2, MAP3K5, MAPK12, MAPK14, MAPK3, MAPK8, MAPKAPK2, MAPKAPK3, MEF2A, MEF2C, MEF2D, MRAS, MTOR, MYL1, MYL4, MYL9, MYLPF, NRAS, PDIA3, PIK3CB, PIK3R1, PIK3R3, PLCD4, PPP3CA, PPP3CB, PPP3R1, PRKACA, PRKAR1A, PRKAR2B, RALA, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, ROCK1, RRAS, SRF, TGFB1, TGFB2, TGFB3, TGFBR2		negative
Neuregulin Signaling	1.33	-0.192	0.576	AKT1, AKT2, AKT3, CRK, EGFR, ERBB2, ERBB3, ERBB4, ERBIN, ERRFI1, HRAS, HSP90AA1, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, KRAS, MAP2K1, MAPK3, MRAS, MTOR, NRAS, PDPK1, PICK1, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, PSEN1, PTPN11, RALA, RNF41, RRAS, TGFA		negative
Angiopoietin Signaling	1.33	0	0.605	AKT1, AKT2, AKT3, CRK, FOXO1, GRB14, HRAS, IKBKB, IKBKG, KRAS, MRAS, NFKB1, NFKBIA, NFKBIB, NRAS, PAK4, PIK3CB, PIK3R1, PIK3R3, PTK2, PTPN11, RALA, RASA1, RELA, RRAS, TEK		no direction
Chronic Myeloid Leukemia Signaling	1.32	0	0.574	AKT1, AKT2, AKT3, CCND1, CCND3, CDKN1A, CRK, E2F6, GAB2, HDAC11, HDAC2, HDAC4, HDAC5, HDAC6, HDAC9, HRAS, IKBKB, IKBKG, KRAS, MAP2K1, MAPK3, MRAS, NFKB1, NRAS, PIK3CB, PIK3R1, PIK3R3, PTPN11, RALA, RBL2, RELA, RRAS, SMAD3, SMAD4, TGFB1, TGFB2, TGFB3, TGFBR2, TP53		no direction
Cholecystokinin/Gastrin-mediated Signaling	1.31	-0.949	0.569	BCAR1, CREM, EGFR, FNBP1, GNA13, HRAS, IL33, ITPR2, JUN, KRAS, MAP2K1, MAP2K3, MAP2K6, MAPK12, MAPK14, MAPK3, MAPK7, MAPK8, MEF2A, MEF2C, MEF2D, MRAS, NRAS, PRKCE, PRKCI, PRKCQ, PTGS2, PTK2, RALA, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, ROCK1, RRAS, SRF		negative
RHOA Signaling	1.31	-0.324	0.571	ACTA1, ACTA2, ACTB, ACTC1, ARHGAP5, ARHGAP6, ARHGEF1, ARHGEF12, ARPC1B, ARPC3, ARPC4, BAIAP2, CDC42EP3, CFL2, DLC1, EZR, GNA13, LPAR4, LPAR6, MPRIP, MYL1, MYL4, MYL9, MYLK, MYLK3, MYLPF, NRP2, PIKFYVE, PTK2, RAPGEF2, RDX, RHOA, RHPN2, ROCK1, SEMA3F, SEPTIN11, SEPTIN7, SEPTIN8, SEPTIN9, TTN		negative
Remodeling of Epithelial Adherens Junctions	1.3	-0.707	0.596	ACTA1, ACTA2, ACTB, ACTC1, ACTN2, ACTN4, ARPC1B, ARPC3, ARPC4, CBLL1, CLIP1, CTNNA1, CTNNB1, DNM1L, DNM3, HGS, MAPRE1, MAPRE3, MET, RAB5C, RALA, TUBA1A, TUBB, TUBB2B, TUBB6, TUBG1, VCL, ZYX		negative
Renal Cell Carcinoma Signaling	1.28	-0.655	0.588	AKT1, AKT2, AKT3, CRK, CUL2, EGLN3, ETS1, FH, HRAS, JUN, KRAS, MAP2K1, MAPK3, MET, MRAS, NRAS, PAK4, PDGFB, PIK3CB, PIK3R1, PIK3R3, PTPN11, RALA, RAPGEF1, RRAS, SLC2A1, TGFA, TGFB1, Ubb, UBC		negative
T Cell Receptor Signaling	1.27	-0.14	0.553	AKT1, AKT1S1, AKT2, AKT3, B2M, BCL10, Calm1 (includes others), CD3G, CD80, CHP1, CTNNB1, DUSP6, HLA-A, HRAS, IKBKB, IKBKG, ITGA3, ITGB1, JUN, KRAS, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAP3K1, MAPK12, MAPK14, MAPK3, MAPK8, MRAS, MTOR, NFAT5, NFATC1, NFATC2, NFKB1, NFKBIA, NFKBIB, NRAS, PDK1, PIK3CB, PIK3R1, PIK3R3, PPP3CA, PPP3CB, PPP3R1, PRKCQ, PTPN11, RALA, RASA1, RELA, RPTOR, RRAS		negative
Epithelial Adherens Junction Signaling	1.26	2.889	0.547	ACVR1, ACVR2A, AFDN, AKT1, AKT2, AKT3, ARHGEF17, ARPC1B, ARPC3, ARPC4, BAIAP2, BMPR2, CDH2, CFL2, CRK, CTNNA1, CTNNB1, EGFR, FER, FGF1, FRMD6, HRAS, KRAS, MET, MRAS, MYH2, MYH4, NECTIN2, NECTIN3, NOTCH1, NOTCH3, NRAS, PAK4, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PRKAA1, PRKAB1, PRKAB2, PRKAG3, RALA, RAPGEF1, RHOA, ROCK1, RRAS, SNAI2, STK3, STK4, TGFB2, TGFBR2, TNS1, VCL, YAP1, YWHAB, YWHAG, YWHAZ		positive
Molecular Mechanisms of Cancer	1.26	0	0.519	ADCY5, ADCY8, AKT1, AKT2, AKT3, APAF1, APH1B, ARHGEF1, ARHGEF12, ARHGEF17, ARHGEF9, BAK1, BAX, BCL2L11, BMP8A, BMPR1B, BMPR2, CAMK2D, CAMK2G, CASP3, CCND1, CCND3, CCNE2, CDC25A, CDK16, CDK19, CDK8, CDK9, CDKN1A, CRK, CTNNA1, CTNNB1, E2F6, FADD, FANCD2, FAS, FNBP1, FOXO1, FZD7, GAB2, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, HAT1, HDAC11, HDAC2, HDAC4, HDAC5, HDAC6, HDAC9, HIPK2, HRAS, IRS1, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, JUN, KRAS, LRP1, MAP2K1, MAP2K3, MAP2K6, MAP3K5, MAPK12, MAPK14, MAPK3, MAPK8, MRAS, NCSTN, NF1, NFKB1, NFKBIA, NFKBIB, NOTCH1, NRAS, PAK4, PIK3CB, PIK3R1, PIK3R3, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, PSEN1, PTK2, PTPN11, RALA, RAPGEF1, RASA1, RBL2, RELA, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, RRAS, SMAD3, SMAD4, STK36, SUFU, TGFB1, TGFB2, TGFB3, TGFBR2, TP53, WNT9A		no direction
BAG2 Signaling Pathway	1.25	-0.728	0.579	CASP3, CDKN1A, HSP90AA1, HSPA2, MAPK14, MAPK3, MAPKAPK2, MAPT, NFKB1, PINK1, PRKN, PSMA1, PSMA2, PSMA4, PSMA7, PSMB1, PSMB2, PSMB7, PSMC2, PSMC3, PSMD1, PSMD11, PSMD12, PSMD14, PSMD4, PSMD5, PSMD6, PSME1, PSME4, RELA, STUB1, TP53, UBE2D1		negative
Role of IL-17F in Allergic Inflammatory Airway Diseases	1.25	2.111	0.652	ATF4, CREB3L2, CXCL10, IL17F, IL17RA, IL17RC, IL6, MAP2K1, MAPK3, NFKB1, RELA, RPS6KA2, RPS6KA5, TRAF3IP2, TRAF6		positive
Role of Tissue Factor in Cancer	1.23	0	0.571	AKT1, AKT2, AKT3, ARRB1, CASP3, CCN1, CCN2, CFL2, EGFR, EGR1, F2, F2RL1, F3, GNA13, HRAS, ITGA3, ITGA6, ITGAV, ITGB1, KRAS, MAPK12, MAPK14, MAPK3, MRAS, MTOR, NRAS, P4HB, PIK3CB, PIK3R1, PIK3R3, PTPN11, RALA, RPS6KA2, RPS6KA5, RRAS, TP53		no direction
Amyloid Processing	1.23	-0.535	0.605	AKT1, AKT2, AKT3, APH1B, APP, BACE1, CAPN1, CAPN2, CAPN3, CAPN7, CAPNS1, CSNK1A1, CSNK1E, MAPK12, MAPK14, MAPK3, MAPT, NCSTN, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PSEN1		negative
IL-17A Signaling in Airway Cells	1.23	1.043	0.605	AKT1, AKT2, AKT3, IKBKB, IKBKG, IL17RA, IL17RC, IL6, MAP2K1, MAPK12, MAPK14, MAPK3, MAPK8, NFKB1, NFKBIA, NFKBIB, PIK3CB, PIK3R1, PIK3R3, RELA, STAT3, TRAF3IP2, TRAF6		positive
IL-7 Signaling Pathway	1.23	-0.229	0.605	AKT1, AKT2, AKT3, BAK1, BAX, CCND1, CCND3, CDC25A, FOXO1, FOXO4, JUN, MAPK12, MAPK14, MAPK3, MCL1, MET, NFATC1, PDPK1, PIK3CB, PIK3R1, PIK3R3, PTK2, SLC2A1		negative
PFKFB4 Signaling Pathway	1.23	-1.279	0.605	AMPD1, ATF4, CREB3L2, FBP1, FBP2, FGF2, GPI, HK2, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK3, PFKM, PRKACA, PRKAR1A, PRKAR2B, RPS6KA5, TGFB1, TGFB2, TGFB3, TKT, TP53		negative
Sumoylation Pathway	1.22	-0.707	0.569	AR, ARHGDIA, CBX4, CEBPA, ETS1, FAS, FNBP1, HDAC2, JUN, KDM1A, MAP3K5, MAPK12, MAPK8, NFKB1, NFKBIA, PCNA, PIAS1, RCOR1, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, RPA1, SENP5, SENP6, SERBP1, SMAD4, SP3, STUB1, SUMO3, TP53, ZEB1		negative
IL-9 Signaling	1.2	1	0.688	CISH, IRS1, IRS2, NFKB1, PIK3CB, PIK3R1, PIK3R3, RELA, SOCS2, SOCS3, STAT3		positive
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis	1.2	0	0.525	ADAMTS4, AKT1, AKT2, AKT3, ATF4, Calm1 (includes others), CAMK2D, CAMK2G, CCL5, CCND1, CEBPA, CEBPG, CHP1, CREB3L2, CSNK1A1, CSNK1E, CTNNB1, DAAM1, F2RL1, FGF2, FZD7, HRAS, IKBKB, IKBKG, IL15, IL16, IL17RA, IL17RC, IL1R1, IL1RAP, IL33, IL6, IL6R, IL6ST, IRAK1, IRAK2, JUN, KRAS, LRP1, LTB, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK14, MAPK3, MAPKAPK2, MRAS, MYD88, NFAT5, NFATC1, NFATC2, NFKB1, NFKBIA, NFKBIB, NGFR, NRAS, PDGFA, PDGFB, PDGFC, PDIA3, PIK3CB, PIK3R1, PIK3R3, PLCD4, PPP3CA, PPP3CB, PPP3R1, PRKCE, PRKCI, PRKCQ, RALA, RELA, RHOA, ROCK1, RRAS, SFRP1, SOCS3, STAT3, TGFB1, TLR1, TLR4, TLR5, TLR6, TNFRSF11B, TNFRSF1B, TRAF2, TRAF3, TRAF3IP2, TRAF6, VCAM1, VEGFD, WNT9A		no direction
FLT3 Signaling in Hematopoietic Progenitor Cells	1.18	-0.392	0.587	AKT1, AKT2, AKT3, ATF4, CREB3L2, EIF4EBP1, GAB2, HRAS, KRAS, MAP2K1, MAPK12, MAPK14, MAPK3, MRAS, MTOR, NRAS, PDPK1, PIK3CB, PIK3R1, PIK3R3, PTPN11, RALA, RPS6KA2, RPS6KA5, RRAS, STAT3, STAT6		negative
Kinetochore Metaphase Signaling Pathway	1.18	-0.6	0.587	ANAPC13, ANAPC2, ANAPC5, ARPP19, BOD1, CDC16, CDC23, CENPA, CENPC, CENPE, H2AX, H2AZ2, PPP1R14C, PPP1R3A, PPP1R7, PPP2R5B, Ppp2r5c, PPP2R5D, RAD21, SMC1A, SMC3, SPDL1, STAG1, STAG2, STAG3, ZW10, ZWINT		negative
IL-6 Signaling	1.18	0.146	0.551	ABCB1, AKT1, AKT2, AKT3, CD14, HRAS, HSPB3, HSPB7, IKBKB, IKBKG, IL1R1, IL1RAP, IL33, IL6, IL6R, IL6ST, JUN, KRAS, LBP, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK12, MAPK14, MAPK3, MAPK8, MAPKAPK2, MCL1, MRAS, NFKB1, NFKBIA, NFKBIB, NGFR, NRAS, PIK3CB, PIK3R1, PIK3R3, PTPN11, RALA, RELA, RRAS, SOCS3, SRF, STAT3, TNFRSF11B, TNFRSF1B, TRAF2, TRAF6		positive
Phagosome Maturation	1.18	0	0.553	ATP6AP1, ATP6AP2, ATP6V0A1, ATP6V0C, ATP6V0D1, ATP6V0E2, ATP6V1A, ATP6V1C1, ATP6V1E1, B2M, CALR, CTSD, CTSF, CTSH, CTSV, CTSZ, Dync1i2, DYNC1LI1, DYNLL1, DYNLRB1, DYNLT1, EEA1, GOSR2, GPAA1, HLA-A, LAMP1, LAMP2, MR1, NAPB, NAPG, PIKFYVE, PRDX6, RAB5C, RILP, STX16, TAP1, TUBA1A, TUBB, TUBB2B, TUBB6, TUBD1, TUBG1, VPS33A, VPS37A, VPS39, VPS41, VTI1B		no direction
SPINK1 General Cancer Pathway	1.17	0	0.621	AKT1, AKT2, AKT3, EGFR, HRAS, IL6, IL6R, KRAS, MAP2K1, MAPK3, MRAS, NRAS, PIK3CB, PIK3R1, PIK3R3, RALA, RRAS, STAT3		no direction
ID1 Signaling Pathway	1.17	-0.124	0.537	ABI1, ACVR1, ACVR2A, AKT1, AKT2, AKT3, APP, ATF3, ATF6, BAX, BHLHB9, BHLHE40, Bhlhe41, BMPR1B, BMPR2, CAV1, CCN2, CCND1, CDKN1A, CHRNB1, CHRNE, CTNNB1, EGFR, EGR1, ETS1, FGF2, FGFR2, FGFRL1, HRAS, ID1, IL6, IL6R, KRAS, LIFR, MAPK12, MAPK14, MAPK3, MRAS, NFKB1, NGFR, NRAS, PDGFC, PIK3CB, PIK3R1, PIK3R3, PLAC8, PLXNB1, PTGER4, RALA, RHOC, RRAS, SEMA4C, SMAD3, SMAD4, STAT3, TGFB1, TGFB2, TGFB3, TGFBR2, TGM2, TNFRSF11B, TNFRSF1B, TP53, VEGFD, ZNF148		negative
HIF1α Signaling	1.17	1.231	0.537	AKT1, AKT2, AKT3, CAMK2D, CAMK2G, CCNG2, CDKN1A, CHP1, COPS5, CUL2, EDN1, EGLN1, EGLN2, EGLN3, EIF4EBP1, FGF2, GPI, HIF1AN, HK2, HRAS, HSP90AA1, HSPA2, IL6, IL6R, JUN, KDM1A, KRAS, LDHA, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK3, MET, MKNK1, MKNK2, MMP14, MRAS, MTOR, NCOA1, NRAS, PDGFB, PDGFC, PIK3CB, PIK3R1, PIK3R3, PKM, PPP3CA, PPP3CB, PPP3R1, PRKCE, PRKCI, PRKCQ, RALA, RRAS, SLC2A1, SLC2A4, SLC2A5, STAT3, STUB1, TF, TGFA, TGFB1, TGFB2, TP53, VEGFD		positive
PPARα/RXRα Activation	1.17	2.101	0.537	ABCA1, ACOX1, ACVR1, ACVR2A, ADCY5, ADCY8, ADIPOR1, ADIPOR2, AP2A2, BMPR2, GHR, GOT2, GPD1, GPD2, HRAS, HSP90AA1, IKBKB, IKBKG, IL1R1, IL1RAP, IL6, INSR, IRS1, JUN, KRAS, LPL, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK14, MAPK3, MAPK8, MED1, MED12, MEF2C, MRAS, NFKB1, NFKBIA, NFKBIB, NR2C2, NR2F1, NRAS, PDIA3, PLCD4, PPARA, PPARGC1A, PRKAA1, PRKAB1, PRKAB2, PRKACA, PRKAG3, PRKAR1A, PRKAR2B, RALA, RELA, RRAS, SLC27A1, SMAD3, SMAD4, TGFB1, TGFB2, TGFB3, TGFBR2, TGS1, TRAF6		positive
Systemic Lupus Erythematosus In T Cell Signaling Pathway	1.17	0.62	0.536	AKT1, AKT1S1, AKT2, AKT3, ATF4, B2M, CASP2, CASP3, CASQ1, CD3G, CD44, CD80, CHP1, CREB3L2, CREM, ELF1, ESR1, EZR, FAS, FNBP1, GADD45A, GNA13, GNAI2, HLA-A, HRAS, IL6, JUN, KRAS, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK3, MRAS, MTOR, NFATC2, NRAS, PDK1, PIK3CB, PIK3R1, PIK3R3, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PPP3CA, PPP3CB, PPP3R1, PTK2, RALA, RDX, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, ROCK1, RPTOR, RRAS, S1PR3, STAT3, STIM1		positive
BEX2 Signaling Pathway	1.16	0.557	0.58	AKT1, AKT2, AKT3, BAK1, CCND1, CDH2, CDKN1A, CTNNB1, ERBB2, JUN, MAPK12, MAPK8, MTOR, NFKB1, NFKBIA, NGFR, PDGFC, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, RELA, SMARCB1, SPP1, STAT3, TSC1, TSC2, VEGFD		positive
B Cell Activating Factor Signaling	1.15	-2.183	0.613	IKBKB, IKBKG, JUN, MAP2K7, MAP3K1, MAPK12, MAPK14, MAPK8, NFAT5, NFATC1, NFATC2, NFKB1, NFKBIA, NFKBIB, RELA, TNFRSF13C, TRAF2, TRAF3, TRAF6		negative
CNTF Signaling	1.15	0.229	0.613	AKT1, HRAS, IL6ST, KRAS, LIFR, MAP2K1, MAPK3, MRAS, MTOR, NRAS, PIK3CB, PIK3R1, PIK3R3, PTPN11, RALA, RPS6KA2, RPS6KA5, RRAS, STAT3		positive
Role of IL-17A in Arthritis	1.15	0	0.613	CCL5, IL17RA, IL17RC, MAP2K1, MAP2K3, MAP2K6, MAPK12, MAPK14, MAPK3, MAPK8, MAPKAPK2, NFKB1, NFKBIA, NFKBIB, PIK3CB, PIK3R1, PIK3R3, PTGS2, RELA		no direction
Role of MAPK Signaling in the Pathogenesis of Influenza	1.14	0	0.571	AKT1, AKT2, AKT3, BAX, CASP3, CCL5, CXCL10, HRAS, KRAS, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAP3K5, MAPK12, MAPK14, MAPK3, MAPK8, MRAS, NRAS, PLA2G3, PLA2G4A, PLA2G4E, PLA2R1, PLAAT3, PLB1, PNPLA8, PRDX6, PTGS2, RABGEF1, RALA, RRAS		no direction
Paxillin Signaling	1.13	0.557	0.567	ACTA1, ACTA2, ACTB, ACTC1, ACTN2, ACTN4, BCAR1, CRK, HRAS, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, KRAS, MAPK12, MAPK14, MAPK8, MRAS, NCK2, NRAS, PAK4, PARVA, PIK3CB, PIK3R1, PIK3R3, PTK2, PTPN12, RALA, RRAS, TLN2, VCL		positive
Lymphotoxin β Receptor Signaling	1.13	-0.229	0.606	AKT1, AKT2, AKT3, APAF1, CASP3, IKBKB, IKBKG, LTB, MAPK3, NFKB1, NFKBIA, PDPK1, PIK3CB, PIK3R1, PIK3R3, RELA, TRAF2, TRAF3, TRAF6, VCAM1		negative
Oxytocin Signaling Pathway	1.13	-0.107	0.524	ABCC9, AKT1, AKT2, AKT3, ARRB1, ATF4, ATP2B1, ATP2B3, ATP2B4, CACNA1C, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, Calm1 (includes others), CCL5, CHP1, CREB3L2, EEF2, EGFR, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, HRAS, HSPB3, HSPB7, IL6, ITPR2, KRAS, LIPE, LPL, MAPK12, MAPK14, MAPK3, MAPK7, MAPK8, MEF2C, MFN2, MPRIP, MRAS, MYH1, MYH2, MYH3, MYH4, MYH8, MYH9, MYL1, MYL4, MYL9, MYLK, NFATC1, NFKB1, NPR3, NRAS, PIK3CB, PIK3R1, PIK3R3, PLA2G3, PLA2G4A, PLA2G4E, PNPLA2, PPARA, PPARD, PPARG, PPP3CA, PPP3CB, PPP3R1, PRKAA1, PRKAB1, PRKAB2, PRKACA, PRKAG3, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, PRKG1, PTGS2, RALA, RELA, RHOA, ROCK1, RRAS		negative
Acute Myeloid Leukemia Signaling	1.13	0.2	0.569	AKT1, AKT2, AKT3, CCND1, CEBPA, CSF2RB, EIF4EBP1, HRAS, IDH1, IDH2, IDH3B, KITLG, KRAS, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK3, MRAS, MTOR, NFKB1, NRAS, PIK3CB, PIK3R1, PIK3R3, PIM1, RALA, RARA, RELA, RRAS, RUNX1, SPI1, STAT3		positive
SAPK/JNK Signaling	1.12	-0.707	0.565	CD3G, CRK, DUSP10, DUSP8, FADD, GADD45A, GNA13, GNB1, GNB2, GNG2, HNRNPK, HRAS, IRS1, JUN, KRAS, MAP2K7, MAP3K1, MAP3K10, MAP3K2, MAP3K20, MAP3K5, MAP4K3, MAPK12, MAPK8, MAPK8IP1, MRAS, NFATC1, NRAS, PIK3CB, PIK3R1, PIK3R3, RALA, RRAS, TP53, TRAF2		negative
RAC Signaling	1.11	-0.354	0.557	ANK1, ARPC1B, ARPC3, ARPC4, BAIAP2, BRK1, CD44, CFL2, CYFIP2, HRAS, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, JUN, KRAS, MAP2K1, MAP2K7, MAP3K1, MAPK3, MAPK8, MCF2L, MRAS, NFKB1, NRAS, PAK4, PIK3CB, PIK3R1, PIK3R3, PIKFYVE, PRKCI, PTK2, RALA, RELA, RHOA, RRAS		negative
MSP-RON Signaling In Cancer Cells Pathway	1.1	0.309	0.551	ACTA2, AKT1, AKT2, AKT3, ATF4, CCND1, CREB3L2, CSF2RB, CTNNB1, EGFR, ELF1, ETS1, ETS2, FLNA, HGFAC, HRAS, ITGA6, ITGB1, JUN, KRAS, MAP2K1, MAPK3, MET, MRAS, MTOR, NFKB1, NFKBIA, NRAS, PDGFC, PIK3CB, PIK3R1, PIK3R3, PTK2, RALA, RELA, RPS6KA2, RRAS, STAT3, TRIM24, VEGFD, YWHAB, YWHAG, YWHAZ		positive
14-3-3-mediated Signaling	1.1	0.707	0.554	AKT1, AKT1S1, AKT2, AKT3, BAX, FOXO1, HRAS, JUN, KRAS, MAP2K1, MAP3K5, MAPK12, MAPK3, MAPK8, MAPT, MRAS, NRAS, PDIA3, PIK3CB, PIK3R1, PIK3R3, PLCD4, PRKCE, PRKCI, PRKCQ, RALA, RRAS, SRPK2, STRADA, TRAF2, TSC1, TSC2, TUBA1A, TUBB, TUBB2B, TUBB6, TUBG1, YAP1, YWHAB, YWHAG, YWHAZ		positive
Docosahexaenoic Acid (DHA) Signaling	1.09	0	0.636	AKT1, AKT2, AKT3, APAF1, APP, BAX, CASP3, FOXO1, PDPK1, PIK3CB, PIK3R1, PIK3R3, PNPLA2, SERPINF1		no direction
CXCR4 Signaling	1.09	-0.59	0.544	ADCY5, ADCY8, AKT1, AKT2, AKT3, BCAR1, CRK, EGR1, FNBP1, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, HRAS, ITPR2, JUN, KRAS, MAP2K1, MAPK12, MAPK3, MAPK8, MRAS, MYL1, MYL4, MYL9, MYLPF, NRAS, PAK4, PIK3CB, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, PTK2, RALA, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, ROCK1, RRAS		negative
Natural Killer Cell Signaling	1.09	0.289	0.545	AKT1, AKT2, AKT3, B2M, CFL2, COL1A2, COL3A1, COL5A3, HLA-A, HRAS, HSPA2, IL12RB2, IL15, ITGB1, KRAS, MAP2K1, MAP2K3, MAP3K1, MAP3K10, MAP3K2, MAP3K5, MAPK12, MAPK14, MAPK3, MICB, MRAS, MTOR, MYD88, NECTIN2, NFAT5, NFATC1, NFATC2, NFKB1, NRAS, PAK4, PIK3CB, PIK3R1, PIK3R3, PRKCQ, PTPN11, RALA, RASSF5, RELA, ROCK1, RRAS, TRAF6, Wasl, WIPF1		positive
PI3K Signaling in B Lymphocytes	1.09	0.302	0.547	AKT1, AKT2, AKT3, ATF3, ATF4, ATF5, ATF6, BCL10, C3, Calm1 (includes others), CAMK2D, CAMK2G, CARD10, CD81, CHP1, HRAS, IKBKB, IKBKG, IL4R, IRS1, IRS2, ITPR2, JUN, KRAS, MAP2K1, MAPK3, MRAS, NFAT5, NFATC1, NFATC2, NFKB1, NFKBIA, NFKBIB, NRAS, PDIA3, PDPK1, PIK3CB, PIK3R1, PLCD4, PPP3CA, PPP3CB, PPP3R1, PRKCI, RALA, RELA, RRAS, TLR4		positive
Netrin Signaling	1.07	-0.816	0.581	ABLIM1, ABLIM2, CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, CHP1, ENAH, ITPR2, NCK2, NFAT5, NFATC1, NFATC2, PPP3CA, PPP3CB, PPP3R1, PRKACA, PRKAR1A, PRKAR2B, PRKG1, RYR1, RYR3		negative
IL-17A Signaling in Fibroblasts	1.06	0	0.625	IKBKB, IKBKG, IL17RA, IL17RC, IL6, JUN, MAPK12, MAPK14, MAPK3, NFKB1, NFKBIA, NFKBIB, RELA, TRAF3IP2, TRAF6		no direction
Superpathway of D-myo-inositol (1,4,5)-trisphosphate Metabolism	1.06	-0.333	0.692	BPNT1, BPNT2, IMPA1, INPP1, INPP5A, INPP5E, INPP5K, INPPL1, IPMK		negative
IL-3 Signaling	1.05	0	0.571	AKT1, AKT2, AKT3, CHP1, CSF2RB, FOXO1, GAB2, HRAS, JUN, KRAS, MAP2K1, MAPK3, MRAS, NRAS, PIK3CB, PIK3R1, PIK3R3, PPP3CA, PPP3CB, PPP3R1, PRKCE, PRKCI, PRKCQ, RALA, RAPGEF1, RRAS, STAT3, STAT6		no direction
Colorectal Cancer Metastasis Signaling	1.04	-1.313	0.526	ADCY5, ADCY8, AKT1, AKT2, AKT3, ARRB1, BAX, CASP3, CCND1, CTNNB1, EGFR, FNBP1, FZD7, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, HRAS, IL6, IL6R, IL6ST, JUN, KRAS, LRP1, MAP2K1, MAPK12, MAPK3, MAPK8, MMP14, MRAS, MSH6, NFKB1, NRAS, PDGFC, PIK3CB, PIK3R1, PIK3R3, PRKACA, PRKAR1A, PRKAR2B, PTGER3, PTGER4, PTGS2, RALA, RELA, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, RRAS, SMAD3, SMAD4, STAT3, TGFB1, TGFB2, TGFB3, TGFBR2, TLR1, TLR4, TLR5, TLR6, TP53, VEGFD, WNT9A		negative
TR/RXR Activation	1.04	0	0.569	AKT1, AKT2, AKT3, ATP2A1, COL6A3, DIO2, GPS2, HP, KLF9, LDLR, MED1, MTOR, NCOA1, PIK3CB, PIK3R1, PIK3R3, PPARGC1A, RXRG, SLC16A2, SLC16A3, SLC2A1, SREBF1, STRBP, SYT12, TBL1XR1, THRA, THRB, UCP2, UCP3		no direction
RANK Signaling in Osteoclasts	1.03	-1.095	0.559	AKT1, AKT2, AKT3, Calm1 (includes others), CHP1, IKBKB, IKBKG, JUN, MAP2K1, MAP2K6, MAP2K7, MAP3K1, MAP3K10, MAP3K2, MAP3K5, MAPK12, MAPK14, MAPK3, MAPK8, NFATC1, NFATC2, NFKB1, NFKBIA, NFKBIB, PIK3CB, PIK3R1, PIK3R3, PPP3CA, PPP3CB, PPP3R1, RELA, TRAF2, TRAF6		negative
CDP-diacylglycerol Biosynthesis I	1.02	2.53	0.667	ABHD5, AGPAT2, AGPAT3, AGPAT4, CDS2, CRLS1, GPAT3, LPGAT1, MBOAT1, MBOAT7		positive
NAD Signaling Pathway	1.01	0.617	0.542	ACADM, AKT1, AKT2, AKT3, ARNTL, DXO, FGF2, H1-0, H1-2, IDH2, LDHA, NADSYN1, NAMPT, NFKB1, NMRK2, NUDT12, PARP4, PARP9, PDGFB, PIK3CB, PIK3R1, PIK3R3, POLR2E, POLR2I, POLR2J, PPARGC1A, PRKAA1, PRKAB1, PRKAB2, PRKAG3, RYR1, RYR3, SIRT2, SIRT5, SIRT6, SLC29A1, SLC29A3, SLC7A5, SREBF1, TGFA, TGFB1, TGFB2, TIPARP, TNKS, TP53		positive
TEC Kinase Signaling	1.01	0	0.539	ACTA1, ACTA2, ACTB, ACTC1, CD3G, FADD, FAS, FNBP1, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, GTF2I, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, MAPK12, MAPK8, MRAS, NFKB1, PAK4, PIK3CB, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, PTK2, RELA, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, STAT3, STAT6, TLR4, TNFSF12		no direction
Systemic Lupus Erythematosus Signaling	1.01	0	0.538	AKT1, AKT2, AKT3, BDKRB2, CD2BP2, CD3G, CD72, CD80, CREM, EFTUD2, HLA-A, HNRNPA2B1, HNRNPC, HRAS, IL33, IL6, IL6R, JUN, KRAS, LSM14A, LSM8, MAPK3, MRAS, MTOR, NFAT5, NFATC1, NFATC2, NRAS, PIK3CB, PIK3R1, PIK3R3, PRPF18, PRPF19, PRPF38A, PRPF4B, PRPF6, RALA, RRAS, SART1, SF3B4, SNRNP27, SNRNP48, SNRPD1, SNRPD3, SNRPN, TNFRSF13C, TXNL4A, ZCRB1, ZMAT5		no direction
April Mediated Signaling	1.01	-2.357	0.6	IKBKB, IKBKG, JUN, MAP2K7, MAP3K1, MAPK12, MAPK14, MAPK8, NFAT5, NFATC1, NFATC2, NFKB1, NFKBIA, NFKBIB, RELA, TRAF2, TRAF3, TRAF6		negative
Role of PI3K/AKT Signaling in the Pathogenesis of Influenza	1.01	1.291	0.6	AKT1, AKT2, AKT3, CCL5, CRK, GNAI2, IRF3, KPNA3, MAP2K1, MAPK3, NFKB1, NFKBIA, NFKBIB, PIK3CB, PIK3R1, PIK3R3, PLAC8, RELA		positive
Endocannabinoid Developing Neuron Pathway	1.01	-0.822	0.545	ADCY5, ADCY8, AKT1, AKT1S1, AKT2, AKT3, ATF4, CCND1, CNR1, CREB3L2, CTNNB1, GNAI2, GNAL, GNB1, GNB2, GNG2, HRAS, KRAS, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK12, MAPK14, MAPK3, MAPK7, MAPK8, MGLL, MRAS, MTOR, NRAS, PIK3CB, PIK3R1, PIK3R3, PRKACA, PRKAR1A, PRKAR2B, RALA, RHOA, RPTOR, RRAS, STAT3		negative
IGF-1 Signaling	1.01	-1.257	0.545	AKT1, AKT2, AKT3, CCN1, CCN2, FOXO1, HRAS, IGFBP2, IGFBP4, IGFBP5, IGFBP6, IGFBP7, IRS1, IRS2, JUN, KRAS, MAP2K1, MAPK3, MAPK8, MRAS, NRAS, PDPK1, PIK3CB, PIK3R1, PIK3R3, PRKACA, PRKAR1A, PRKAR2B, PRKCI, PTK2, PTPN11, RALA, RASA1, RRAS, SOCS2, SOCS3, SOCS7, SRF, STAT3, YWHAB, YWHAG, YWHAZ		negative
PPAR Signaling	1.01	-0.48	0.548	HRAS, HSP90AA1, IKBKB, IKBKG, IL1R1, IL1RAP, IL33, INSR, JUN, KRAS, MAP2K1, MAPK3, MED1, MRAS, NCOA1, NFKB1, NFKBIA, NFKBIB, NGFR, NR1H3, NR2F1, NRAS, PDGFA, PDGFB, PDGFC, PDGFRA, PPARA, PPARD, PPARG, PPARGC1A, PTGS2, RALA, RELA, RRAS, SNW1, SRA1, TNFRSF11B, TNFRSF1B, TRAF2, TRAF6		negative
2-ketoglutarate Dehydrogenase Complex	0.996	0	1	DLD, DLST, OGDH		no direction
Citrulline Biosynthesis	0.996	0	1	GLS, LOC102724788/PRODH, OAT		no direction
Heme Biosynthesis from Uroporphyrinogen-III I	0.996	0	1	CPOX, FECH, UROD		no direction
Melatonin Degradation II	0.996	0	1	MAOA, MAOB, SMOX		no direction
Oxidized GTP and dGTP Detoxification	0.996	0	1	DDX6, DXO, RUVBL2		no direction
Phosphatidylcholine Biosynthesis I	0.996	0	1	CHKA, PCYT1A, PHKA1		no direction
Protein Kinase A Signaling	0.983	0	0.509	ADCY5, ADCY8, ADD1, ADD2, ADD3, AKAP1, AKAP11, AKAP13, AKAP6, ANAPC13, ANAPC2, ANAPC5, ATF4, Calm1 (includes others), CAMK2D, CAMK2G, CDC14B, CDC16, CDC23, CDC25A, CHP1, CREB3L2, CREM, CTNNB1, DUSP1, DUSP10, DUSP16, DUSP18, DUSP2, DUSP6, DUSP8, EPM2A, FLNA, FLNB, FLNC, GLI3, GNA13, GNAI2, GNB1, GNB2, GNG2, GYS1, H1-0, H1-2, H3-3A/H3-3B, ITPR2, LIPE, MAP2K1, MAP3K1, MAPK3, MYH2, MYH4, MYL1, MYL4, MYL9, MYLK, MYLK3, MYLPF, NFAT5, NFATC1, NFATC2, NFKB1, NFKBIA, NFKBIB, NGFR, PDE1C, PDE7A, PDE7B, PDE8A, PDIA3, PHKA2, PHKB, PHKG1, PLCD4, PPP1R14C, PPP1R3A, PPP1R7, PPP2CA, PPP3CA, PPP3CB, PPP3R1, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, PTGS2, PTK2, PTPN11, PTPN12, PTPN14, PTPN21, PTPRB, PTPRE, PYGM, RELA, RHOA, ROCK1, RYR1, RYR3, SIRPA, SMAD3, SMAD4, TGFB1, TGFB2, TGFB3, TGFBR2, TNNI1, TNNI2, TNNI3, TNS2, TTN, UBASH3B, YWHAB, YWHAG, YWHAZ		no direction
Phenylalanine Degradation IV (Mammalian, via Side Chain)	0.983	-1.633	0.75	AASDH, ALDH3A2, GOT2, MAOA, MAOB, SMOX		negative
Putrescine Degradation III	0.983	0	0.75	ALDH1A1, ALDH3A2, Aldh3b2, MAOA, MAOB, SMOX		no direction
Endoplasmic Reticulum Stress Pathway	0.982	0	0.647	ATF4, ATF6, CALR, CASP3, DDIT3, MAP3K5, MAPK8, MBTPS1, TAOK3, TRAF2, XBP1		no direction
Th17 Activation Pathway	0.968	1.342	0.579	CD3G, HSP90AA1, IL12RB2, IL17F, IL1R1, IL6, IL6R, IRAK1, IRAK2, MTOR, MYD88, NFAT5, NFATC1, NFATC2, NFKB1, PTGER4, RELA, RORA, RUNX1, SOCS3, STAT3, TRAF6		positive
Macropinocytosis Signaling	0.961	-0.258	0.575	ABI1, ACTN4, CD14, HRAS, ITGB1, KRAS, MET, MRAS, MRC1, NRAS, PDGFA, PDGFB, PDGFC, PIK3CB, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, RAB34, RALA, RHOA, RRAS		negative
Thrombin Signaling	0.952	-0.577	0.525	ADCY5, ADCY8, AKT1, AKT2, AKT3, ARHGEF1, ARHGEF10L, ARHGEF12, ARHGEF17, ARHGEF9, CAMK2D, CAMK2G, EGFR, F2, F2R, FNBP1, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, HRAS, IKBKB, ITPR2, KRAS, MAP2K1, MAPK12, MAPK14, MAPK3, MPRIP, MRAS, MYL1, MYL4, MYL9, MYLK, MYLPF, NFKB1, NRAS, PDIA3, PDPK1, PIK3CB, PIK3R1, PIK3R3, PLCD4, PRKCE, PRKCI, PRKCQ, PTK2, RALA, RELA, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, ROCK1, RRAS		negative
IL-13 Signaling Pathway	0.935	0.186	0.558	AKT1, AKT2, AKT3, CTNNB1, DUSP1, IL17RA, IL17RC, IL33, IL4R, JUN, MAOA, MAPK12, MAPK14, MAPK3, MTOR, PDGFA, PIK3CB, PIK3R1, PIK3R3, RHOA, ROCK1, SOCS3, STAT3, STAT6, TGFB1, TGFB2, TGFB3, TP53, TRAF6		positive
Tumor Microenvironment Pathway	0.932	0.429	0.532	AKT1, AKT2, AKT3, CCND1, CD274, CD44, COL1A2, COL3A1, FAS, FGF1, FGF12, FGF13, FGF16, FGF18, FGF2, FGF6, FOXO1, FOXO4, HLA-A, HRAS, IL6, IL6R, JUN, KRAS, MAP2K1, MAPK3, MMP14, MRAS, NFKB1, NRAS, PDGFA, PDGFB, PDGFC, PIK3CB, PIK3R1, PIK3R3, PTGS2, RALA, RELA, RRAS, SLC16A1, SLC2A1, SLC2A4, SPP1, STAT3, TGFB1, TGFB2, TGFB3, TNC, VEGFD		positive
PTEN Signaling	0.93	1.265	0.533	AKT1, AKT2, AKT3, BCAR1, BCL2L11, BMPR1B, BMPR2, CASP3, CCND1, CDKN1A, CNKSR3, EGFR, FGFR2, FOXO1, FOXO4, GHR, HRAS, IKBKB, IKBKG, INPP5K, INPPL1, INSR, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, KRAS, MAP2K1, MAPK3, MAST2, MRAS, NFKB1, NGFR, NRAS, PDGFRA, PDPK1, PIK3CB, PIK3R1, PIK3R3, PTK2, RALA, RELA, RRAS, SIRT6, TGFBR2		positive
LPS-stimulated MAPK Signaling	0.93	0.186	0.554	CD14, HRAS, IKBKB, IKBKG, JUN, KRAS, LBP, MAP2K1, MAP2K3, MAP2K6, MAP3K5, MAPK12, MAPK14, MAPK3, MAPK8, MRAS, NFKB1, NFKBIA, NFKBIB, NRAS, PIK3CB, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, RALA, RELA, RRAS, SRF, TLR4		positive
Apelin Endothelial Signaling Pathway	0.927	0.156	0.535	ADCY5, ADCY8, AKT1, AKT2, AKT3, APLN, Calm1 (includes others), GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, HDAC4, HDAC5, HRAS, JUN, KLF2, KRAS, MAP2K1, MAPK12, MAPK3, MAPK8, MEF2A, MEF2C, MEF2D, MRAS, MTOR, NFKB1, NRAS, PIK3CB, PIK3R1, PIK3R3, PRKAA1, PRKAB1, PRKAB2, PRKAG3, PRKCE, PRKCI, PRKCQ, RALA, RELA, RRAS, SMAD3, TEK, VCAM1		positive
Glioblastoma Multiforme Signaling	0.927	-0.469	0.535	AKT1, AKT2, AKT3, CCND1, CCND3, CCNE2, CDKN1A, CTNNB1, E2F6, EGFR, FNBP1, FOXO1, FZD7, HRAS, ITPR2, KRAS, MAP2K1, MAPK3, MRAS, MTOR, NF1, NRAS, PDGFA, PDGFB, PDGFC, PDGFRA, PDIA3, PIK3CB, PIK3R1, PIK3R3, PLCD4, RALA, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, RRAS, TP53, TSC1, TSC2, WNT9A		negative
T Cell Exhaustion Signaling Pathway	0.927	0	0.535	ACVR1, ACVR2A, AKT1, AKT2, AKT3, BMPR2, CD274, CD3G, CD80, EOMES, FOXO1, HLA-A, HRAS, IFNAR2, IL12RB2, IL6, IL6R, JUN, KRAS, MAPK12, MAPK3, MAPK8, MRAS, MTOR, NFAT5, NFATC1, NFATC2, NRAS, PDK1, PIK3CB, PIK3R1, PIK3R3, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PRDM1, PRKCQ, PTPN11, RALA, RRAS, SMAD3, STAT3, TGFB1, TGFBR2		no direction
NGF Signaling	0.924	-1.48	0.542	AKT1, AKT2, AKT3, ATF4, BAX, CREB3L2, CRK, HRAS, IKBKB, IKBKG, KRAS, MAP2K1, MAP3K1, MAP3K10, MAP3K2, MAP3K5, MAPK12, MAPK3, MAPK7, MAPK8, MRAS, NFKB1, NGFR, NRAS, PDPK1, PIK3CB, PIK3R1, PIK3R3, PTPN11, RALA, RELA, RHOA, ROCK1, RPS6KA2, RPS6KA5, RRAS, TP53, TRAF6, TRIO		negative
Pancreatic Adenocarcinoma Signaling	0.924	-0.2	0.541	AKT1, AKT2, AKT3, CCND1, CCNE2, CDKN1A, E2F6, EGFR, ERBB2, HDAC11, HDAC2, HDAC4, HDAC5, HDAC6, HDAC9, KRAS, MAP2K1, MAPK12, MAPK3, MAPK8, NFKB1, NOTCH1, PDGFC, PIK3CB, PIK3R1, PIK3R3, PTGS2, RALA, RBL2, RELA, SMAD3, SMAD4, STAT3, TGFA, TGFB1, TGFB2, TGFB3, TGFBR2, TP53, VEGFD		negative
AMPK Signaling	0.921	-1.155	0.517	ACACB, ACTB, ADRB2, AK2, AK3, AKT1, AKT1S1, AKT2, AKT3, ARID1A, ARID2, ATF4, CAB39, CCND1, CDKN1A, CHRNB1, CHRNE, CKM, CPT1A, CREB3L2, EEF2, EIF4EBP1, EPM2A, FOXO1, FOXO4, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, GYS1, INSR, IRS1, IRS2, LIPE, MAP2K3, MAPK12, MAPK14, MRAS, MTOR, PFKM, PIK3CB, PIK3R1, PIK3R3, PPARGC1A, PPM1A, PPM1B, PPM1F, PPM1G, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PRKAA1, PRKAB1, PRKAB2, PRKACA, PRKAG3, PRKAR1A, PRKAR2B, RAB1A, RAB6A, RPTOR, SLC2A1, SLC2A4, SMARCA2, SMARCB1, SMARCD2, SMARCD3, STIM1, STRADA, TSC1, TSC2, ULK1		negative
Role of NFAT in Cardiac Hypertrophy	0.903	-0.896	0.519	ADCY5, ADCY8, AKT1, AKT2, AKT3, CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, Calm1 (includes others), CAMK2D, CAMK2G, CHP1, CSNK1A1, CTF1, GNAI2, GNB1, GNB2, GNG2, HDAC11, HDAC2, HDAC4, HDAC5, HDAC6, HDAC9, HRAS, IL6, IL6ST, ITPR2, KRAS, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAP3K1, MAPK12, MAPK14, MAPK3, MAPK8, MEF2A, MEF2C, MEF2D, MRAS, NRAS, PDIA3, PIK3CB, PIK3R1, PIK3R3, PLCD4, PPP3CA, PPP3CB, PPP3R1, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, RALA, RCAN1, RRAS, SLC8A3, TGFB1, TGFB2, TGFB3, TGFBR2		negative
LPS/IL-1 Mediated Inhibition of RXR Function	0.888	-1.461	0.521	ABCA1, ABCB1, ABCC3, ABCC4, ABCG1, ACOX1, ACSL1, ACSL3, ACSL5, ACSL6, ALDH1A1, ALDH1L1, ALDH3A2, APOE, CD14, CHST10, CHST3, CPT1A, CRAT, CYP2U1, FMO1, GSTM1, GSTM3, GSTM5, GSTO1, HS2ST1, HS3ST3A1, HS3ST5, HS6ST1, IL1R1, IL1RAP, IL33, IRAK1, JUN, LBP, MAOA, MAOB, MAP2K7, MAP3K1, MAPK8, MGST3, MYD88, NCOA1, NDST1, NDST4, NGFR, NR1H2, NR1H3, NR1H4, PLTP, PPARA, PPARGC1A, RARA, SLC27A1, SMOX, SOD3, SREBF1, TLR4, TNFRSF11B, TNFRSF1B, TRAF2, TRAF6, XPO1		negative
nNOS Signaling in Neurons	0.879	0	0.586	Calm1 (includes others), CAPN1, CAPN2, CAPN3, CAPN7, CAPNS1, CHP1, GRIN1, GRIN2A, GRINA, PFKM, PPP3CA, PPP3CB, PPP3R1, PRKCE, PRKCI, PRKCQ		no direction
Inhibition of Matrix Metalloproteases	0.872	0.816	0.667	ADAM10, LRP1, MMP14, SDC2, TFPI2, THBS2, TIMP2, TIMP3		positive
Maturity Onset Diabetes of Young (MODY) Signaling	0.871	0	0.581	ABCC8, ABCC9, ALDOB, APOE, APOL6, CACNA1C, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, CEL, GAPDH, INSR, KLF11, NFKB1, OGDH, UCP2		no direction
Endometrial Cancer Signaling	0.858	-0.943	0.571	AKT1, AKT2, AKT3, CCND1, CTNNA1, CTNNB1, ERBB2, HRAS, KRAS, MAP2K1, MAPK3, MRAS, NRAS, PDPK1, PIK3CB, PIK3R1, PIK3R3, RALA, RRAS, TP53		negative
Insulin Receptor Signaling	0.853	0	0.528	AKT1, AKT2, AKT3, CRK, EIF2B2, EIF2B4, EIF4EBP1, EPM2A, FOXO1, FOXO4, GYS1, HRAS, INPP5K, INPPL1, INSR, IRS1, IRS2, KRAS, LIPE, MAP2K1, MAPK3, MAPK8, MRAS, MTOR, NRAS, PDPK1, PIK3CB, PIK3R1, PIK3R3, PPP1R14C, PPP1R3A, PPP1R7, PRKACA, PRKAR1A, PRKAR2B, PRKCI, PTPN11, RALA, RAPGEF1, RHOQ, RPTOR, RRAS, SLC2A4, SOCS3, TRIP10, TSC1, TSC2		no direction
EGF Signaling	0.853	-0.218	0.568	AKT1, AKT2, AKT3, EGFR, HRAS, ITPR2, JUN, MAP2K1, MAP2K7, MAP3K1, MAPK12, MAPK14, MAPK3, MAPK8, MTOR, PIK3CB, PIK3R1, PIK3R3, RASA1, SRF, STAT3		negative
PKCθ Signaling in T Lymphocytes	0.848	-0.667	0.53	BCL10, CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, CAMK2D, CAMK2G, CD3G, CD80, CHP1, HLA-A, HRAS, IKBKB, IKBKG, ITPR2, JUN, KRAS, MAP3K1, MAP3K10, MAP3K2, MAP3K5, MAPK3, MAPK8, MRAS, NFAT5, NFATC1, NFATC2, NFKB1, NFKBIA, NFKBIB, NRAS, PIK3CB, PIK3R1, PIK3R3, PPP3CA, PPP3CB, PPP3R1, PRKCQ, RALA, RELA, RRAS		negative
GADD45 Signaling	0.843	-2.041	0.558	ACVR1, ACVR2A, CCND1, CCND3, CCNE2, CDKN1A, GADD45A, GADD45G, MAP2K3, MAP2K6, MAP2K7, MAPK12, MAPK14, MAPK8, NFKB1, PCNA, RELA, SMAD3, SMAD4, TGFB1, TGFB2, TGFB3, TGFBR2, TP53		negative
Apoptosis Signaling	0.84	0	0.535	APAF1, BAK1, BAX, BCL2L11, CAPN1, CAPN2, CAPN3, CAPN7, CAPNS1, CASP2, CASP3, DFFA, FAS, HRAS, IKBKB, IKBKG, KRAS, LMNA, MAP2K1, MAP2K7, MAP3K5, MAPK3, MAPK8, MCL1, MRAS, NFKB1, NFKBIA, NFKBIB, NRAS, PRKCE, PRKCQ, RALA, RELA, ROCK1, RRAS, SPTAN1, TNFRSF1B, TP53		no direction
Thyroid Cancer Signaling	0.838	-0.192	0.551	AKT1, AKT2, AKT3, BDNF, CCND1, CTNNB1, FOXO1, HRAS, INSR, IRS1, IRS2, JUN, KRAS, MAP2K1, MAPK3, MRAS, MTOR, NRAS, NTF3, PDK1, PIK3CB, PIK3R1, PIK3R3, RALA, RET, RRAS, TP53		negative
Agrin Interactions at Neuromuscular Junction	0.837	-1.633	0.549	ACTA1, ACTA2, ACTB, ACTC1, CTTN, DAG1, EGFR, ERBB2, ERBB3, ERBB4, GABPA, HRAS, ITGB1, JUN, KRAS, LAMA2, LAMB1, MAPK12, MAPK3, MAPK8, MRAS, MUSK, NRAS, PAK4, PTK2, RALA, RAPSN, RRAS		negative
Hypoxia Signaling in the Cardiovascular System	0.837	0.302	0.549	AKT1, ATF4, COPS5, CREB3L2, EDN1, HIF1AN, HSP90AA1, JUN, LDHA, NFKBIA, NFKBIB, NQO1, P4HB, SLC2A4, TP53, UBE2A, UBE2B, UBE2D1, UBE2D2, UBE2E1, UBE2E2, UBE2H, UBE2J1, UBE2L3, UBE2M, UBE2N, UBE2Q2, UBE2V2		positive
Role of MAPK Signaling in Inhibiting the Pathogenesis of Influenza	0.836	0.557	0.545	BAX, CASP3, CCL5, CXCL10, EIF2AK2, IL6, JUN, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAP3K5, MAPK12, MAPK14, MAPK3, MAPK8, MYD88, NFKB1, NFKBIA, NFKBIB, PLA2G3, PLA2G4A, PLA2G4E, PLA2R1, PLAAT3, PLB1, PNPLA8, PRDX6, PTGS2, TLR4		positive
Non-Small Cell Lung Cancer Signaling	0.836	-1.279	0.541	AKT1, AKT2, AKT3, CCND1, CCND3, E2F6, EGFR, ERBB2, HDAC11, HDAC2, HDAC4, HDAC5, HDAC6, HDAC9, HRAS, ITPR2, KRAS, MAP2K1, MAPK3, MRAS, NRAS, PDPK1, PIK3CB, PIK3R1, PIK3R3, RALA, RASSF5, RBL2, RRAS, RXRG, STK4, TGFA, TP53		negative
Wound Healing Signaling Pathway	0.832	-0.372	0.516	ACTA2, ACVR1, ACVR2A, BMPR2, CCL5, COL1A2, COL20A1, COL3A1, COL4A1, COL4A2, COL5A2, COL5A3, COL6A3, COL7A1, EGFR, F2, FGF2, FGFR2, HRAS, IKBKB, IL15, IL17F, IL1R1, IL1RAP, IL33, IL6, ITGA3, ITGA6, ITGB1, JUN, KRAS, LAMA2, LAMA5, LAMB1, LTB, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK12, MAPK3, MAPK8, MRAS, NFKB1, NFKBIA, NFKBIB, NGFR, NRAS, PDGFA, PDGFB, PDGFC, RALA, RRAS, SNAI2, TGFA, TGFB1, TGFB2, TGFB3, TGFBR2, TNFRSF11B, TNFRSF1B, TNFSF12, TRAF2, TRAF6, VEGFD		negative
Inositol Pyrophosphates Biosynthesis	0.831	1	0.8	IP6K1, IP6K3, IPMK, PPIP5K1		positive
γ-glutamyl Cycle	0.831	0	0.8	CHAC2, GGT5, GSS, OPLAH		no direction
Tight Junction Signaling	0.821	0	0.517	ACTA1, ACTA2, ACTB, ACTC1, AFDN, AKT1, AKT2, AKT3, CEBPA, CNKSR3, CSTF2, CTNNA1, CTNNB1, EPB41, F11R, GOSR2, GPAA1, JUN, MARK2, MPDZ, MYH1, MYH2, MYH3, MYH4, MYH8, MYH9, MYL1, MYL4, MYL9, MYLK, NAPB, NAPG, NECTIN2, NECTIN3, NFKB1, NGFR, NUDT21, PALS1, PATJ, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PRKACA, PRKAR1A, PRKAR2B, PRKCI, RELA, RHOA, SAFB, SPTAN1, STX16, TGFB1, TGFB2, TGFB3, TGFBR2, TNFRSF11B, TNFRSF1B, VCL, VTI1B		no direction
IL-8 Signaling	0.818	-0.544	0.517	AKT1, AKT2, AKT3, BAX, CCND1, CCND3, EGFR, EIF4EBP1, FNBP1, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, HRAS, IKBKB, IKBKG, IRAK1, IRAK2, ITGAV, JUN, KRAS, MAP2K1, MAPK12, MAPK3, MAPK8, MRAS, MTOR, MYL9, NFKB1, NFKBIA, NFKBIB, NRAS, PDGFC, PIK3CB, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, PTGS2, PTK2, RALA, RELA, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, ROCK1, RRAS, TEK, TRAF6, VCAM1, VEGFD		negative
Hepatic Fibrosis / Hepatic Stellate Cell Activation	0.815	0	0.518	ACTA2, BAX, CCL5, CCN2, CD14, COL1A2, COL20A1, COL3A1, COL4A1, COL4A2, COL5A2, COL5A3, COL6A3, COL7A1, EDN1, EGFR, FAS, FGF1, FGF2, FGFR2, IFNAR2, IGFBP4, IGFBP5, IL1R1, IL1RAP, IL4R, IL6, IL6R, LBP, MET, MYH1, MYH2, MYH3, MYH4, MYH8, MYH9, MYL1, MYL4, MYL9, NFKB1, NGFR, PDGFA, PDGFB, PDGFC, PDGFRA, RELA, SMAD3, SMAD4, TGFA, TGFB1, TGFB2, TGFB3, TGFBR2, TIMP2, TLR4, TNFRSF11B, TNFRSF1B, VCAM1, VEGFD		no direction
DNA Methylation and Transcriptional Repression Signaling	0.801	0	0.611	GATAD2A, H3-3A/H3-3B, H4C3, H4C9, HDAC2, MECP2, MTA1, MTA2, MTA3, SAP30, SUDS3		no direction
Role of JAK family kinases in IL-6-type Cytokine Signaling	0.801	0	0.611	IL6, IL6R, IL6ST, MAPK12, MAPK14, MAPK3, MAPK8, OSMR, PTPN11, SOCS3, STAT3		no direction
IL-17A Signaling in Gastric Cells	0.787	0.333	0.6	CCL5, CXCL10, EGFR, IL17RA, IL17RC, JUN, MAPK12, MAPK14, MAPK3, MAPK8, NFKB1, RELA		positive
Role of RIG1-like Receptors in Antiviral Innate Immunity	0.787	0.632	0.6	DDX58, FADD, IKBKB, IKBKG, IRF3, NFKB1, NFKBIA, NFKBIB, RELA, TRAF2, TRAF3, TRAF6		positive
Ephrin A Signaling	0.777	0	0.591	ADAM10, BCAR1, CFL2, EPHA3, EPHA7, NGFR, PIK3CB, PIK3R1, PIK3R3, PTK2, PTPN11, RHOA, ROCK1		no direction
Fatty Acid β-oxidation I	0.777	0.277	0.591	ACAA2, ACADM, ACSL1, ACSL3, ACSL5, ACSL6, ECI1, ECI2, HADH, HADHA, HSD17B4, SCP2, SLC27A1		positive
RAR Activation	0.774	0	0.512	ACTB, ADCY5, ADCY8, Akr1b10, AKR1B10, AKT1, AKT2, AKT3, ALDH1A1, ARID1A, ARID2, CARM1, CCNH, CSF2RB, DHRS3, DHRS4, DUSP1, GTF2H2, GTF2H5, JUN, MAP2K1, MAP3K1, MAP3K5, MAPK12, MAPK14, MAPK8, MAPKAPK2, MED1, NCOA1, NFKB1, NR2F1, NR2F2, PDPK1, PIK3CB, PIK3R1, PIK3R3, PNRC1, PPARGC1A, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, RARA, RARG, RBP3, RBP4, RDH16, RDH5, RELA, RXRG, SMAD3, SMAD4, SMARCA2, SMARCB1, SMARCD2, SMARCD3, SNW1, SORBS3, SRA1, TGFB1, TGFB2, TGFB3, TRIM24		no direction
p38 MAPK Signaling	0.771	0.493	0.525	ATF4, CREB3L2, DDIT3, DUSP1, DUSP10, FADD, FAS, H3-3A/H3-3B, HSPB3, HSPB7, IL1R1, IL1RAP, IL33, IRAK1, IRAK2, MAP2K3, MAP2K6, MAP3K5, MAPK12, MAPK14, MAPKAPK2, MAPKAPK3, MAPT, MEF2A, MEF2C, MEF2D, MKNK1, MKNK2, PLA2G3, PLA2G4A, PLA2G4E, RPS6KA2, RPS6KA5, SRF, TGFB1, TGFB2, TGFB3, TGFBR2, TNFRSF1B, TP53, TRAF2, TRAF6		positive
IL-17 Signaling	0.769	0.469	0.526	AKT1, AKT2, AKT3, HRAS, HSP90AA1, IL15, IL17F, IL17RA, IL17RC, IL17RE, IL33, IL6, JUN, KRAS, LTB, MAP2K3, MAP2K6, MAPK12, MAPK14, MAPK3, MAPK8, MRAS, NFKB1, NRAS, PDGFC, PIK3CB, PIK3R1, PIK3R3, PTGS2, RALA, RELA, RRAS, TGFB1, TGFB2, TGFB3, TNFRSF11B, TNFSF12, TRAF2, TRAF3IP2, TRAF6, VEGFD		positive
Role of MAPK Signaling in Promoting the Pathogenesis of Influenza	0.766	0	0.526	ATP6AP1, ATP6AP2, ATP6V0A1, ATP6V0C, ATP6V0D1, ATP6V0E2, ATP6V1A, ATP6V1C1, ATP6V1E1, BAX, CASP3, HRAS, JUN, KRAS, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAP3K5, MAPK12, MAPK14, MAPK3, MAPK8, MRAS, NFKB1, NFKBIA, NFKBIB, NRAS, PLA2G3, PLA2G4A, PLA2G4E, PLA2R1, PLAAT3, PLB1, PNPLA8, PRDX6, PTGS2, RABGEF1, RALA, RRAS		no direction
Prostate Cancer Signaling	0.762	0	0.528	AKT1, AKT2, AKT3, AR, ATF4, CCND1, CCNE2, CDKN1A, CREB3L2, CTNNB1, E2F6, FOXO1, HDAC11, HDAC2, HDAC4, HDAC5, HDAC6, HDAC9, HRAS, HSP90AA1, KRAS, MAP2K1, MAPK3, MRAS, MTOR, NFKB1, NFKBIA, NFKBIB, NRAS, PDPK1, PIK3CB, PIK3R1, PIK3R3, RALA, RBL2, RELA, RRAS, TP53		no direction
Sertoli Cell-Sertoli Cell Junction Signaling	0.761	0	0.513	ACTA1, ACTA2, ACTB, ACTC1, ACTN2, ACTN4, AFDN, AKT1, AKT2, AKT3, BCAR1, CTNNA1, CTNNB1, EPB41, EPN2, F11R, HRAS, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, JUN, KEAP1, KRAS, MAP2K1, MAP2K3, MAP2K7, MAP3K1, MAP3K10, MAP3K2, MAP3K20, MAP3K5, MAPK12, MAPK14, MAPK3, MAPK8, MRAS, NECTIN2, NECTIN3, NRAS, PALS2, PRKACA, PRKAR1A, PRKAR2B, PRKG1, RALA, RRAS, SORBS1, SPTAN1, SPTBN1, TGFB3, TJAP1, TUBA1A, TUBB, TUBB2B, TUBB6, TUBG1, VCL		no direction
Fatty Acid Activation	0.759	0.447	0.714	ACSL1, ACSL3, ACSL5, ACSL6, SLC27A1		positive
CD28 Signaling in T Helper Cells	0.758	-1.061	0.529	AKT1, AKT2, AKT3, ARPC1B, ARPC3, ARPC4, BCL10, Calm1 (includes others), CD3G, CD80, CHP1, HLA-A, IKBKB, IKBKG, ITPR2, JUN, MAP2K1, MAP3K1, MAPK12, MAPK8, NFAT5, NFATC1, NFATC2, NFKB1, NFKBIA, NFKBIB, PDPK1, PIK3CB, PIK3R1, PIK3R3, PPP3CA, PPP3CB, PPP3R1, PRKCQ, PTPN11, RELA		negative
nNOS Signaling in Skeletal Muscle Cells	0.757	0	0.571	CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, Calm1 (includes others), CAPN3, DAG1, DMD, ITPR2, RYR1, RYR3, SNTA1, SNTB2		no direction
Type I Diabetes Mellitus Signaling	0.756	0.707	0.53	APAF1, CASP3, CD3G, CD80, CPE, FADD, FAS, HLA-A, IKBKB, IKBKG, IL1R1, IL1RAP, IRAK1, IRF1, MAP2K3, MAP2K6, MAP2K7, MAP3K5, MAPK12, MAPK14, MAPK8, MYD88, NFKB1, NFKBIA, NFKBIB, NGFR, PIAS1, RELA, SOCS2, SOCS3, SOCS7, TNFRSF11B, TNFRSF1B, TRAF2, TRAF6		positive
Melanoma Signaling	0.753	-0.243	0.567	AKT1, AKT2, AKT3, CCND1, CDKN1A, HRAS, KRAS, MAP2K1, MAPK3, MRAS, NRAS, PIK3CB, PIK3R1, PIK3R3, RALA, RRAS, TP53		negative
B Cell Receptor Signaling	0.752	-1.192	0.513	AKT1, AKT2, AKT3, ATF4, BCL10, Calm1 (includes others), CAMK2D, CAMK2G, CARD10, CFL2, CREB3L2, EGR1, ETS1, FOXO1, GAB2, HRAS, IKBKB, IKBKG, INPP5K, INPPL1, JUN, KRAS, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAP3K1, MAP3K10, MAP3K2, MAP3K5, MAPK12, MAPK14, MAPK3, MAPK8, MEF2C, MRAS, MTOR, NFAT5, NFATC1, NFATC2, NFKB1, NFKBIA, NFKBIB, NRAS, PDPK1, PIK3CB, PIK3R1, PIK3R3, PPP3CA, PPP3CB, PPP3R1, PRKCQ, PTK2, PTPN11, RALA, RASSF5, RELA, RRAS		negative
NF-κB Signaling	0.752	-0.927	0.513	AKT1, AKT2, AKT3, AZI2, BCL10, BMPR1B, BMPR2, CARD10, CD3G, EGFR, EIF2AK2, FADD, FGFR2, GHR, HDAC2, HRAS, IKBKB, IKBKG, IL1R1, IL33, INSR, IRAK1, KRAS, MAP2K6, MAP2K7, MAP3K1, MAPK8, MRAS, MYD88, NFKB1, NFKBIA, NFKBIB, NGFR, NRAS, PDGFRA, PELI1, PIK3CB, PIK3R1, PIK3R3, PRKACA, PRKCQ, RALA, RELA, RRAS, TAB3, TGFA, TGFBR2, TLR1, TLR4, TLR5, TLR6, TNFAIP3, TNFRSF11B, TNFRSF1B, TRAF2, TRAF3, TRAF6, UBE2N		negative
Ceramide Signaling	0.749	-0.73	0.534	AKT1, AKT2, AKT3, CTSD, HRAS, JUN, KRAS, MAP2K1, MAP3K1, MAPK3, MAPK8, MRAS, NFKB1, NGFR, NRAS, NSMAF, PIK3CB, PIK3R1, PIK3R3, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, RALA, RELA, RRAS, S1PR1, S1PR3, TNFRSF11B, TNFRSF1B		negative
UVB-Induced MAPK Signaling	0.747	0.943	0.559	AKT1, EGFR, EIF4EBP1, H3-3A/H3-3B, JUN, MAP2K1, MAPK12, MAPK14, MAPK3, MAPK8, MTOR, PIK3CB, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, RPS6KA5, TP53		positive
GP6 Signaling Pathway	0.746	-0.186	0.537	ADAM10, AKT1, AKT2, AKT3, Calm1 (includes others), COL1A2, COL20A1, COL3A1, COL4A1, COL4A2, COL5A2, COL5A3, COL6A3, COL7A1, LAMA2, LAMA4, LAMA5, LAMB1, LAMB2, PDPK1, PIK3CB, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, PTK2, RASGRP2, SCHIP1		negative
MYC Mediated Apoptosis Signaling	0.744	0.218	0.553	ADRB2, APAF1, BAX, BCL2L11, CASP2, CASP3, CRADD, FADD, FAS, IKBKB, IKBKG, MCL1, NFKB1, NGFR, PRKACA, PRKAR1A, PRKAR2B, TNFRSF11B, TNFRSF1B, TP53, TRAF2		positive
Estrogen-Dependent Breast Cancer Signaling	0.743	-1.342	0.548	AKR1B10, AKT1, AKT2, AKT3, ATF4, CCND1, CREB3L2, EGFR, ESR1, HRAS, HSD17B4, JUN, KRAS, MAPK3, MRAS, NFKB1, NRAS, PIK3CB, PIK3R1, PIK3R3, RALA, RELA, RRAS		negative
FAT10 Signaling Pathway	0.743	0	0.55	HTT, MAP1LC3B, NUB1, PSMA1, PSMA2, PSMA4, PSMA7, PSMB1, PSMB2, PSMB7, PSMC2, PSMC3, PSMD1, PSMD11, PSMD12, PSMD14, PSMD4, PSMD5, PSMD6, PSME1, PSME4, SQSTM1		no direction
Adipogenesis pathway	0.711	0	0.517	AGPAT2, AKT1, ARNTL, BMPR1B, BMPR2, CCNH, CEBPA, CTNNB1, DDIT3, EZH2, FBXW7, FGF1, FGF2, FGFR2, FGFRL1, FOXO1, FZD7, GTF2H2, GTF2H5, HAT1, HDAC11, HDAC2, HDAC4, HDAC5, HDAC6, HDAC9, KDM1A, LPIN1, LPL, NOCT, NR1D1, NR2F2, PPARG, PPIP5K1, RUNX1T1, SAP30, SIRT2, SLC2A4, SMAD3, SREBF1, TBL1XR1, TGFB1, TP53, XBP1, ZNF423		no direction
Hereditary Breast Cancer Signaling	0.702	0	0.519	ACTB, AKT1, AKT2, AKT3, ARID1A, ARID2, CCND1, CCND3, CDKN1A, FANCD2, GADD45A, GADD45G, H2AX, HDAC11, HDAC2, HDAC4, HDAC5, HDAC6, HDAC9, HRAS, KRAS, MRAS, MSH6, NRAS, PIK3CB, PIK3R1, PIK3R3, POLR2E, POLR2I, POLR2J, RALA, RPA1, RRAS, SMARCA2, SMARCB1, SMARCD2, SMARCD3, TP53, TUBG1, Ubb, UBC, WEE1		no direction
Insulin Secretion Signaling Pathway	0.696	0	0.503	ABCC8, ABCC9, ADCY5, ADCY8, AGO2, AGO4, ATF4, CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, CAMK2D, CAMK2G, CLCN3, CPE, CREB3L2, DLAT, DLD, EIF2B2, EIF2B4, EIF4EBP1, EIF4EBP2, EIF4G3, GHR, GOSR2, GPAA1, INSR, ITPR2, KCNB1, KLF11, MAPK12, MAPK14, MAPK3, MTOR, NAPB, NAPG, PAIP1, PC, PDHA1, PDIA3, PIK3CB, PIK3R1, PIK3R3, PLCD4, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, PRLR, RPS6KA5, RYR1, RYR3, SEC11C, SEC61A1, SEC61A2, SLC2A1, SLC2A4, SLC2A5, SPCS1, SRP14, SRP68, SSR2, SSR3, SSR4, STAT3, STAT6, STX16, VTI1B		no direction
DNA damage-induced 14-3-3σ Signaling	0.694	0	0.636	AKT1, AKT2, AKT3, CCNE2, HUS1, RAD17, TP53		no direction
IL-12 Signaling and Production in Macrophages	0.687	0	0.521	AKT1, AKT2, AKT3, APOE, IKBKB, IKBKG, IL12RB2, IRF1, JUN, MAF, MAP2K1, MAPK12, MAPK14, MAPK3, MAPK8, MYD88, NCOA1, NFKB1, NFKBIA, NFKBIB, PIK3CB, PIK3R1, PIK3R3, PPARG, PRKCE, PRKCI, PRKCQ, RBP4, RELA, SPI1, STAT6, TGFB1, TGFB2, TGFB3, TLR4, TRAF6, ZNF668		no direction
Production of Nitric Oxide and Reactive Oxygen Species in Macrophages	0.681	0	0.509	AKT1, AKT2, AKT3, APOE, FNBP1, IKBKB, IKBKG, IRF1, JUN, MAP2K1, MAP2K7, MAP3K1, MAP3K10, MAP3K2, MAP3K5, MAPK12, MAPK14, MAPK3, MAPK8, NFKB1, NFKBIA, NFKBIB, NGFR, PIK3CB, PIK3R1, PIK3R3, PPARA, PPM1J, PPP1R14C, PPP1R3A, PPP1R7, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PRKCE, PRKCI, PRKCQ, RBP4, RELA, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, SIRPA, SPI1, TLR4, TNFRSF11B, TNFRSF1B		no direction
Tryptophan Degradation X (Mammalian, via Tryptamine)	0.677	0	0.615	AKR1B10, Akr1b10, ALDH1A1, ALDH3A2, Aldh3b2, MAOA, MAOB, SMOX		no direction
Interferon Signaling	0.665	0.707	0.6	BAK1, BAX, IFIT3, IFNAR2, IRF1, MED14, PIAS1, RELA, TAP1		positive
Acetate Conversion to Acetyl-CoA	0.664	0	1	ACSL1, ACSS1		no direction
Cardiolipin Biosynthesis II	0.664	0	1	PGS1, PTPMT1		no direction
Creatine-phosphate Biosynthesis	0.664	0	1	CKM, CKMT2		no direction
Epoxysqualene Biosynthesis	0.664	0	1	FDFT1, SQLE		no direction
Folate Polyglutamylation	0.664	0	1	FPGS, MTHFD1		no direction
GDP-L-fucose Biosynthesis II (from L-fucose)	0.664	0	1	FCSK, FPGT		no direction
GDP-glucose Biosynthesis	0.664	0	1	HK2, PGM1		no direction
Glucose and Glucose-1-phosphate Degradation	0.664	0	1	HK2, PGM1		no direction
Glycerol Degradation I	0.664	0	1	GPD1, GPD2		no direction
Glycerol-3-phosphate Shuttle	0.664	0	1	GPD1, GPD2		no direction
Glycine Degradation (Creatine Biosynthesis)	0.664	0	1	GAMT, GATM		no direction
Lysine Degradation V	0.664	0	1	AASDH, AASDHPPT		no direction
Methylglyoxal Degradation I	0.664	0	1	GLO1, HAGHL		no direction
UDP-D-xylose and UDP-D-glucuronate Biosynthesis	0.664	0	1	UGDH, UXS1		no direction
Endocannabinoid Cancer Inhibition Pathway	0.663	-0.438	0.51	ADCY5, ADCY8, AKT1, AKT1S1, AKT2, AKT3, ATF3, ATF4, CASP2, CASP3, CASQ1, CCND1, CCND3, CCNE2, CDKN1A, CNR1, CREB3L2, CTNNB1, DDIT3, GNA13, GNAI2, GNAL, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK14, MAPK3, MTOR, NSMAF, PDGFC, PIK3CB, PIK3R1, PIK3R3, PRKAA1, PRKAB1, PRKAB2, PRKACA, PRKAG3, PRKAR1A, PRKAR2B, PTK2, RHOA, ROCK1, RPTOR, SNAI2, SPTLC2, TWIST1, VEGFD		negative
Neurotrophin/TRK Signaling	0.659	-0.784	0.529	AKT1, ATF4, BDNF, CREB3L2, HRAS, JUN, KRAS, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAP3K5, MAPK3, MAPK8, MRAS, NGFR, NRAS, NTF3, PDPK1, PIK3CB, PIK3R1, PIK3R3, PTPN11, RALA, RRAS, SPRY1, SPRY2		negative
PDGF Signaling	0.659	-0.962	0.529	CAV1, CAV3, CRK, EIF2AK2, HRAS, INPP5K, INPPL1, JUN, KRAS, MAP2K1, MAP3K1, MAPK3, MAPK8, MRAS, NRAS, PDGFA, PDGFB, PDGFC, PDGFRA, PIK3CB, PIK3R1, PIK3R3, RALA, RASA1, RRAS, SRF, STAT3		negative
VDR/RXR Activation	0.657	-0.535	0.531	CCL5, CCNC, CD14, CDKN1A, CEBPA, CXCL10, CYP27B1, FOXO1, GADD45A, HES1, IGFBP5, IGFBP6, KLF4, MED1, NCOA1, PDGFA, PPARD, PRKCE, PRKCI, PRKCQ, RXRG, SPP1, TGFB2, THBD, VDR, YY1		negative
Polyamine Regulation in Colon Cancer	0.655	-0.6	0.532	AKT1, AKT1S1, AKT2, AKT3, AZIN1, BCL2L11, CTNNB1, DHPS, JUN, KRAS, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK3, MTA1, MTOR, PPARG, RHOA, RPTOR, SLC3A2, SMOX, STIM1, TP53, TRPC1		negative
IL-15 Signaling	0.652	0	0.533	AKT1, AKT1S1, AKT2, AKT3, HRAS, IL15, KRAS, MAP2K1, MAPK12, MAPK14, MAPK3, MRAS, MTOR, NFKB1, NRAS, PIK3CB, PIK3R1, PIK3R3, RALA, RELA, RPTOR, RRAS, STAT3, STAT6		no direction
Antiproliferative Role of TOB in T Cell Signaling	0.651	-0.302	0.579	CCNE2, CD3G, CUL1, PABPC4, SMAD3, SMAD4, TGFB1, TGFB2, TGFB3, TGFBR2, TOB1		negative
Superpathway of Methionine Degradation	0.651	-0.632	0.579	AHCYL1, AHCYL2, ALKBH8, CDO1, DLD, GOT2, MAT2A, MMUT, PCCA, PRMT3, PRMT5		negative
Ephrin B Signaling	0.648	-0.471	0.537	ABI1, CFL2, CTNNB1, EFNB1, EPHB2, EPHB3, EPHB6, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, HNRNPK, HRAS, ITSN1, MAPK3, MRAS, NCK2, PTK2, RHOA, ROCK1		negative
CD27 Signaling in Lymphocytes	0.645	-1.213	0.541	APAF1, CASP3, IKBKB, IKBKG, JUN, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAP3K1, MAP3K10, MAP3K2, MAP3K5, MAPK12, MAPK8, NFKB1, NFKBIA, NFKBIB, RELA, TRAF2		negative
Crosstalk between Dendritic Cells and Natural Killer Cells	0.645	1.604	0.541	ACTA1, ACTA2, ACTB, ACTC1, CAMK2D, CAMK2G, CD80, CSF2RB, FAS, HLA-A, IL15, IL6, LTB, MICB, NECTIN2, NFKB1, RELA, TLN2, TLR4, TNFRSF1B		positive
Mitotic Roles of Polo-Like Kinase	0.644	-0.707	0.543	ANAPC13, ANAPC2, ANAPC5, CAPN1, CDC16, CDC23, CDC25A, HSP90AA1, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, RAD21, SMC1A, SMC3, STAG2, TGFB1, WEE1		negative
Role of JAK1 and JAK3 in γc Cytokine Signaling	0.643	0	0.545	HRAS, IL15, IL4R, IRS1, IRS2, KRAS, MAPK3, MRAS, NRAS, PIK3CB, PIK3R1, PIK3R3, PTPN11, RALA, RRAS, SOCS3, STAT3, STAT6		no direction
Triacylglycerol Degradation	0.643	3.051	0.56	ABHD6, CEL, LIPE, LIPG, LPL, MGLL, NDST1, NDST4, PLA1A, PLB1, PNPLA2, PNPLA7, PPME1, PRDX6		positive
Apelin Pancreas Signaling Pathway	0.642	2.324	0.552	APLN, DDIT3, MAPK12, MAPK8, NFKB1, PIK3CB, PIK3R1, PIK3R3, PRKAA1, PRKAB1, PRKAB2, PRKACA, PRKAG3, PRKAR1A, PRKAR2B, RELA		positive
Heparan Sulfate Biosynthesis (Late Stages)	0.642	-0.258	0.556	CHST10, CHST3, EXT1, EXTL2, HS2ST1, HS3ST3A1, HS3ST5, HS6ST1, LIPE, NDST1, NDST4, PLA1A, PNPLA7, PPME1, PRDX6		negative
Xenobiotic Metabolism General Signaling Pathway	0.631	-0.324	0.513	AKT1, AKT2, AKT3, GSTM1, GSTM3, GSTM5, GSTO1, HRAS, KEAP1, KRAS, MAF, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAP3K1, MAP3K10, MAP3K2, MAP3K5, MAPK12, MAPK14, MAPK3, MAPK7, MAPK8, MGST3, MRAS, NQO1, NR1H2, NR1H3, NR1H4, NRAS, PIK3CB, PIK3R1, PIK3R3, PPARA, PRKCE, PRKCI, PRKCQ, RALA, RRAS		negative
Systemic Lupus Erythematosus In B Cell Signaling Pathway	0.622	0.492	0.5	AKT1, AKT2, AKT3, BCL10, BCL2L11, Calm1 (includes others), CCND1, CCND3, CD72, CHP1, CTNNB1, FOXO1, FOXO4, HRAS, IFIT3, IFNAR2, IL15, IL17F, IL33, IL6, IL6R, IL6ST, INPP5K, INPPL1, IRAK1, IRF3, JUN, KRAS, LTB, MAP2K1, MAPK3, MCL1, MRAS, MTOR, MYD88, NFAT5, NFATC1, NFATC2, NFKB1, NRAS, PDPK1, PIK3CB, PIK3R1, PIK3R3, PPP3CA, PPP3CB, PPP3R1, PRKCE, PRKCI, PRKCQ, PTPN11, RALA, RASGRP2, RELA, RRAS, SHE, STAT3, STING1, TGFB1, TGFB2, TGFB3, TNFRSF13C, TNFSF12, TRAF2, TRAF3, TRAF6		positive
Huntington's Disease Signaling	0.617	0.48	0.494	AKT1, AKT2, AKT3, AP2A2, APAF1, ATF4, ATP5F1C, ATP5F1D, ATP5MC1, BAX, BDNF, CAPN1, CAPN2, CAPN3, CAPN7, CAPNS1, CASP2, CASP3, CASQ1, CREB3L2, CTSD, DNAJB1, DNM1L, DNM3, EGFR, GLS, GNB1, GNB2, GNG2, GOSR2, GPAA1, HDAC11, HDAC2, HDAC4, HDAC5, HDAC6, HDAC9, HRAS, HSPA2, HTT, IFT57, JUN, MAP2K7, MAP3K10, MAPK3, MAPK8, MTOR, NAPB, NAPG, PDPK1, PENK, PIK3CB, PIK3R1, PIK3R3, POLR2E, POLR2I, POLR2J, PRKCE, PRKCI, PRKCQ, PSMA1, PSMA2, PSMA4, PSMA7, PSMB1, PSMB2, PSMB7, PSMC2, PSMC3, PSMD1, PSMD11, PSMD12, PSMD14, PSMD4, PSMD5, PSMD6, PSME1, PSME4, RASA1, RCOR1, SDHD, STX16, TCERG1, TGM2, TP53, Ubb, UBC, VTI1B		positive
Endocannabinoid Neuronal Synapse Pathway	0.616	1.414	0.514	ABHD6, ADCY5, ADCY8, CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, CHP1, CNR1, GNAI2, GNAL, GNB1, GNB2, GNG2, GRIN1, GRIN2A, GRINA, ITPR2, MAPK12, MAPK14, MAPK3, MAPK7, MAPK8, MGLL, PDIA3, PLCD4, PPP3CA, PPP3CB, PPP3R1, PRKACA, PRKAR1A, PRKAR2B, PTGS2		positive
Sphingosine-1-phosphate Signaling	0.608	-0.354	0.515	ADCY5, ADCY8, AKT1, AKT2, AKT3, ASAH2, CASP2, CASP3, CASQ1, FNBP1, GNA13, GNAI2, MAPK3, PDGFA, PDGFB, PDGFC, PDGFRA, PDIA3, PIK3CB, PIK3R1, PIK3R3, PLCD4, PTK2, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, S1PR1, S1PR3		negative
IL-1 Signaling	0.601	-1.225	0.516	ADCY5, ADCY8, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, IKBKB, IKBKG, IL1R1, IL1RAP, IRAK1, IRAK2, JUN, MAP2K3, MAP2K6, MAP2K7, MAP3K1, MAPK12, MAPK14, MAPK8, MRAS, MYD88, NFKB1, NFKBIA, NFKBIB, PRKACA, PRKAR1A, PRKAR2B, RELA, TRAF6		negative
Amyotrophic Lateral Sclerosis Signaling	0.597	0.626	0.517	AKT3, ALS2, APAF1, BAX, CACNA1C, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, CAPN1, CAPN2, CAPN3, CAPN7, CAPNS1, CASP3, GLUL, GRIN1, GRIN2A, GRINA, HECW1, PDGFC, PIK3CB, PIK3R1, PIK3R3, PPP3CA, RAB5C, RNF19A, SSR4, TP53, VEGFD		positive
ERBB Signaling	0.597	0	0.517	AKT1, EGFR, ERBB2, ERBB3, ERBB4, FOXO1, HRAS, JUN, KRAS, MAP2K1, MAP2K3, MAP2K6, MAPK12, MAPK14, MAPK3, MAPK8, MRAS, MTOR, NCK2, NRAS, PAK4, PDPK1, PIK3CB, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, RALA, RRAS, TGFA		no direction
Virus Entry via Endocytic Pathways	0.597	0	0.517	ACTA1, ACTA2, ACTB, ACTC1, AP1S2, AP2A2, AP3B1, B2M, CAV1, CXADR, FLNA, FLNB, FLNC, FOLR1, HLA-A, HRAS, ITGB1, ITSN1, KRAS, MR1, MRAS, NRAS, PIK3CB, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, RALA, RRAS, TFRC		no direction
STAT3 Pathway	0.591	-2.535	0.506	BMPR1B, BMPR2, CDC25A, CDKN1A, CISH, CSF2RB, EGFR, FGF2, FGFR2, GHR, HRAS, IL12RB2, IL17RA, IL17RC, IL17RD, IL17RE, IL1R1, IL4R, IL6R, IL6ST, INSR, KRAS, MAP2K1, MAP3K10, MAP3K20, MAPK12, MAPK14, MAPK3, MAPK8, MRAS, NGFR, NRAS, PDGFB, PDGFRA, PIM1, RALA, RRAS, SOCS2, SOCS3, SOCS7, STAT3, TGFA, TGFB1, TGFB2, TGFBR2		negative
NER (Nucleotide Excision Repair, Enhanced Pathway)	0.59	1.043	0.518	CCNH, CETN2, Cops2, COPS5, COPS7A, COPS8, CUL4A, DDB1, DNA2, GTF2H2, GTF2H5, H3-3A/H3-3B, H4C3, H4C9, NEDD8, PCNA, POLD1, POLD2, POLD4, POLE3, POLK, POLR2E, POLR2I, POLR2J, RAD23B, RPA1, TOP2A, TOP2B, UBE2N		positive
Clathrin-mediated Endocytosis Signaling	0.582	0	0.5	AAK1, ACTA1, ACTA2, ACTB, ACTC1, AP1S2, AP2A2, AP3B1, APOE, ARPC1B, ARPC3, ARPC4, ARRB1, CHP1, CTTN, DAB2, DNM1L, DNM3, EPHB2, F2, F2R, FGF1, FGF12, FGF13, FGF16, FGF18, FGF2, FGF6, HGS, HIP1R, ITGB1, LDLR, LDLRAP1, MET, MYO1E, PDGFA, PDGFB, PDGFC, PIK3CB, PIK3R1, PIK3R3, PPP3CA, PPP3CB, PPP3R1, RAB11B, RAB5C, RBP4, SH3GL1, SH3GLB1, SNX9, TF, TFRC, Ubb, UBC, USP9X, VEGFD		no direction
Acetyl-CoA Biosynthesis I (Pyruvate Dehydrogenase Complex)	0.58	0	0.75	DLAT, DLD, PDHA1		no direction
Myo-inositol Biosynthesis	0.58	0	0.75	BPNT2, IMPA1, ISYNA1		no direction
ERK5 Signaling	0.575	-1.633	0.521	AKT1, ATF4, CREB3L2, CTF1, EGFR, GNA13, HRAS, IL6ST, KRAS, MAP3K2, MAPK7, MEF2A, MEF2C, MEF2D, MRAS, NRAS, PTPN11, RALA, RPS6KA2, RPS6KA5, RRAS, WNK1, YWHAB, YWHAG, YWHAZ		negative
Neuroinflammation Signaling Pathway	0.575	1.806	0.494	ACVR1, ACVR2A, AKT1, AKT2, AKT3, APH1B, APP, ATF4, B2M, BACE1, BDNF, BMPR2, CASP3, CCL5, CD80, CHP1, CREB3L2, CTNNB1, CXCL10, FAS, GABRA1, GLS, GLUL, GRIN1, GRIN2A, GRINA, HLA-A, IDE, IKBKB, IKBKG, IL1R1, IL6, IL6R, IRAK1, IRAK2, IRF3, JUN, MAPK12, MAPK14, MAPK3, MAPK7, MAPK8, MAPT, MFGE8, MR1, MYD88, NCSTN, NFAT5, NFATC1, NFATC2, NFKB1, NTF3, PIK3CB, PIK3R1, PIK3R3, PLA2G3, PLA2G4A, PLA2G4E, PPP3CA, PPP3CB, PPP3R1, PSEN1, PTGS2, PYCARD, RELA, SLC1A3, TGFB1, TGFB2, TGFB3, TGFBR2, TLR1, TLR4, TLR5, TLR6, TRAF3, TRAF6, VCAM1		positive
Oxytocin In Brain Signaling Pathway	0.574	-0.412	0.5	AKT1, AKT2, AKT3, ATF4, CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, Calm1 (includes others), CREB3L2, DDIT3, EGFR, GNAI2, GNAL, GNB1, GNB2, GNG2, HRAS, IL6, ITPR2, KRAS, MAP2K1, MAPK3, MAPK7, MEF2A, MEF2C, MEF2D, MRAS, MTOR, NFKB1, NRAS, PIK3CB, PIK3R1, PIK3R3, PLA2G3, PLA2G4A, PLA2G4E, PLA2R1, PLAAT3, PLB1, PNPLA8, PRDX6, PRKCE, PRKCI, PRKCQ, PTGS2, PYCARD, RALA, RGS2, RRAS, TLR4		negative
ERK/MAPK Signaling	0.563	1.236	0.496	ATF4, BCAR1, CREB3L2, CRK, DUSP1, DUSP2, DUSP6, EIF4EBP1, ELF1, ESR1, ETS1, ETS2, H3-3A/H3-3B, HRAS, HSPB3, HSPB7, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, KRAS, MAP2K1, MAPK3, MKNK1, MKNK2, MRAS, NFATC1, NRAS, PAK4, PIK3CB, PIK3R1, PIK3R3, PLA2G3, PLA2G4A, PLA2G4E, PPARG, PPM1J, PPP1R14C, PPP1R3A, PPP1R7, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PTK2, RALA, RAPGEF1, RPS6KA5, RRAS, SRF, STAT3, TLN2, YWHAB, YWHAG, YWHAZ		positive
ERBB4 Signaling	0.56	0.243	0.525	AKT1, APH1B, ERBB4, HRAS, KRAS, MAP2K1, MAPK3, MRAS, NCSTN, NRAS, PDPK1, PIK3CB, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, PSEN1, RALA, RRAS, YAP1		positive
Phospholipase C Signaling	0.552	-2.213	0.493	ADCY5, ADCY8, ARHGEF1, ARHGEF12, ARHGEF17, ARHGEF9, ATF4, Calm1 (includes others), CD3G, CHP1, CREB3L2, FNBP1, GNA13, GNB1, GNB2, GNG2, HDAC11, HDAC2, HDAC4, HDAC5, HDAC6, HDAC9, HRAS, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, ITPR2, KRAS, MAP2K1, MAPK3, MEF2A, MEF2C, MEF2D, MPRIP, MRAS, MYL1, MYL4, MYL9, MYLPF, NFAT5, NFATC1, NFATC2, NFKB1, NRAS, PLA2G3, PLA2G4A, PLA2G4E, PLCD4, PPP3CA, PPP3CB, PPP3R1, PRKCE, PRKCI, PRKCQ, RALA, RELA, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, RRAS, TGM2		negative
Cholesterol Biosynthesis I	0.55	1	0.667	FDFT1, NSDHL, SC5D, SQLE		positive
Cholesterol Biosynthesis II (via 24,25-dihydrolanosterol)	0.55	1	0.667	FDFT1, NSDHL, SC5D, SQLE		positive
Cholesterol Biosynthesis III (via Desmosterol)	0.55	1	0.667	FDFT1, NSDHL, SC5D, SQLE		positive
Leukotriene Biosynthesis	0.55	1	0.667	DPEP1, GGT5, LTA4H, MGST3		positive
Prostanoid Biosynthesis	0.55	-1	0.667	PTGES, PTGES2, PTGIS, PTGS2		negative
iNOS Signaling	0.549	0.258	0.529	Calm1 (includes others), CD14, IKBKB, IKBKG, IRAK1, IRAK2, IRF1, JUN, LBP, MAPK12, MAPK14, MYD88, NFKB1, NFKBIA, NFKBIB, RELA, TLR4, TRAF6		positive
Apelin Muscle Signaling Pathway	0.546	0	0.531	AKT1, AKT2, AKT3, APLN, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, MRAS, PPARGC1A, PRKAA1, PRKAB1, PRKAB2, PRKAG3, SLC2A4		no direction
Gαq Signaling	0.545	-0.16	0.5	AKT1, AKT2, AKT3, Calm1 (includes others), CHP1, EPM2A, FNBP1, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, GYS1, HTR2B, IKBKB, IKBKG, ITPR2, MAP2K1, MAPK3, MRAS, NFATC1, NFATC2, NFKB1, NFKBIA, NFKBIB, PIK3CB, PIK3R1, PIK3R3, PPP3CA, PPP3CB, PPP3R1, PRKCE, PRKCI, PRKCQ, RELA, RGS2, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, ROCK1		negative
Telomerase Signaling	0.544	0	0.507	AKT1, AKT2, AKT3, CDKN1A, EGFR, ELF1, ETS1, ETS2, HDAC11, HDAC2, HDAC4, HDAC5, HDAC6, HDAC9, HRAS, HSP90AA1, KRAS, MAP2K1, MAPK3, MRAS, NRAS, PDPK1, PIK3CB, PIK3R1, PIK3R3, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, RALA, RRAS, TERF2IP, TP53		no direction
Cell Cycle Control of Chromosomal Replication	0.539	1.291	0.536	CDC45, CDK16, CDK19, CDK8, CDK9, DNA2, MCM4, MCM6, MCM9, ORC5, PCNA, POLD1, RPA1, TOP2A, TOP2B		positive
Glutamate Receptor Signaling	0.539	0.447	0.536	Calm1 (includes others), GLS, GLUL, GNB1, GNB2, GNG2, GRIN1, GRIN2A, GRINA, HOMER1, PICK1, SLC17A6, SLC17A8, SLC1A1, SLC1A3		positive
Role of Hypercytokinemia/hyperchemokinemia in the Pathogenesis of Influenza	0.539	2.84	0.536	CCL5, CXCL10, DDX58, EIF2AK2, IFIT3, IFNAR2, IL33, IL6, IRF3, MYD88, NFKB1, PYCARD, RSAD2, S1PR1, TLR4		positive
Triacylglycerol Biosynthesis	0.539	2.324	0.536	ABHD5, AGPAT2, AGPAT3, AGPAT4, CRLS1, DGAT2, ELOVL1, GPAT3, LPGAT1, LPIN1, LPIN2, MBOAT1, MBOAT7, Plpp1, PLPP3		positive
4-1BB Signaling in T Lymphocytes	0.536	0.577	0.538	IKBKB, IKBKG, JUN, MAP2K1, MAP3K5, MAPK12, MAPK14, MAPK3, MAPK8, NFKB1, NFKBIA, NFKBIB, RELA, TRAF2		positive
D-myo-inositol (1,3,4)-trisphosphate Biosynthesis	0.536	0.447	0.625	INPP5A, INPP5E, INPP5K, INPPL1, IPMK		positive
γ-linolenate Biosynthesis II (Animals)	0.536	0.447	0.625	ACSL1, ACSL3, ACSL5, ACSL6, SLC27A1		positive
Inhibition of Angiogenesis by TSP1	0.533	-1.155	0.542	AKT1, AKT2, AKT3, CASP3, CD47, JUN, MAPK12, MAPK14, MAPK8, SDC2, TGFB1, TGFBR2, TP53		negative
Small Cell Lung Cancer Signaling	0.531	-0.728	0.508	AKT1, AKT2, AKT3, APAF1, CCND1, CCND3, CCNE2, E2F6, HDAC11, HDAC2, HDAC4, HDAC5, HDAC6, HDAC9, IKBKB, IKBKG, NFKB1, NFKBIA, NFKBIB, PIK3CB, PIK3R1, PIK3R3, PTGS2, PTK2, RBL2, RELA, RXRG, TP53, TRAF2, TRAF3, TRAF6		negative
Unfolded protein response	0.531	0.688	0.508	ATF4, ATF6, CALR, CD82, CEBPA, CEBPG, DDIT3, DNAJA4, DNAJB1, DNAJB2, DNAJB5, DNAJC12, DNAJC19, DNAJC21, DNAJC4, DNAJC7, DNAJC9, HSPA2, HSPH1, MAP2K7, MAP3K5, MAPK8, MBTPS1, OS9, P4HB, PPARG, SREBF1, SYVN1, TRAF2, UBXN4, XBP1		positive
p53 Signaling	0.531	0.426	0.508	AKT1, AKT2, AKT3, APAF1, BAX, CCND1, CCNK, CDKN1A, COQ8A, CTNNB1, FAS, GADD45A, GADD45G, HDAC9, HIPK2, JUN, MAPK14, MAPK8, MDM4, MED1, PCNA, PIAS1, PIK3CB, PIK3R1, PIK3R3, SERPINE2, SNAI2, STAG1, TP53, TP53BP2, TP53INP1		positive
Cell Cycle Regulation by BTG Family Proteins	0.53	-0.447	0.545	BTG1, BTG2, CCND1, CCNE2, CNOT7, E2F6, NOCT, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D		negative
OX40 Signaling Pathway	0.53	-1.265	0.545	B2M, CD3G, HLA-A, JUN, MAPK12, MAPK8, NFKB1, NFKBIA, NFKBIB, RELA, TRAF2, TRAF3		negative
Oncostatin M Signaling	0.53	0	0.545	HRAS, IL6ST, KRAS, MAP2K1, MAPK3, MRAS, NRAS, OSMR, RALA, RRAS, STAT3, TIMP3		no direction
Cysteine Biosynthesis III (mammalia)	0.529	0.447	0.6	AHCYL1, AHCYL2, ALKBH8, MAT2A, PRMT3, PRMT5		positive
Dopamine Degradation	0.529	0	0.6	ALDH1A1, ALDH3A2, Aldh3b2, MAOA, MAOB, SMOX		no direction
Methionine Degradation I (to Homocysteine)	0.529	0.447	0.6	AHCYL1, AHCYL2, ALKBH8, MAT2A, PRMT3, PRMT5		positive
The Visual Cycle	0.529	-0.447	0.6	Akr1b10, AKR1B10, DHRS3, DHRS4, RBP3, RDH5		negative
Aryl Hydrocarbon Receptor Signaling	0.528	1.257	0.5	ALDH1A1, ALDH1L1, ALDH3A2, APAF1, BAX, CCND1, CCND3, CCNE2, CDKN1A, CTSD, ESR1, FAS, GSTM1, GSTM3, GSTM5, GSTO1, HSP90AA1, HSPB3, HSPB7, IL6, JUN, MAPK3, MAPK8, MED1, MGST3, NEDD8, NFIA, NFIB, NFIC, NFIX, NFKB1, NQO1, NR2F1, RARA, RARG, RBL2, RELA, RXRG, TGFB1, TGFB2, TGFB3, TGM2, TP53		positive
Noradrenaline and Adrenaline Degradation	0.526	-0.378	0.583	ALDH1A1, ALDH3A2, Aldh3b2, DHRS4, MAOA, MAOB, SMOX		negative
Superpathway of Cholesterol Biosynthesis	0.526	1.633	0.583	ACAA2, FDFT1, GGPS1, HADHA, NSDHL, SC5D, SQLE		positive
Glycolysis I	0.526	1.265	0.556	ALDOA, ALDOB, BPGM, FBP1, FBP2, GAPDH, GPI, PFKM, PKM, TPI1		positive
Glutaryl-CoA Degradation	0.525	0.378	0.571	ACAA2, CDYL, GCDH, HACD1, HACD2, HADH, HADHA, HSD17B4		positive
Serotonin Receptor Signaling	0.525	0	0.571	ADCY5, ADCY8, HTR1B, HTR2B, MAOA, MAOB, SMOX, TPH1		no direction
Tryptophan Degradation III (Eukaryotic)	0.525	0.378	0.571	ACAA2, CDYL, GCDH, HACD1, HACD2, HADH, HADHA, HSD17B4		positive
IL-22 Signaling	0.525	-0.333	0.562	AKT1, AKT2, AKT3, MAPK12, MAPK14, MAPK3, MAPK8, SOCS3, STAT3		negative
Glioma Signaling	0.523	-0.192	0.5	AKT1, AKT2, AKT3, Calm1 (includes others), CAMK2D, CAMK2G, CCND1, CCND3, CDKN1A, E2F6, EGFR, HDAC11, HDAC2, HDAC4, HDAC5, HDAC6, HDAC9, HRAS, IDH1, IDH2, IDH3B, KRAS, MAP2K1, MAPK3, MRAS, MTOR, NRAS, PDGFA, PDGFB, PDGFC, PDGFRA, PIK3CB, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, RALA, RBL2, RRAS, TGFA, TP53		negative
Human Embryonic Stem Cell Pluripotency	0.514	0	0.5	ACVR1, AKT1, AKT2, AKT3, BDNF, BMP8A, BMPR1B, BMPR2, CTNNB1, FGF2, FGFR2, FGFRL1, FOXO1, FZD7, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, MRAS, NOG, NTF3, PDGFA, PDGFB, PDGFC, PDGFRA, PDPK1, PIK3CB, PIK3R1, PIK3R3, S1PR1, S1PR3, SMAD3, SMAD4, TGFB1, TGFB2, TGFB3, TGFBR2, WNT9A		no direction
Gap Junction Signaling	0.513	0	0.495	ACTA1, ACTA2, ACTB, ACTC1, ADCY5, ADCY8, AKT1, AKT2, AKT3, CAV1, CSNK1A1, CSNK1E, CTNNB1, EGFR, GJA5, GJC1, GNAI2, HRAS, HTR2B, ITPR2, KRAS, MAP2K1, MAP3K2, MAPK3, MAPK7, MRAS, NPR3, NRAS, PDIA3, PIK3CB, PIK3R1, PIK3R3, PLCD4, PPP3CA, PPP3CB, PPP3R1, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, PRKG1, RALA, RRAS, SP3, TUBA1A, TUBB, TUBB2B, TUBB6, TUBG1		no direction
Ferroptosis Signaling Pathway	0.51	0.493	0.5	ABCA1, ANGPTL4, ATF4, CDKN1A, EMP1, FANCD2, FDFT1, FTH1, G3BP1, GSS, H2AX, H2AZ2, HRAS, IREB2, KEAP1, KRAS, MAP2K1, MAPK3, MRAS, NRAS, PRKAA1, PRKAB1, PRKAB2, PRKAG3, RALA, RBL2, RRAS, SLC11A2, SLC1A5, SLC3A2, SLC7A11, SQSTM1, STAT3, TF, TFRC, TP53, TXNRD1, WWTR1, YAP1		positive
Induction of Apoptosis by HIV1	0.493	0.853	0.511	APAF1, BAK1, BAX, CASP3, DFFA, FADD, FAS, IKBKB, IKBKG, MAP2K7, MAP3K5, MAPK12, MAPK8, NFKB1, NFKBIA, NFKBIB, NGFR, RELA, SLC25A3, TNFRSF11B, TNFRSF1B, TP53, TRAF2		positive
GDNF Family Ligand-Receptor Interactions	0.488	-0.688	0.512	DOK4, GFRA4, HRAS, IRS1, IRS2, ITPR2, JUN, KRAS, MAP2K1, MAPK12, MAPK3, MAPK8, MRAS, NRAS, PDLIM7, PIK3CB, PIK3R1, PIK3R3, RALA, RASA1, RET, RRAS		negative
Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis	0.486	0	0.491	ADAMTS4, ADAMTS5, AKT1, AKT2, AKT3, BMP8A, BMPR1B, BMPR2, Calm1 (includes others), CHP1, CSNK1A1, CSNK1E, CTNNB1, FOXO1, FZD7, IKBKB, IKBKG, IL1R1, IL1RAP, IL33, IL6, JUN, LRP1, MAP2K3, MAP2K6, MAP2K7, MAP3K5, MAPK12, MAPK14, MAPK3, MAPK8, MMP14, NFAT5, NFATC1, NFATC2, NFKB1, NFKBIA, NFKBIB, NGFR, PIK3CB, PIK3R1, PIK3R3, PPP3CA, PPP3CB, PPP3R1, RELA, SFRP1, SMAD4, SPP1, TGFB1, TNFRSF11B, TNFRSF1B, TRAF2, TRAF6, WNT9A		no direction
FcγRIIB Signaling in B Lymphocytes	0.483	-1.941	0.512	AKT1, CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, HRAS, ITPR2, KRAS, MAPK12, MAPK8, MRAS, NRAS, PDPK1, PIK3CB, PIK3R1, PIK3R3, RALA, RRAS		negative
Pyridoxal 5'-phosphate Salvage Pathway	0.483	0.894	0.512	ACVR2A, ADPGK, AKT2, CDK8, CSNK1A1, EIF2AK2, GRK4, GRK5, HIPK1, IRAK1, MAP2K1, MAP2K3, MAP2K6, MAPK3, MAPK7, MAPK8, PIM1, PRKAA1, PRKCE, PRKCQ, PRPF4B		positive
Death Receptor Signaling	0.476	1.976	0.5	ACTA1, ACTA2, ACTB, ACTC1, APAF1, CASP2, CASP3, CRADD, DFFA, FADD, FAS, HSPB3, HSPB7, IKBKB, IKBKG, LMNA, MAP2K7, MAP3K5, MAPK8, NFKB1, NFKBIA, NFKBIB, PARP4, PARP9, RELA, ROCK1, SPTAN1, TIPARP, TNFRSF1B, TNFSF12, TNKS, TRAF2		positive
IL-15 Production	0.476	-0.354	0.5	AATK, DSTYK, EGFR, EPHA3, EPHB2, EPHB3, ERBB2, ERBB3, ERBB4, FER, FGFR2, IL15, IL6, INSR, IRF1, IRF3, LMTK2, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MERTK, MET, MUSK, NFKB1, PDGFRA, PRKCI, PTK2, RELA, RET, ROS1, TEK		negative
ERB2-ERBB3 Signaling	0.473	-0.943	0.514	AKT1, CCND1, ERBB2, ERBB3, FOXO1, HRAS, JUN, KRAS, MAP2K1, MAPK3, MRAS, NRAS, PDPK1, PIK3CB, PIK3R1, PIK3R3, RALA, RRAS, STAT3		negative
Thrombopoietin Signaling	0.473	0.688	0.514	GAB2, HRAS, IRS2, JUN, KRAS, MAP2K1, MAPK3, MRAS, NRAS, PIK3CB, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, PTPN11, RALA, RRAS, STAT3		positive
Aldosterone Signaling in Epithelial Cells	0.472	2.183	0.494	CRYAB, DNAJB1, DNAJB2, DNAJB5, DNAJC12, DNAJC19, DNAJC2, DNAJC21, DNAJC28, DNAJC4, DNAJC7, DNAJC9, DUSP1, HSP90AA1, HSPA13, HSPA2, HSPA4L, HSPB3, HSPB6, HSPB7, HSPB8, HSPE1, HSPH1, ICMT, ITPR2, KCNMA1, KRAS, MAP2K1, MAPK3, PDIA3, PDPK1, PIK3CB, PIK3R1, PIK3R3, PIKFYVE, PLCD4, PRKCE, PRKCI, PRKCQ, SLC12A2, SLC9A1, TRAP1		positive
Erythropoietin Signaling Pathway	0.468	-0.469	0.494	AKT1, AKT2, AKT3, APAF1, CCND1, CSF2RB, CTNNB1, HRAS, IL15, IL17F, IL33, IL6, IRS2, ITPR2, JUN, KRAS, LTB, MAP2K1, MAPK3, MRAS, MTOR, NFKB1, NFKBIA, NFKBIB, NRAS, PDPK1, PIK3CB, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, RALA, RELA, RRAS, TGFB1, TGFB2, TGFB3, TNFSF12, TP53, TRPC3		negative
Apelin Cardiomyocyte Signaling Pathway	0.466	1.461	0.5	AKT1, AKT2, AKT3, APLN, ATP2A1, ATP2A3, GNAI2, MAPK12, MAPK14, MAPK3, MAPK7, MAPK8, MYL1, MYL4, MYL9, MYLK, MYLPF, PDIA3, PIK3CB, PIK3R1, PIK3R3, PLCD4, PRKCE, PRKCI, PRKCQ, SLC8A3, SLC9A1, SLC9A2, SLC9A6, TGFB1		positive
White Adipose Tissue Browning Pathway	0.463	0.164	0.494	ADCY5, ADCY8, ATF4, BDNF, CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, CREB3L2, DIO2, FGFR2, FGFRL1, HIF1AN, ITPR2, LDHA, LIPE, MAPK12, MAPK14, NDN, PPARA, PPARG, PPARGC1A, PRKAA1, PRKAB1, PRKAB2, PRKACA, PRKAG3, PRKAR1A, PRKAR2B, PRKG1, RARA, RARG, RUNX1T1, RXRG, SLC16A1, THRA, THRB		positive
ICOS-ICOSL Signaling in T Helper Cells	0.461	-0.2	0.5	AKT1, AKT2, AKT3, Calm1 (includes others), CAMK2D, CAMK2G, CD3G, CD80, CHP1, GAB2, HLA-A, IKBKB, IKBKG, ITPR2, NFAT5, NFATC1, NFATC2, NFKB1, NFKBIA, NFKBIB, PDPK1, PIK3CB, PIK3R1, PIK3R3, PPP3CA, PPP3CB, PPP3R1, PRKCQ, RELA		negative
p70S6K Signaling	0.458	1	0.494	AKT1, AKT2, AKT3, BCAP31, EEF2, EGFR, F2, F2R, F2RL1, GNAI2, HRAS, IL4R, IRS1, KRAS, MAP2K1, MAPK3, MAPT, MRAS, MTOR, NRAS, PDIA3, PDPK1, PIK3CB, PIK3R1, PIK3R3, PLCD4, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PRKCE, PRKCI, PRKCQ, RALA, RRAS, YWHAB, YWHAG, YWHAZ		positive
MIF Regulation of Innate Immunity	0.456	0.5	0.516	CD14, CD74, JUN, MAPK12, MAPK3, MAPK8, NFKB1, NFKBIA, NFKBIB, PLA2G3, PLA2G4A, PLA2G4E, PTGS2, RELA, TLR4, TP53		positive
Toll-like Receptor Signaling	0.455	-0.447	0.5	CD14, EIF2AK2, IKBKB, IKBKG, IL33, IRAK1, IRAK2, JUN, LBP, MAP2K3, MAP2K6, MAP3K1, MAPK12, MAPK14, MAPK8, MYD88, NFKB1, NFKBIA, PPARA, RELA, TLR1, TLR4, TLR5, TLR6, TNFAIP3, TRAF6, Ubb, UBC		negative
Cell Cycle: G2/M DNA Damage Checkpoint Regulation	0.451	0	0.517	BORA, CDKN1A, CUL1, GADD45A, HIPK2, MDM4, PTPMT1, TOP2A, TOP2B, TP53, TRIP12, WEE1, YWHAB, YWHAG, YWHAZ		no direction
FXR/RXR Activation	0.45	0	0.5	AKT1, AKT2, AKT3, APOE, C3, CYP27A1, FBP1, FOXO1, IL33, ITIH4, LPL, MAPK12, MAPK8, MLXIPL, NR1H3, NR1H4, PLTP, PPARA, PPARG, PPARGC1A, RARA, RBP4, SERPINF1, SREBF1, TF, TTR, VLDLR		no direction
Mouse Embryonic Stem Cell Pluripotency	0.45	0.192	0.5	AKT1, AKT2, AKT3, BMPR2, CTNNB1, DVL3, FZD7, HRAS, ID1, IL6ST, KRAS, LIFR, MAP2K1, MAPK12, MAPK14, MAPK3, MRAS, NRAS, PIK3CB, PIK3R1, PIK3R3, PTPN11, RALA, RRAS, SMAD4, STAT3, TP53		positive
fMLP Signaling in Neutrophils	0.443	-0.522	0.493	ARPC1B, ARPC3, ARPC4, Calm1 (includes others), CHP1, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, HRAS, ITPR2, KRAS, MAP2K1, MAPK3, MRAS, NFAT5, NFATC1, NFATC2, NFKB1, NFKBIA, NFKBIB, NRAS, PIK3CB, PIK3R1, PIK3R3, PPP3CA, PPP3CB, PPP3R1, PRKCE, PRKCI, PRKCQ, RALA, RELA, RRAS		negative
Salvage Pathways of Pyrimidine Ribonucleotides	0.439	0.816	0.5	ACVR2A, ADPGK, AKT2, APOBEC2, CDK8, CMPK2, CSNK1A1, EIF2AK2, GRK4, GRK5, HIPK1, IRAK1, MAP2K1, MAP2K3, MAP2K6, MAPK3, MAPK7, MAPK8, PIM1, PRKAA1, PRKCE, PRKCQ, PRPF4B, UCK2, UCKL1		positive
Synaptogenesis Signaling Pathway	0.434	-0.465	0.482	ADCY5, ADCY8, AFDN, AKT1, AKT2, AKT3, AP2A2, APOE, ARPC1B, ARPC3, ARPC4, ATF4, BDNF, CACNB1, CACNB4, CADM1, Calm1 (includes others), CAMK2D, CAMK2G, CDH10, CDH15, CDH17, CDH2, CDH23, CDH5, CREB3L2, CRK, CTNNB1, EFNB1, EIF4EBP1, EIF4EBP2, EPHA3, EPHA7, EPHB2, EPHB3, EPHB6, GOSR2, GPAA1, GRIN1, GRIN2A, GRINA, HRAS, ITSN1, KRAS, LRP1, MAPK14, MAPK3, MAPT, MRAS, MTOR, NAP1L1, NAP1L4, NAPB, NAPG, NECTIN3, NRAS, PIK3CB, PIK3R1, PIK3R3, PRKACA, PRKAR1A, PRKAR2B, PRKCE, RAB5C, RALA, RAPGEF1, RASGRP2, RHOA, RRAS, SHE, STX16, STXBP3, STXBP5, SYT11, SYT12, THBS2, THBS4, VLDLR, VTI1B		negative
TNFR2 Signaling	0.433	0.302	0.522	IKBKB, IKBKG, JUN, MAP3K1, MAPK8, NFKB1, NFKBIA, NFKBIB, RELA, TNFAIP3, TNFRSF1B, TRAF2		positive
Role of JAK2 in Hormone-like Cytokine Signaling	0.426	0	0.524	GHR, IRS1, IRS2, PRLR, PTPN11, SH2B1, SIRPA, SOCS2, SOCS3, SOCS7, STAT3		no direction
Bladder Cancer Signaling	0.422	-0.243	0.492	CCND1, CDKN1A, E2F6, EGFR, ERBB2, FGF1, FGF12, FGF13, FGF16, FGF18, FGF2, FGF6, HDAC11, HDAC2, HDAC4, HDAC5, HDAC6, HDAC9, HRAS, KRAS, MAP2K1, MAPK3, MMP14, MRAS, NRAS, PDGFC, RALA, RBL2, RPS6KA5, RRAS, TP53, VEGFD		negative
Osteoarthritis Pathway	0.422	0.885	0.484	ADAMTS4, ADAMTS5, ANXA5, ATF4, BMPR2, CASP2, CASP3, CASQ1, CREB3L2, CTNNA1, CTNNB1, DDIT4, FADD, FGF18, FGF2, FZD7, GLI3, H19, HDAC4, HES1, HTRA1, IL1R1, IL1RAP, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, LRP1, MEF2C, MTOR, MYBBP1A, NAMPT, NFKB1, NOTCH1, PDGFC, PPARD, PPARG, PPARGC1A, PRKAA1, PRKAB1, PRKAB2, PRKAG3, PTGS2, RBP4, RELA, S1PR3, SIK3, SMAD3, SMAD4, SPP1, TGFB1, TGFBR2, TIMP3, TLR4, TNFRSF1B, VEGFD		positive
Transcriptional Regulatory Network in Embryonic Stem Cells	0.419	0	0.526	CDYL, EOMES, H3-3A/H3-3B, H4C3, H4C9, MYF5, RIF1, STAT3, TRIM24, ZFHX3		no direction
Role of NFAT in Regulation of the Immune Response	0.416	-1.265	0.485	AKT1, AKT2, AKT3, Calm1 (includes others), CD3G, CD80, CHP1, CSNK1A1, CSNK1E, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, HLA-A, HRAS, IKBKB, IKBKG, ITPR2, JUN, KPNA3, KPNB1, KRAS, MAP2K1, MAPK3, MEF2A, MEF2C, MEF2D, MRAS, NFAT5, NFATC1, NFATC2, NFKB1, NFKBIA, NFKBIB, NRAS, PIK3CB, PIK3R1, PIK3R3, PPP3CA, PPP3CB, PPP3R1, PRKCQ, RALA, RCAN1, RELA, RRAS, XPO1		negative
PXR/RXR Activation	0.409	-0.894	0.5	ABCB1, ABCC3, AKT1, AKT2, AKT3, ALDH1A1, ALDH3A2, CPT1A, FOXO1, GSTM1, IL6, INSR, NCOA1, PPARA, PPARGC1A, PRKACA, PRKAR1A, PRKAR2B, RELA, SCD		negative
ATM Signaling	0.4	0.209	0.491	ATF4, CBX5, CDC25A, CDKN1A, CREB3L2, FANCD2, GADD45A, GADD45G, H2AX, JUN, MAPK12, MAPK14, MAPK8, MDM4, NFKBIA, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, RAD17, RNF168, SMC1A, SMC3, TLK2, TP53, TRIM28, ZEB1		positive
Th2 Pathway	0.4	2.041	0.491	ACVR1, ACVR2A, APH1B, BMPR2, CD3G, CD80, HLA-A, IL12RB2, IL33, IL4R, JUN, MAF, NCSTN, NFATC2, NFKB1, NOTCH1, NOTCH3, PIK3CB, PIK3R1, PIK3R3, PRKCQ, PSEN1, S1PR1, SOCS3, SPI1, STAT6, TGFB1, TGFBR2		positive
CDK5 Signaling	0.4	-0.87	0.487	ADCY5, ADCY8, BDNF, CAPN1, EGR1, GNAL, HRAS, ITGA3, ITGA6, ITGB1, KRAS, LAMA2, LAMA5, LAMB1, MAP2K1, MAPK12, MAPK14, MAPK3, MAPK7, MAPK8, MAPT, MRAS, NGFR, NRAS, PPM1J, PPP1R14C, PPP1R3A, PPP1R7, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PRKACA, PRKAR1A, PRKAR2B, RALA, RRAS		negative
Lipid Antigen Presentation by CD1	0.398	0	0.538	AP2A2, B2M, CALR, CD1D, CD3G, PDIA3, PSAP		no direction
Parkinson's Signaling	0.398	0	0.538	CASP3, MAPK12, MAPK14, MAPK8, PRKN, SNCAIP, UCHL1		no direction
Androgen Signaling	0.392	0.408	0.484	AR, CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, Calm1 (includes others), CALR, CCND1, CCNH, DNAJB1, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, GTF2A1, GTF2E1, GTF2H2, GTF2H5, H3-3A/H3-3B, HSP90AA1, ITPR2, JUN, MAPK3, MRAS, NCOA1, NFKB1, POLR2E, POLR2I, POLR2J, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, RELA, SMAD3, TAF12, TAF15		positive
Dermatan Sulfate Degradation (Metazoa)	0.39	0.816	0.545	CEMIP, FGFRL1, GM2A, HEXA, HYAL2, OGA		positive
Ethanol Degradation II	0.39	0.816	0.545	ACSL1, ACSS1, ALDH1A1, ALDH3A2, Aldh3b2, DHRS4		positive
Mitochondrial L-carnitine Shuttle Pathway	0.39	0.816	0.545	ACSL1, ACSL3, ACSL5, ACSL6, CPT1A, SLC27A1		positive
Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency	0.388	0.229	0.491	AKT1, AKT2, AKT3, BMP8A, BMPR1B, BMPR2, CTNNB1, FZD7, HRAS, IL6ST, KRAS, LIFR, MAP2K1, MAPK3, MRAS, NRAS, PIK3CB, PIK3R1, PIK3R3, RALA, RIF1, RRAS, SMAD4, STAT3, TP53, WNT9A		positive
GNRH Signaling	0.386	-1.406	0.481	ADCY5, ADCY8, ATF4, CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, Calm1 (includes others), CAMK2D, CAMK2G, CREB3L2, EGFR, EGR1, GNAI2, GNB1, GNB2, GNG2, HRAS, ITPR2, JUN, KRAS, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAP3K1, MAP3K10, MAP3K2, MAP3K5, MAPK12, MAPK14, MAPK3, MAPK7, MAPK8, MRAS, NFKB1, NRAS, PAK4, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, PTK2, RALA, RELA, RRAS		negative
Hepatic Cholestasis	0.386	0	0.481	ABCB1, ABCC3, ADCY5, ADCY8, CD14, CYP27A1, ESR1, IKBKB, IKBKG, IL15, IL17F, IL1R1, IL1RAP, IL33, IL6, INSR, IRAK1, IRAK2, JUN, LBP, LTB, MAPK12, MAPK8, MYD88, NFKB1, NFKBIA, NFKBIB, NGFR, NR1H2, NR1H3, NR1H4, PPARA, PPRC1, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, RARA, RELA, SREBF1, TGFB1, TGFB2, TGFB3, TLR4, TNFRSF11B, TNFRSF1B, TNFSF12, TRAF2, TRAF6		no direction
G Beta Gamma Signaling	0.384	0	0.486	AKT1, AKT2, AKT3, CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, CAV1, CAV3, EGFR, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, HRAS, ITPR2, KRAS, MAPK3, MRAS, NRAS, PDPK1, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, RALA, RRAS		no direction
1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian)	0.381	0.447	0.556	INPP5A, INPP5E, INPP5K, INPPL1, IPMK		positive
Chondroitin Sulfate Degradation (Metazoa)	0.381	0.447	0.556	CEMIP, GM2A, HEXA, HYAL2, OGA		positive
Glucocorticoid Receptor Signaling	0.375	0	0.473	ACTB, ADRB2, AKT1, AKT2, AKT3, ANXA1, AR, ARID1A, ARID2, ATP5F1C, ATP5F1D, ATP5MC1, B2M, BCL2L11, CAV1, CCL5, CCNH, CD163, CD3G, CDKN1A, CEBPA, CHP1, CSF2RB, DUSP1, EGFR, ESR1, FBP1, FKBP4, FKBP5, GABPA, GHR, GTF2A1, GTF2E1, GTF2H2, GTF2H5, H3-3A/H3-3B, HLA-A, HP, HRAS, HSP90AA1, HSPA2, IKBKB, IKBKG, IL12RB2, IL17RA, IL17RC, IL17RD, IL17RE, IL1R1, IL4R, IL6, IL6R, IL6ST, IRF3, JUN, KRAS, KRT19, KRT80, MAP2K1, MAP2K7, MAP3K1, MAPK12, MAPK14, MAPK3, MAPK8, MED1, MED14, MRAS, MT-CYB, MT-ND1, MT-ND2, MT-ND4, NCOA1, NDUFA10, NDUFA6, NDUFA9, NDUFAF1, NDUFB5, NDUFB7, NDUFS1, NDUFV1, NDUFV2, NFAT5, NFATC1, NFATC2, NFKB1, NFKBIA, NFKBIB, NRAS, PC, PDK4, PIK3CB, PIK3R1, PIK3R3, PLA2G3, PLA2G4A, PLA2G4E, POLR2E, POLR2I, POLR2J, PPARG, PPP3CA, PPP3CB, PPP3R1, PRKAA1, PRKAB1, PRKAB2, PRKACA, PRKAG3, PTGS2, RALA, RARA, RARG, RELA, RPS6KA5, RRAS, RXRG, SDHD, SLC37A4, SMAD3, SMAD4, SMARCA2, SMARCB1, SMARCD2, SMARCD3, SRA1, STAT3, TAF12, TAF15, TAT, TFB1M, TGFB1, TGFB2, TGFB3, TGFBR2, TRAF2, TRAF6, TSC22D3, UQCRC2, VCAM1		no direction
Cleavage and Polyadenylation of Pre-mRNA	0.371	0	0.571	CSTF2, NUDT21, PABPN1, PAPOLA		no direction
Fatty Acid α-oxidation	0.371	0	0.571	ALDH1A1, ALDH3A2, Aldh3b2, PTGS2		no direction
Methylglyoxal Degradation III	0.371	0	0.571	Akr1b10, AKR1B10, AKR7A2, PRXL2B		no direction
Mismatch Repair in Eukaryotes	0.371	0	0.571	MSH6, PCNA, POLD1, RPA1		no direction
Sucrose Degradation V (Mammalian)	0.371	2	0.571	ALDOA, ALDOB, GALM, TPI1		positive
Superpathway of Citrulline Metabolism	0.371	1	0.571	ASL, GLS, LOC102724788/PRODH, OAT		positive
PD-1, PD-L1 cancer immunotherapy pathway	0.369	0.447	0.489	AKT1, AKT2, AKT3, B2M, CBLB, CD274, CD80, HLA-A, MR1, NGFR, PDCD4, PIK3CB, PIK3R1, PIK3R3, PRKCQ, PTPN11, SMAD3, TGFB1, TGFB2, TGFB3, TNFRSF11B, TNFRSF1B, YAP1		positive
Coronavirus Pathogenesis Pathway	0.363	1.26	0.478	ACE, ADAM9, AR, ATF4, ATP6AP1, ATP6V1A, BAX, BCL2L11, CASP3, CCL5, CCND1, CCNE2, DDIT3, DDX58, E2F6, HDAC11, HDAC2, HDAC4, HDAC5, HDAC6, HDAC9, IFNAR2, IKBKB, IL17RA, IL6, IRF3, JUN, KPNB1, MAPK12, MAPK14, MAPK3, MAPK8, NFKB1, NFKBIA, NFKBIB, NPC1, PIKFYVE, PTGES2, PTGS2, PYCARD, RBL2, RELA, RPS27L, RPS5, RPS7, SMAD3, SMAD4, STAT3, STING1, TGFB1, TGFBR2, TOMM70, TP53, TRAF3		positive
IL-10 Signaling	0.362	0	0.489	CD14, IKBKB, IKBKG, IL1R1, IL1RAP, IL33, IL4R, IL6, JUN, LBP, MAP2K3, MAP2K6, MAPK12, MAPK14, MAPK8, NFKB1, NFKBIA, NFKBIB, RELA, SOCS3, STAT3, TRAF6		no direction
2-oxobutanoate Degradation I	0.361	0	0.6	DLD, MMUT, PCCA		no direction
Glycogen Biosynthesis II (from UDP-D-Glucose)	0.361	0	0.6	EPM2A, GBE1, GYS1		no direction
Hematopoiesis from Pluripotent Stem Cells	0.361	0	0.6	CD3G, IL6, KITLG		no direction
Heme Biosynthesis II	0.361	0	0.6	CPOX, FECH, UROD		no direction
Oleate Biosynthesis II (Animals)	0.361	0	0.6	SCD, Scd2, UFSP1		no direction
Fc Epsilon RI Signaling	0.361	-0.73	0.484	AKT1, AKT2, AKT3, HRAS, INPP5K, INPPL1, KRAS, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK12, MAPK14, MAPK3, MAPK8, MRAS, NRAS, PDPK1, PIK3CB, PIK3R1, PIK3R3, PLA2G3, PLA2G4A, PLA2G4E, PRKCE, PRKCI, PRKCQ, PTPN11, RALA, RRAS		negative
Role of PKR in Interferon Induction and Antiviral Response	0.361	-0.333	0.481	APAF1, ATF3, BAX, CASP3, DDX58, EIF2AK2, FADD, FAS, HSP90AA1, HSPA2, IFNAR2, IKBKB, IKBKG, IRF1, IRF3, JUN, MAP2K3, MAP2K6, MAP2K7, MAPK12, MAPK14, MAPK3, MAPK8, MYD88, NFKB1, NFKBIA, NFKBIB, PDGFA, PDGFB, PDGFC, PYCARD, RELA, STAT3, TARBP2, TLR4, TP53, TRAF3, TRAF6		negative
TWEAK Signaling	0.359	0.832	0.5	APAF1, CASP3, FADD, IKBKB, IKBKG, NFKB1, NFKBIA, NFKBIB, RELA, TNFRSF12A, TNFSF12, TRAF2, TRAF3		positive
Cell Cycle: G1/S Checkpoint Regulation	0.356	-0.243	0.488	CCND1, CCND3, CCNE2, CDC25A, CDKN1A, CUL1, E2F6, FOXO1, HDAC11, HDAC2, HDAC4, HDAC5, HDAC6, HDAC9, RBL2, SMAD3, SMAD4, TGFB1, TGFB2, TGFB3, TP53		negative
HIPPO signaling	0.355	1.091	0.483	AJUBA, AMOT, CD44, CSNK1E, CUL1, FAT4, FRMD6, ITCH, MOB1A, PATJ, PPM1J, PPP1R14C, PPP1R3A, PPP1R7, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, SMAD3, SMAD4, STK3, STK4, TEAD1, TP53BP2, WWTR1, YAP1, YWHAB, YWHAG, YWHAZ		positive
1,25-dihydroxyvitamin D3 Biosynthesis	0.348	0	0.667	CYP27B1, POR		no direction
Arginine Biosynthesis IV	0.348	0	0.667	ASL, OAT		no direction
Biotin-carboxyl Carrier Protein Assembly	0.348	0	0.667	ACACB, HLCS		no direction
Fatty Acid β-oxidation III (Unsaturated, Odd Number)	0.348	0	0.667	ECI1, ECI2		no direction
Folate Transformations I	0.348	0	0.667	MTHFD1, MTHFR		no direction
GDP-mannose Biosynthesis	0.348	0	0.667	GPI, MPI		no direction
Hematopoiesis from Multipotent Stem Cells	0.348	0	0.667	IL15, KITLG		no direction
L-cysteine Degradation I	0.348	0	0.667	CDO1, GOT2		no direction
Lysine Degradation II	0.348	0	0.667	AASDH, AASDHPPT		no direction
Molybdenum Cofactor Biosynthesis	0.348	0	0.667	GPHN, MOCS2		no direction
PRPP Biosynthesis I	0.348	0	0.667	PRPS1, PRPS2		no direction
Pathogenesis of Multiple Sclerosis	0.348	0	0.667	CCL5, CXCL10		no direction
Phosphatidylethanolamine Biosynthesis II	0.348	0	0.667	CHKA, ETNK1		no direction
Leptin Signaling in Obesity	0.342	0.577	0.487	ADCY5, ADCY8, AKT1, AKT2, AKT3, FOXO1, MAP2K1, MAPK3, PDIA3, PIK3CB, PIK3R1, PIK3R3, PLCD4, PRKACA, PRKAR1A, PRKAR2B, PTPN11, SOCS3, STAT3		positive
Coronavirus Replication Pathway	0.342	-1.508	0.5	ACE, BAG3, COPA, COPB2, COPG2, DDX1, TUBA1A, TUBB, TUBB2B, TUBB6, ZCRB1		negative
Spliceosomal Cycle	0.342	0.302	0.5	BUD13, CASC3, DDX39B, EFTUD2, MAGOH, PRPF18, PRPF19, SF3A1, SF3B2, SF3B4, SF3B6		positive
UVA-Induced MAPK Signaling	0.337	0.258	0.481	CASP3, EGFR, HRAS, JUN, KRAS, MAPK12, MAPK14, MAPK3, MAPK8, MRAS, MTOR, NRAS, PARP4, PARP9, PDIA3, PIK3CB, PIK3R1, PIK3R3, PLCD4, RALA, RPS6KA2, RPS6KA5, RRAS, TIPARP, TNKS, TP53		positive
Xenobiotic Metabolism Signaling	0.336	0	0.473	ABCB1, ABCC3, ALDH1A1, ALDH1L1, ALDH3A2, CAMK2D, CAMK2G, CHST10, CHST3, DNAJC7, FMO1, GSTM1, GSTM3, GSTM5, GSTO1, HDAC4, HDAC5, HRAS, HS2ST1, HS3ST3A1, HS3ST5, HS6ST1, HSP90AA1, IL6, KEAP1, KRAS, MAF, MAOA, MAOB, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAP3K1, MAP3K10, MAP3K2, MAP3K5, MAPK12, MAPK14, MAPK3, MAPK7, MAPK8, MED1, MGST3, MRAS, NCOA1, NDST1, NDST4, NFKB1, NQO1, NRAS, PIK3CB, PIK3R1, PIK3R3, PPARGC1A, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PRKCE, PRKCI, PRKCQ, RALA, RELA, RRAS, SMOX, SNW1, SOD3, SRA1		no direction
Renin-Angiotensin Signaling	0.334	0.365	0.478	ACE, ADCY5, ADCY8, CCL5, HRAS, ITPR2, JUN, KRAS, MAP2K1, MAP3K1, MAPK12, MAPK14, MAPK3, MAPK8, MRAS, NFKB1, NRAS, PAK4, PIK3CB, PIK3R1, PIK3R3, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, PTK2, RALA, RELA, RRAS, SHE, STAT3		positive
MSP-RON Signaling Pathway	0.333	0	0.5	ACTA1, ACTA2, ACTB, ACTC1, CSF2RB, PIK3CB, PIK3R1, PIK3R3, RPS6KA2, TLR4		no direction
Retinol Biosynthesis	0.333	1.414	0.5	AKR1B10, Akr1b10, CEL, DHRS3, DHRS4, LIPE, LIPG, LPL, PLB1, PNPLA2		positive
4-hydroxybenzoate Biosynthesis	0.332	0	1	TAT		no direction
4-hydroxyphenylpyruvate Biosynthesis	0.332	0	1	TAT		no direction
Acyl Carrier Protein Metabolism	0.332	0	1	AASDHPPT		no direction
Adenine and Adenosine Salvage VI	0.332	0	1	ADK		no direction
Alanine Biosynthesis II	0.332	0	1	GPT2		no direction
Alanine Degradation III	0.332	0	1	GPT2		no direction
Arginine Degradation VI (Arginase 2 Pathway)	0.332	0	1	OAT		no direction
Asparagine Biosynthesis I	0.332	0	1	ASNS		no direction
D-mannose Degradation	0.332	0	1	MPI		no direction
Diphthamide Biosynthesis	0.332	0	1	EEF2		no direction
Dolichol and Dolichyl Phosphate Biosynthesis	0.332	0	1	DOLK		no direction
Geranylgeranyldiphosphate Biosynthesis	0.332	0	1	GGPS1		no direction
Glutamine Biosynthesis I	0.332	0	1	GLUL		no direction
Glutamine Degradation I	0.332	0	1	GLS		no direction
Glutathione Biosynthesis	0.332	0	1	GSS		no direction
Glycine Betaine Degradation	0.332	0	1	SRR		no direction
Histidine Degradation III	0.332	0	1	MTHFD1		no direction
Inosine-5'-phosphate Biosynthesis II	0.332	0	1	PAICS		no direction
L-glutamine Biosynthesis II (tRNA-dependent)	0.332	0	1	GATB		no direction
L-serine Degradation	0.332	0	1	SRR		no direction
Lactose Degradation III	0.332	0	1	GLB1		no direction
Pentose Phosphate Pathway (Oxidative Branch)	0.332	0	1	H6PD		no direction
Proline Biosynthesis II (from Arginine)	0.332	0	1	OAT		no direction
Protein Citrullination	0.332	0	1	PADI2		no direction
S-methyl-5-thio-α-D-ribose 1-phosphate Degradation	0.332	0	1	APIP		no direction
Spermine and Spermidine Degradation I	0.332	0	1	SMOX		no direction
Taurine Biosynthesis	0.332	0	1	CDO1		no direction
Thymine Degradation	0.332	0	1	DPYD		no direction
Thyroid Hormone Biosynthesis	0.332	0	1	CTSD		no direction
Thyroid Hormone Metabolism I (via Deiodination)	0.332	0	1	DIO2		no direction
Thyronamine and Iodothyronamine Metabolism	0.332	0	1	DIO2		no direction
Trehalose Degradation II (Trehalase)	0.332	0	1	HK2		no direction
Uracil Degradation II (Reductive)	0.332	0	1	DPYD		no direction
Prolactin Signaling	0.33	-0.408	0.481	HRAS, IRF1, IRS1, JUN, KCNMA1, KRAS, MAP2K1, MAPK3, MRAS, NRAS, PDPK1, PIK3CB, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, PRLR, PTPN11, RALA, RRAS, SOCS2, SOCS3, SOCS7, STAT3		negative
Eicosanoid Signaling	0.327	-0.378	0.486	CYSLTR1, DPEP1, LTA4H, PLA2G3, PLA2G4A, PLA2G4E, PLA2R1, PLAAT3, PLB1, PNPLA8, PRDX6, PTGER3, PTGER4, PTGES, PTGES2, PTGIS, PTGS2		negative
IL-2 Signaling	0.327	-0.775	0.486	AKT1, AKT2, AKT3, HRAS, JUN, KRAS, MAP2K1, MAPK3, MAPK8, MRAS, NRAS, PIK3CB, PIK3R1, PIK3R3, PTPN11, RALA, RRAS		negative
TNFR1 Signaling	0.327	1	0.486	APAF1, CASP2, CASP3, CRADD, FADD, IKBKB, IKBKG, JUN, MAP3K1, MAPK8, NFKB1, NFKBIA, NFKBIB, PAK4, RELA, TNFAIP3, TRAF2		positive
Apelin Liver Signaling Pathway	0.323	0.333	0.5	APLN, COL1A2, COL3A1, COL5A3, EDN1, FAS, IRS1, MAPK12, MAPK8		positive
Dermatan Sulfate Biosynthesis (Late Stages)	0.323	-0.333	0.5	CHST10, CHST3, DSE, HS2ST1, HS3ST3A1, HS3ST5, HS6ST1, NDST1, NDST4		negative
α-Adrenergic Signaling	0.322	-0.688	0.477	ADCY5, ADCY8, Calm1 (includes others), EPM2A, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, GYS1, HRAS, ITPR2, KRAS, MAP2K1, MAPK3, MRAS, NRAS, PHKA2, PHKB, PHKG1, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, PYGM, RALA, RRAS, SLC8A3		negative
Th1 and Th2 Activation Pathway	0.311	0	0.474	ACVR1, ACVR2A, APH1B, BMPR2, CD274, CD3G, CD80, HLA-A, IL12RB2, IL33, IL4R, IL6, IL6R, IRF1, JUN, MAF, MAP2K6, NCSTN, NFATC1, NFATC2, NFIL3, NFKB1, NOTCH1, NOTCH3, PIK3CB, PIK3R1, PIK3R3, PRKCQ, PSEN1, S1PR1, SOCS3, SPI1, STAT3, STAT6, TGFB1, TGFBR2		no direction
WNT/β-catenin Signaling	0.311	0.845	0.473	ACVR1, ACVR2A, AKT1, AKT2, AKT3, APPL2, BMPR2, CCND1, CD44, CDH2, CDH5, CSNK1A1, CSNK1E, CTNNB1, DVL3, FZD7, JUN, KREMEN1, LRP1, MARK2, PPARD, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, RARA, RARG, RUVBL2, SFRP1, SOX11, SOX4, SOX6, TGFB1, TGFB2, TGFB3, TGFBR2, TLE3, TLE4, TP53, Ubb, UBC, WNT9A		positive
Activation of IRF by Cytosolic Pattern Recognition Receptors	0.31	-1.291	0.484	DDX58, FADD, IKBKB, IKBKG, IL6, IRF3, JUN, MAPK12, MAPK8, NFKB1, NFKBIA, NFKBIB, RELA, TRAF3, TRAF6		negative
Heparan Sulfate Biosynthesis	0.31	-0.258	0.484	CHST10, CHST3, EXT1, EXTL2, HS2ST1, HS3ST3A1, HS3ST5, HS6ST1, LIPE, NDST1, NDST4, PLA1A, PNPLA7, PPME1, PRDX6		negative
Role of CHK Proteins in Cell Cycle Checkpoint Control	0.31	-0.632	0.484	ATMIN, CDC25A, CDKN1A, E2F6, HUS1, PCNA, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, RAD17, RPA1, TLK2, TP53		negative
Atherosclerosis Signaling	0.304	0	0.475	APOE, COL1A2, COL3A1, COL5A3, F3, GLG1, IL33, IL6, LPL, NFKB1, PDGFA, PDGFB, PDGFC, PLA2G3, PLA2G4A, PLA2G4E, PLA2R1, PLAAT3, PLB1, PNPLA8, PRDX6, RBP4, RELA, SELP, TGFB1, TNFRSF12A, TNFSF12, VCAM1		no direction
3-phosphoinositide Biosynthesis	0.303	-0.762	0.47	ATP1A1, ATP1A2, CA3, CDC25A, CDIPT, CILP, DUSP1, DUSP10, DUSP13, DUSP16, DUSP2, DUSP6, DUSP8, FIG4, HACD2, INPPL1, IPMK, MDP1, MTMR6, NOCT, NUDT12, NUDT14, NUDT4, NUDT9, PGAM5, PIK3CB, PIK3R1, PIK3R3, PIKFYVE, PLPP7, PPFIA1, PPFIBP2, PPIP5K1, PPM1J, PPP1R14C, PPP1R3A, PPP1R7, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PPP3CA, PPP3CB, PPP3R1, PPP4C, PPP4R1, PPP5C, PRUNE1, PTPN11, PTPN12, RASA1, SIRPA, SOCS3, THTPA, WBP11		negative
mTOR Signaling	0.303	-1.021	0.47	AKT1, AKT1S1, AKT2, AKT3, ATG13, DDIT4, DGKZ, EIF3D, EIF3E, EIF3F, EIF3M, EIF4EBP1, EIF4EBP2, EIF4G3, FNBP1, HRAS, INSR, IRS1, KRAS, MAPK3, MRAS, MTOR, NRAS, PDGFC, PDPK1, PIK3CB, PIK3R1, PIK3R3, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PRKAA1, PRKAB1, PRKAB2, PRKAG3, PRKCE, PRKCI, PRKCQ, PRR5L, RALA, RHOA, RHOB, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RND1, RPS27L, RPS5, RPS6KA2, RPS6KA5, RPS7, RPTOR, RRAS, TSC1, TSC2, ULK1, VEGFD		negative
Glutathione-mediated Detoxification	0.3	-0.816	0.5	Gsta4, GSTM1, GSTM3, GSTM5, GSTO1, MGST3, PTGES		negative
Retinoate Biosynthesis I	0.3	0.378	0.5	Akr1b10, AKR1B10, ALDH1A1, DHRS3, DHRS4, RDH16, RDH5		positive
Superpathway of Inositol Phosphate Compounds	0.299	-0.14	0.469	ATP1A1, ATP1A2, CA3, CDC25A, CDIPT, CILP, DUSP1, DUSP10, DUSP13, DUSP16, DUSP2, DUSP6, DUSP8, FIG4, HACD2, INPP5A, INPP5E, INPP5K, INPPL1, IP6K1, IP6K3, IPMK, MDP1, MTMR6, NOCT, NUDT12, NUDT14, NUDT4, NUDT9, PGAM5, PIK3CB, PIK3R1, PIK3R3, PIKFYVE, PLCD4, PLPP7, PPFIA1, PPFIBP2, PPIP5K1, PPM1J, PPP1R14C, PPP1R3A, PPP1R7, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PPP3CA, PPP3CB, PPP3R1, PPP4C, PPP4R1, PPP5C, PRUNE1, PTPN11, PTPN12, RASA1, SIRPA, SOCS3, THTPA, WBP11		negative
P2Y Purigenic Receptor Signaling Pathway	0.294	-0.18	0.471	ADCY5, ADCY8, AKT1, AKT2, AKT3, ATF4, CREB3L2, GNAI2, GNB1, GNB2, GNG2, HRAS, JUN, KRAS, MAP2K1, MAPK3, MRAS, NFKB1, NRAS, PDIA3, PIK3CB, PIK3R1, PIK3R3, PLCD4, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, RALA, RELA, RRAS		negative
BER (Base Excision Repair) Pathway	0.293	0.277	0.481	ARL6IP5, HUWE1, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK3, NEIL1, NF1, PCNA, POLB, RPA1, TP53		positive
BMP signaling pathway	0.292	-1.043	0.473	BMP8A, BMPR1B, BMPR2, FST, HRAS, JUN, KRAS, MAGED1, MAP2K1, MAPK12, MAPK14, MAPK3, MAPK8, MRAS, NFKB1, NOG, NRAS, PITX2, PRKACA, PRKAR1A, PRKAR2B, RALA, RELA, RRAS, SMAD4, ZNF423		negative
Growth Hormone Signaling	0.288	0.943	0.475	CEBPA, GHR, IRS1, MAPK3, PDPK1, PIK3CB, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, RPS6KA2, RPS6KA5, SLC2A4, SOCS2, SOCS3, SOCS7, SRF, STAT3		positive
Role of p14/p19ARF in Tumor Suppression	0.286	-1.633	0.5	PIK3CB, PIK3R1, PIK3R3, SF3A1, TP53, UBTF		negative
D-myo-inositol (1,4,5,6)-Tetrakisphosphate Biosynthesis	0.285	-0.949	0.468	ATP1A1, ATP1A2, CA3, CDC25A, CILP, DUSP1, DUSP10, DUSP13, DUSP16, DUSP2, DUSP6, DUSP8, FIG4, HACD2, INPPL1, IPMK, MDP1, MTMR6, NOCT, NUDT12, NUDT14, NUDT4, NUDT9, PGAM5, PIKFYVE, PLPP7, PPFIA1, PPFIBP2, PPIP5K1, PPM1J, PPP1R14C, PPP1R3A, PPP1R7, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PPP3CA, PPP3CB, PPP3R1, PPP4C, PPP4R1, PPP5C, PRUNE1, PTPN11, PTPN12, RASA1, SIRPA, SOCS3, THTPA, WBP11		negative
D-myo-inositol (3,4,5,6)-tetrakisphosphate Biosynthesis	0.285	-0.949	0.468	ATP1A1, ATP1A2, CA3, CDC25A, CILP, DUSP1, DUSP10, DUSP13, DUSP16, DUSP2, DUSP6, DUSP8, FIG4, HACD2, INPPL1, IPMK, MDP1, MTMR6, NOCT, NUDT12, NUDT14, NUDT4, NUDT9, PGAM5, PIKFYVE, PLPP7, PPFIA1, PPFIBP2, PPIP5K1, PPM1J, PPP1R14C, PPP1R3A, PPP1R7, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PPP3CA, PPP3CB, PPP3R1, PPP4C, PPP4R1, PPP5C, PRUNE1, PTPN11, PTPN12, RASA1, SIRPA, SOCS3, THTPA, WBP11		negative
Cyclins and Cell Cycle Regulation	0.285	0.243	0.472	CCND1, CCND3, CCNE2, CCNH, CDC25A, CDKN1A, CUL1, E2F6, HDAC11, HDAC2, HDAC4, HDAC5, HDAC6, HDAC9, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, RBL2, TGFB1, TGFB2, TGFB3, TP53, WEE1		positive
HER-2 Signaling in Breast Cancer	0.284	-0.525	0.467	AKT1, AKT1S1, AKT2, AKT3, BCL2L11, CASP3, CCND1, CCNE2, CDKN1A, COX5A, COX6A1, COX7A2, COX7B, Cox8b, EGFR, ELF1, ERBB2, ERBB3, ETS1, ETS2, FOXO1, HRAS, IKBKB, IKBKG, ITGB1, JUN, KPNB1, KRAS, MAP2K1, MAPK3, MRAS, MT-CO1, MTOR, NFKB1, NFKBIA, NFKBIB, NRAS, NUP205, NUP43, NUP58, NUP88, PARD6G, PDK1, PIK3CB, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, PTGS2, RALA, RBL2, RELA, RPTOR, RRAS, SEC13, SEH1L, SMAD3, SMAD4, STAT3, TGFA, TP53, TSC1, TSC2		negative
MIF-mediated Glucocorticoid Regulation	0.283	1.155	0.48	CD14, CD74, MAPK3, NFKB1, NFKBIA, NFKBIB, PLA2G3, PLA2G4A, PLA2G4E, PTGS2, RELA, TLR4		positive
Th1 Pathway	0.278	1.706	0.471	APH1B, CD274, CD3G, CD80, HLA-A, IL12RB2, IL6, IL6R, IRF1, MAP2K6, NCSTN, NFATC1, NFATC2, NFIL3, NFKB1, NOTCH1, NOTCH3, PIK3CB, PIK3R1, PIK3R3, PRKCQ, PSEN1, SOCS3, STAT3		positive
Ethanol Degradation IV	0.271	1.342	0.5	ACSL1, ACSS1, ALDH1A1, ALDH3A2, Aldh3b2		positive
Isoleucine Degradation I	0.271	0	0.5	ACAA2, BCAT2, DLD, HADHA, HSD17B4		no direction
Adrenomedullin signaling pathway	0.271	0	0.466	ADCY5, ADCY8, AKT1, AKT2, AKT3, BAX, C3, Calm1 (includes others), CASP3, CFH, HRAS, IL33, ITPR2, KCNN3, KRAS, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK12, MAPK14, MAPK3, MAPK7, MAPK8, MRAS, MYLK, MYLK3, NFKB1, NPR3, NRAS, PDIA3, PIK3CB, PIK3R1, PIK3R3, PLCD4, PPARG, PRKACA, PRKAR1A, PRKAR2B, PRKG1, PTK2, RALA, RAMP3, RELA, RRAS, RXRG, SHE, TTN		no direction
VEGF Signaling	0.27	0.392	0.468	ACTA1, ACTA2, ACTB, ACTC1, ACTN2, ACTN4, AKT1, AKT2, AKT3, EIF2B2, EIF2B4, FOXO1, HRAS, KRAS, MAP2K1, MAPK3, MRAS, NRAS, PDGFC, PIK3CB, PIK3R1, PIK3R3, PTK2, PTPN11, RALA, ROCK1, RRAS, VCL, VEGFD		positive
Cellular Effects of Sildenafil (Viagra)	0.269	0	0.467	ACTA1, ACTA2, ACTB, ACTC1, ADCY5, ADCY8, CACNA1C, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, Calm1 (includes others), ITPR2, KCNN3, MPRIP, MYH1, MYH2, MYH3, MYH4, MYH8, MYH9, MYL1, MYL4, MYL9, MYLK, MYLPF, PABPC4, PDE1C, PDIA3, PLCD4, PRKACA, PRKAR1A, PRKAR2B, PRKG1		no direction
Xenobiotic Metabolism CAR Signaling Pathway	0.267	-0.469	0.466	ABCB1, ABCC3, ALDH1A1, ALDH1L1, ALDH3A2, CHST10, CHST3, DNAJC7, EGFR, FMO1, GSTM1, GSTM3, GSTM5, GSTO1, HS2ST1, HS3ST3A1, HS3ST5, HS6ST1, HSP90AA1, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK3, MED1, MGST3, NCOA1, NDST1, NDST4, PPARGC1A, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PRKCE, PRKCI, PRKCQ, SNW1, SOD3, SRA1		negative
MSP-RON Signaling In Macrophages Pathway	0.265	0.218	0.468	ATF4, CREB3L2, GAB2, HRAS, IKBKB, IKBKG, JUN, KRAS, MAPK3, MRAS, NFKB1, NRAS, PIK3CB, PIK3R1, PIK3R3, PTGS2, RALA, RELA, RRAS, SOCS3, STAT3, TLR4		positive
Chondroitin Sulfate Biosynthesis (Late Stages)	0.262	-0.632	0.476	CHPF, CHST10, CHST3, CSGALNACT2, HS2ST1, HS3ST3A1, HS3ST5, HS6ST1, NDST1, NDST4		negative
Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells	0.251	0.816	0.474	APAF1, B2M, CASP3, CD3G, DFFA, FADD, FAS, HLA-A, MR1		positive
Assembly of RNA Polymerase III Complex	0.229	0	0.5	GTF3C2, GTF3C3, SF3A1		no direction
Chondroitin and Dermatan Biosynthesis	0.229	0	0.5	CHPF, CHPF2, CSGALNACT2		no direction
Differential Regulation of Cytokine Production in Macrophages and T Helper Cells by IL-17A and IL-17F	0.229	0	0.5	CCL5, IL17F, IL6		no direction
Extrinsic Prothrombin Activation Pathway	0.229	0	0.5	F2, F3, THBD		no direction
Glycogen Degradation III	0.229	0	0.5	GAA, PGM1, PYGM		no direction
Superpathway of Geranylgeranyldiphosphate Biosynthesis I (via Mevalonate)	0.229	0	0.5	ACAA2, GGPS1, HADHA		no direction
Pyrimidine Ribonucleotides De Novo Biosynthesis	0.224	0.816	0.467	CANT1, CMPK2, CTPS1, DDX3X, DHX29, DHX9, SLC25A42		positive
Pyrimidine Ribonucleotides Interconversion	0.224	0.816	0.467	CANT1, CMPK2, CTPS1, DDX3X, DHX29, DHX9, SLC25A42		positive
TCA Cycle II (Eukaryotic)	0.224	-1.134	0.467	DLD, DLST, FH, IDH3A, IDH3B, OGDH, SDHD		negative
Bile Acid Biosynthesis, Neutral Pathway	0.198	0	0.5	CYP27A1, SCP2		no direction
Glutathione Redox Reactions II	0.198	0	0.5	PDIA3, TXNDC12		no direction
Ketolysis	0.198	0	0.5	ACAA2, HADHA		no direction
Methylmalonyl Pathway	0.198	0	0.5	MMUT, PCCA		no direction
Pentose Phosphate Pathway	0.198	0	0.5	H6PD, TKT		no direction
Arginine Degradation I (Arginase Pathway)	0.146	0	0.5	OAT		no direction
Ascorbate Recycling (Cytosolic)	0.146	0	0.5	GSTO1		no direction
Aspartate Biosynthesis	0.146	0	0.5	GOT2		no direction
Dolichyl-diphosphooligosaccharide Biosynthesis	0.146	0	0.5	ALG5		no direction
Galactose Degradation I (Leloir Pathway)	0.146	0	0.5	GALM		no direction
Glutamate Degradation II	0.146	0	0.5	GOT2		no direction
Glycine Cleavage Complex	0.146	0	0.5	DLD		no direction
Hypusine Biosynthesis	0.146	0	0.5	DHPS		no direction
NAD Biosynthesis III	0.146	0	0.5	NAMPT		no direction
NAD Biosynthesis from 2-amino-3-carboxymuconate Semialdehyde	0.146	0	0.5	NADSYN1		no direction
NAD Salvage Pathway III	0.146	0	0.5	NMRK2		no direction
NAD biosynthesis II (from tryptophan)	0.146	0	0.5	NADSYN1		no direction
Palmitate Biosynthesis I (Animals)	0.146	0	0.5	CBR4		no direction
Proline Degradation	0.146	0	0.5	LOC102724788/PRODH		no direction
Putrescine Biosynthesis III	0.146	0	0.5	AZIN2		no direction
Pyruvate Fermentation to Lactate	0.146	0	0.5	LDHA		no direction
S-adenosyl-L-methionine Biosynthesis	0.146	0	0.5	MAT2A		no direction
Serotonin and Melatonin Biosynthesis	0.146	0	0.5	TPH1		no direction
Tetrahydrofolate Salvage from 5,10-methenyltetrahydrofolate	0.146	0	0.5	MTHFD1		no direction
Trans, trans-farnesyl Diphosphate Biosynthesis	0.146	0	0.5	GGPS1		no direction
Tyrosine Degradation I	0.146	0	0.5	TAT		no direction
Urea Cycle	0.146	0	0.5	ASL		no direction
1D-myo-inositol Hexakisphosphate Biosynthesis V (from Ins(1,3,4)P3)	0	0	0.333	IPMK		no direction
3-phosphoinositide Degradation	0	-0.905	0.458	ATP1A1, ATP1A2, CA3, CDC25A, CILP, DUSP1, DUSP10, DUSP13, DUSP16, DUSP2, DUSP6, DUSP8, FIG4, HACD2, INPP5E, INPP5K, INPPL1, MDP1, MTMR1, MTMR6, NOCT, NUDT12, NUDT14, NUDT4, NUDT9, PGAM5, PIKFYVE, PLPP7, PPFIA1, PPFIBP2, PPIP5K1, PPM1J, PPP1R14C, PPP1R3A, PPP1R7, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PPP3CA, PPP3CB, PPP3R1, PPP4C, PPP4R1, PPP5C, PRUNE1, PTPMT1, PTPN11, PTPN12, RASA1, SIRPA, SOCS3, THTPA, WBP11		negative
Acetone Degradation I (to Methylglyoxal)	0	0	0.308	AKR1B10, CYP2U1, POR, PRXL2B		no direction
Acyl-CoA Hydrolysis	0	0	0.143	THEM4		no direction
Agranulocyte Adhesion and Diapedesis	0	0	0.349	ACTA1, ACTA2, ACTB, ACTC1, CCL5, Ccl7, CDH5, CXCL10, CXCL13, EZR, GLG1, GNAI2, IL1R1, IL33, ITGA3, ITGA6, ITGB1, MMP14, MYH1, MYH2, MYH3, MYH4, MYH8, MYH9, MYL1, MYL4, MYL9, RDX, SELP, VCAM1		no direction
Airway Inflammation in Asthma	0	0	0.455	IL17F, IL33, TGFB1, TGFB2, TGFB3		no direction
Airway Pathology in Chronic Obstructive Pulmonary Disease	0	0	0.436	FGF1, FGF12, FGF13, FGF16, FGF18, FGF2, FGF6, IL15, IL17F, IL33, IL6, LTB, RBP4, TGFB1, TGFB2, TGFB3, TNFSF12		no direction
Allograft Rejection Signaling	0	0	0.312	B2M, CD3G, CD80, FAS, HLA-A		no direction
Altered T Cell and B Cell Signaling in Rheumatoid Arthritis	0	0	0.463	CD3G, CD80, CXCL13, FAS, HLA-A, IL15, IL33, IL6, LTB, NFKB1, RELA, SPP1, TGFB1, TLR1, TLR4, TLR5, TLR6, TNFRSF13C, TRAF3		no direction
Androgen Biosynthesis	0	0	0.25	Gsta4		no direction
Antigen Presentation Pathway	0	0	0.444	B2M, CALR, CD74, HLA-A, MR1, PDIA3, TAP1, TAPBP		no direction
Antioxidant Action of Vitamin C	0	-0.447	0.426	CSF2RB, GSTO1, IKBKB, IKBKG, MAPK12, MAPK14, MAPK3, MAPK8, NFKB1, NFKBIA, NFKBIB, PDIA3, PLA2G3, PLA2G4A, PLA2G4E, PLA2R1, PLAAT3, PLB1, PLCD4, PNPLA8, PRDX6, RELA, SLC2A1, SLC2A4, SLC2A5, TXNRD1		negative
Antiproliferative Role of Somatostatin Receptor 2	0	-0.258	0.459	CDKN1A, GNB1, GNB2, GNG2, HRAS, KRAS, MAP2K1, MAPK3, MRAS, NPR3, NRAS, PIK3CB, PIK3R1, PIK3R3, PTPN11, RALA, RRAS		negative
Apelin Adipocyte Signaling Pathway	0	1.528	0.444	ADCY5, ADCY8, APLN, GNAI2, GPX3, Gsta4, GSTM1, LIPE, MAPK12, MAPK14, MAPK3, MAPK7, MAPK8, MGST3, PPARGC1A, PRDX6, PRKAA1, PRKAB1, PRKAB2, PRKACA, PRKAG3, PRKAR1A, PRKAR2B, PTGES		positive
Arsenate Detoxification I (Glutaredoxin)	0	0	0.333	GSTO1		no direction
Aspartate Degradation II	0	0	0.333	GOT2		no direction
Assembly of RNA Polymerase I Complex	0	0	0.4	TAF1B, UBTF		no direction
Assembly of RNA Polymerase II Complex	0	-0.632	0.435	CCNH, GTF2A1, GTF2E1, GTF2H2, GTF2H5, POLR2E, POLR2I, POLR2J, TAF12, TAF15		negative
Autoimmune Thyroid Disease Signaling	0	0	0.25	CD3G, CD80, FAS, HLA-A		no direction
B Cell Development	0	0	0.143	CD80, HLA-A		no direction
Basal Cell Carcinoma Signaling	0	0.378	0.429	BMP8A, CTNNB1, DVL3, FZD7, GLI3, STK36, SUFU, TP53, WNT9A		positive
Branched-chain α-keto acid Dehydrogenase Complex	0	0	0.25	DLD		no direction
Breast Cancer Regulation by Stathmin1	0	0.322	0.398	ADGRA3, ADGRG1, ADGRL3, ADRB2, ARHGEF1, ARHGEF12, ARHGEF17, ARHGEF9, ATF4, BDKRB2, CAMK2D, CAMK2G, CCND1, CCND3, CNR1, CREB3L2, CRHR2, CYSLTR1, E2F6, F2R, F2RL1, FGF2, FZD7, GNA13, GNB1, GNB2, GNG2, GPR155, GPR34, GPR37L1, GPRC5C, GPRC6A, HRAS, HTR1B, HTR2B, JUN, KRAS, LGR4, LPAR4, LPAR6, MAP2K1, MAPK3, MC5R, MRAS, MTOR, NFKB1, NPY1R, NRAS, PDGFB, PDGFC, PIK3CB, PIK3R1, PIK3R3, PPM1J, PPP1R14C, PPP1R3A, PPP1R7, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PPP4C, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, PTGER3, PTGER4, RALA, RB1CC1, RHOA, RLIM, RRAS, RXFP1, S1PR1, S1PR3, STAT3, TGFA, TGFB1, TGFB2, TP53, TUBA1A, TUBB, TUBB2B, TUBB6, TUBG1, UHMK1, VEGFD		positive
Bupropion Degradation	0	0	0.2	CYP2U1, POR		no direction
CCR3 Signaling in Eosinophils	0	0.447	0.452	Calm1 (includes others), CFL2, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, HRAS, ITPR2, KRAS, MAP2K1, MAPK12, MAPK14, MAPK3, MPRIP, MRAS, MYLK, NRAS, PAK4, PIK3CB, PIK3R1, PIK3R3, PLA2G3, PLA2G4A, PLA2G4E, PRKCE, PRKCI, PRKCQ, RALA, RHOA, ROCK1, RRAS		positive
CCR5 Signaling in Macrophages	0	0.302	0.464	CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, Calm1 (includes others), CCL5, CD3G, FAS, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, ITPR2, JUN, MAPK12, MAPK14, MAPK8, MRAS, PRKCE, PRKCI, PRKCQ		positive
CDC42 Signaling	0	-1.279	0.44	ARPC1B, ARPC3, ARPC4, B2M, BAIAP2, CD3G, CFL2, CLIP1, EXOC1, EXOC6, HLA-A, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, JUN, MAPK12, MAPK14, MAPK8, MPRIP, MYL1, MYL4, MYL9, MYLK, MYLPF, PAK4, PRKCI, RALA, RASA1, WIPF1		negative
CMP-N-acetylneuraminate Biosynthesis I (Eukaryotes)	0	0	0.333	CMAS		no direction
CREB Signaling in Neurons	0	-1.222	0.385	ADCY5, ADCY8, ADGRA3, ADGRG1, ADGRL3, ADRB2, AKT1, AKT2, AKT3, ATF4, BDKRB2, BMPR1B, BMPR2, CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, Calm1 (includes others), CAMK2D, CAMK2G, CNR1, CREB3L2, CRHR2, CYSLTR1, EGFR, F2R, F2RL1, FGF2, FGFR2, FZD7, GHR, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, GPR155, GPR34, GPR37L1, GPRC5C, GPRC6A, GRIN1, GRIN2A, HRAS, HTR1B, HTR2B, INSR, ITPR2, KRAS, LGR4, LPAR4, LPAR6, MAP2K1, MAPK3, MC5R, MRAS, NGFR, NPY1R, NRAS, PDGFB, PDGFRA, PDIA3, PIK3CB, PIK3R1, PIK3R3, PLCD4, POLR2E, POLR2I, POLR2J, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, PTGER3, PTGER4, RALA, RRAS, RXFP1, S1PR1, S1PR3, TGFA, TGFB1, TGFB2, TGFBR2		negative
CTLA4 Signaling in Cytotoxic T Lymphocytes	0	0	0.463	AKT1, AKT2, AKT3, AP1S2, AP2A2, B2M, CD3G, CD80, HLA-A, MR1, PIK3CB, PIK3R1, PIK3R3, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PTPN11		no direction
Calcium-induced T Lymphocyte Apoptosis	0	-0.5	0.459	ATP2A1, ATP2A3, Calm1 (includes others), CAPN2, CD3G, CHP1, HDAC2, HLA-A, ITPR2, MEF2D, NFATC2, PPP3CA, PPP3CB, PPP3R1, PRKCE, PRKCI, PRKCQ		negative
Cardiac β-adrenergic Signaling	0	-0.626	0.4	ADCY5, ADCY8, AKAP1, AKAP11, AKAP13, AKAP6, ATP2A1, ATP2A3, CACNA1C, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, MRAS, PDE1C, PDE7A, PDE7B, PDE8A, PKIA, PPM1J, PPP1R14C, PPP1R3A, PPP1R7, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PRKACA, PRKAR1A, PRKAR2B, SLC8A3		negative
Cardiomyocyte Differentiation via BMP Receptors	0	0	0.364	BMPR1B, BMPR2, MEF2C, SMAD4		no direction
Ceramide Biosynthesis	0	0	0.333	SPTLC2		no direction
Ceramide Degradation	0	0	0.333	ASAH2		no direction
Chemokine Signaling	0	-0.894	0.444	Calm1 (includes others), CAMK2D, CAMK2G, CCL5, GNAI2, HRAS, JUN, KRAS, MAP2K1, MAPK12, MAPK14, MAPK3, MAPK8, MPRIP, MRAS, NRAS, PTK2, RALA, RHOA, RRAS		negative
Choline Biosynthesis III	0	0	0.286	PCYT1A, PHKA1		no direction
Chondroitin Sulfate Biosynthesis	0	-0.905	0.423	CHPF, CHPF2, CHST10, CHST3, CSGALNACT2, HS2ST1, HS3ST3A1, HS3ST5, HS6ST1, NDST1, NDST4		negative
Circadian Rhythm Signaling	0	0	0.463	ADCY5, ADCY8, AKT1S1, ARNTL, ATF4, BDNF, BHLHE40, CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, CAMK2D, CAMK2G, CIRBP, CREB3L2, CSNK1E, EIF4EBP1, EIF4EBP2, GNAI2, GNB1, GNB2, GNG2, GRIN1, GRIN2A, GRINA, H3-3A/H3-3B, HRAS, ITPR2, KRAS, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK3, MKNK1, MKNK2, MRAS, MTOR, NFIL3, NGFR, NPR3, NR1D1, NR1D2, NRAS, PDIA3, PER1, PLCD4, PRKAA1, PRKAB1, PRKAB2, PRKACA, PRKAG3, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, PRKG1, RALA, RORA, RORB, RPS6KA5, RPTOR, RRAS, RYR1, RYR3		no direction
Citrulline-Nitric Oxide Cycle	0	0	0.333	ASL		no direction
Coagulation System	0	0	0.462	BDKRB2, F2, F2R, F3, PLAT, THBD		no direction
Colanic Acid Building Blocks Biosynthesis	0	0	0.429	GPI, MPI, UGDH		no direction
Communication between Innate and Adaptive Immune Cells	0	0	0.441	B2M, CCL5, CD3G, CD80, CXCL10, HLA-A, IL15, IL33, IL6, MR1, TLR1, TLR4, TLR5, TLR6, TNFRSF13C		no direction
Complement System	0	0.447	0.333	C1QBP, C2, C3, CFB, CFH		positive
Corticotropin Releasing Hormone Signaling	0	-0.378	0.41	ADCY5, ADCY8, ATF4, BDNF, CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, Calm1 (includes others), CNR1, CREB3L2, CRHR2, GLI3, GNAI2, ITPR2, JUN, MAP2K1, MAPK12, MAPK14, MAPK3, MEF2A, MEF2C, MEF2D, NPR3, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, PTGS2		negative
D-myo-inositol (1,4,5)-Trisphosphate Biosynthesis	0	0	0.375	CDIPT, PIKFYVE, PLCD4		no direction
D-myo-inositol-5-phosphate Metabolism	0	-0.949	0.443	ATP1A1, ATP1A2, CA3, CDC25A, CILP, DUSP1, DUSP10, DUSP13, DUSP16, DUSP2, DUSP6, DUSP8, FIG4, HACD2, INPPL1, MDP1, MTMR6, NOCT, NUDT12, NUDT14, NUDT4, NUDT9, PGAM5, PIKFYVE, PLCD4, PLPP7, PPFIA1, PPFIBP2, PPIP5K1, PPM1J, PPP1R14C, PPP1R3A, PPP1R7, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PPP3CA, PPP3CB, PPP3R1, PPP4C, PPP4R1, PPP5C, PRUNE1, PTPN11, PTPN12, RASA1, SIRPA, SOCS3, THTPA, WBP11		negative
DNA Double-Strand Break Repair by Homologous Recombination	0	0	0.286	ATRX, RPA1		no direction
Dendritic Cell Maturation	0	1.151	0.464	AKT1, AKT2, AKT3, ATF4, B2M, CD1D, CD3G, CD80, COL1A2, COL3A1, COL5A3, CREB3L2, HLA-A, IKBKB, IKBKG, IL15, IL33, IL6, LTB, MAPK12, MAPK14, MAPK3, MAPK8, MR1, MYD88, NFKB1, NFKBIA, NFKBIB, NGFR, PDIA3, PIK3CB, PIK3R1, PIK3R3, PLCD4, RELA, TLR4, TNFRSF11B, TNFRSF1B, TRAF6		positive
Dermatan Sulfate Biosynthesis	0	-0.577	0.429	CHPF, CHPF2, CHST10, CHST3, CSGALNACT2, DSE, HS2ST1, HS3ST3A1, HS3ST5, HS6ST1, NDST1, NDST4		negative
Differential Regulation of Cytokine Production in Intestinal Epithelial Cells by IL-17A and IL-17F	0	0	0.4	CCL5, IL17F		no direction
Dopamine Receptor Signaling	0	-1.342	0.356	ADCY5, ADCY8, MAOA, MAOB, PPM1J, PPP1R14C, PPP1R3A, PPP1R7, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PRKACA, PRKAR1A, PRKAR2B, SMOX		negative
Dopamine-DARPP32 Feedback in cAMP Signaling	0	-0.686	0.43	ADCY5, ADCY8, ATF4, ATP2A1, ATP2A3, CACNA1C, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, Calm1 (includes others), CHP1, CREB3L2, CREM, CSNK1A1, CSNK1E, GNAI2, GRIN1, GRIN2A, GRINA, ITPR2, KCNJ2, PDIA3, PLCD4, PPM1J, PPP1R14C, PPP1R3A, PPP1R7, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PPP3CA, PPP3CB, PPP3R1, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, PRKG1		negative
EIF2 Signaling	0	0	0.367	ACTA1, ACTA2, ACTB, ACTC1, AGO2, AGO4, AKT1, AKT2, AKT3, ATF3, ATF4, ATF5, CCND1, DDIT3, EIF2AK1, EIF2AK2, EIF2B2, EIF2B4, EIF3D, EIF3E, EIF3F, EIF3M, EIF4G3, EIF5B, HRAS, INSR, KRAS, MAP2K1, MAPK3, MRAS, NRAS, PAIP1, PDPK1, PIK3CB, PIK3R1, PIK3R3, RALA, RPL10A, RPL15, RPL22, Rpl22l1, RPL8, RPS27L, RPS5, RPS7, RRAS, SREBF1		no direction
Endothelin-1 Signaling	0	0.16	0.396	ADCY5, ADCY8, CASP2, CASP3, CASQ1, EDN1, GNA13, GNAI2, GNAL, HRAS, ITPR2, JUN, KRAS, MAPK12, MAPK14, MAPK3, MAPK7, MAPK8, MRAS, NRAS, PDIA3, PIK3CB, PIK3R1, PIK3R3, PLA2G3, PLA2G4A, PLA2G4E, PLA2R1, PLAAT3, PLB1, PLCD4, PNPLA8, PRDX6, PRKCE, PRKCI, PRKCQ, PTGS2, RALA, RRAS, SHE		positive
Estrogen Biosynthesis	0	0	0.235	AKR1B10, CYP2U1, HSD17B4, POR		no direction
Estrogen Receptor Signaling	0	-0.417	0.461	ADCY5, ADCY8, AKT1, AKT2, AKT3, ATF4, ATP5F1C, ATP5F1D, ATP5MC1, CACNA1C, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, CARM1, CAV1, CCNC, CCND1, CDK8, CDKN1A, CFL2, CREB3L2, DDX5, EGFR, EIF2B2, EIF2B4, EIF4EBP1, ESR1, FBXO32, FOXO1, FOXO4, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, GPS2, HES1, HRAS, HSP90AA1, JUN, KRAS, MAP2K1, MAPK3, MCU, MED1, MED12, MED12L, MED14, MED20, MED21, MED6, MMP14, MPRIP, MRAS, MT-CYB, MT-ND1, MT-ND2, MT-ND4, MTOR, MYL1, MYL4, MYL9, MYLPF, NCOA1, NDUFA10, NDUFA6, NDUFA9, NDUFAF1, NDUFB5, NDUFB7, NDUFS1, NDUFV1, NDUFV2, NFKB1, NOTCH1, NRAS, PCNA, PDGFC, PDIA3, PELP1, PIK3CB, PIK3R1, PIK3R3, PLCD4, PPARGC1A, PRKAA1, PRKAB1, PRKAB2, PRKACA, PRKAG3, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, RALA, RBFOX2, RELA, RHOA, ROCK1, RRAS, SDHD, SHE, SRA1, TBL1XR1, TP53, TRIM63, UQCRC2, VEGFD		negative
Estrogen-mediated S-phase Entry	0	-0.816	0.4	CCND1, CCNE2, CDC25A, CDKN1A, E2F6, ESR1		negative
FAK Signaling	0	0	0.46	ACVR1, ACVR2A, ADGRA3, ADGRG1, ADGRL3, ADRB2, AGO2, AKT1, AKT2, AKT3, ARPC1B, ARPC3, ARPC4, ASAP1, BCAR1, BCAR3, BDKRB2, BMPR2, CAPN1, CAPN2, CAPN3, CAPN7, CAPNS1, CCND1, CD3G, CDH5, CNR1, COL1A2, COL3A1, COL5A3, CRHR2, CRK, CSF2RB, CTNNB1, CYSLTR1, ECM1, EFNB1, EGFR, ELF1, ERBB2, ETS1, ETS2, F2R, F2RL1, FZD7, GHR, GPR155, GPR34, GPR37L1, GPRC5C, GPRC6A, HRAS, HTR1B, HTR2B, IL12RB2, IL17RA, IL17RC, IL17RD, IL17RE, IL1R1, IL33, IL4R, IL6R, IL6ST, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, JUN, KRAS, LGR4, LPAR4, LPAR6, MAP2K1, MAPK12, MAPK14, MAPK3, MAPK7, MAPK8, MC5R, MET, MMP14, MRAS, MTOR, NCK2, NEDD9, NFKB1, NPY1R, NRAS, PAK4, PDGFRA, PDPK1, PIK3CB, PIK3R1, PIK3R3, PTGER3, PTGER4, PTK2, PTPN12, RALA, RASA1, RB1CC1, RHOA, RRAS, RXFP1, S1PR1, S1PR3, SDCBP, SH3GL1, SOCS2, SOCS3, SOCS7, TGFB1, TGFB2, TGFB3, TGFBR2, TP53, Wasl, WIPF1		no direction
Factors Promoting Cardiogenesis in Vertebrates	0	-0.73	0.457	ACVR1, ACVR2A, ATF4, BMP8A, BMPR1B, BMPR2, CAMK2D, CAMK2G, CCND1, CREB3L2, CTNNB1, FZD7, GJA5, LRP1, MAPK12, MAPK14, MAPK8, MEF2C, NOG, PDIA3, PLCD4, PRKCE, PRKCI, PRKCQ, RHOA, ROCK1, SMAD4, TGFB1, TGFB2, TGFB3, TGFBR2, WNT9A		negative
Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes	0	1.46	0.397	ACTA1, ACTA2, ACTB, ACTC1, AKT1, AKT2, AKT3, ARPC1B, ARPC3, ARPC4, CRK, EZR, GAB2, MAPK3, MYO5A, NCK2, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, RAB11B, TLN2		positive
G Protein Signaling Mediated by Tubby	0	0	0.444	GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, INSR, MRAS		no direction
G-Protein Coupled Receptor Signaling	0	-0.178	0.433	ADCY5, ADCY8, ADGRA3, ADGRG1, ADGRL3, ADRB2, AKT1, AKT2, AKT3, AMOT, ARRB1, ATF4, BDKRB2, Calm1 (includes others), CAMK2D, CAMK2G, CARD10, CCND1, CHP1, CNR1, CREB3L2, CRHR2, CRK, CTNNB1, CYSLTR1, DUSP1, DUSP6, F2R, F2RL1, FOXO1, FOXO4, FZD7, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, GPR155, GPR34, GPR37L1, GPRC5C, GPRC6A, GRK4, GRK5, HRAS, HTR1B, HTR2B, IKBKB, IKBKG, JUN, KCNN3, KRAS, LGR4, LPAR4, LPAR6, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAP3K1, MAP3K10, MAP3K2, MAP3K5, MAPK12, MAPK14, MAPK3, MAPK7, MAPK8, MC5R, MEF2A, MEF2C, MEF2D, MKNK1, MRAS, MTOR, MYL1, MYL4, MYL9, MYLK, MYLK3, MYLPF, NFAT5, NFATC1, NFATC2, NFKB1, NFKBIA, NFKBIB, NPR3, NPY1R, NRAS, PAK4, PDE1C, PDE7A, PDE7B, PDE8A, PDPK1, PIK3CB, PIK3R1, PIK3R3, PPP3CA, PPP3CB, PPP3R1, PREX1, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PTGER3, PTGER4, PTK2, RALA, RAPGEF1, RASA1, RELA, RGS2, ROCK1, RRAS, RXFP1, S1PR1, S1PR3, SIX1, SRF, STAT3, TTN, WWTR1, YAP1		negative
GABA Receptor Signaling	0	0	0.426	ADCY5, ADCY8, AP2A2, CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, GABRA1, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, GPHN, ITPR2, KCNN3, MRAS, Ubb, UBC		no direction
GPCR-Mediated Integration of Enteroendocrine Signaling Exemplified by an L Cell	0	-2.53	0.37	ADCY5, ADCY8, ADRB2, GNAI2, ITPR2, PDIA3, PLCD4, PRKACA, PRKAR1A, PRKAR2B		negative
GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells	0	0.894	0.377	ADCY5, ADCY8, CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, GNAI2, GNG2, ITPR2, PDIA3, PLCD4, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ		positive
Glucocorticoid Biosynthesis	0	0	0.333	Gsta4		no direction
Gluconeogenesis I	0	1.414	0.444	ALDOA, ALDOB, BPGM, FBP1, FBP2, GAPDH, GPI, ME2		positive
Glutathione Redox Reactions I	0	0	0.375	GPX3, Gsta4, GSTM1, MGST3, PRDX6, PTGES		no direction
Glycogen Degradation II	0	0	0.4	PGM1, PYGM		no direction
Graft-versus-Host Disease Signaling	0	0	0.333	CD3G, CD80, FAS, HLA-A, IL33, IL6		no direction
Granulocyte Adhesion and Diapedesis	0	0	0.303	CCL5, Ccl7, CDH5, CXCL10, CXCL13, EZR, GLG1, GNAI2, IL1R1, IL1RAP, IL33, ITGB1, MMP14, NGFR, RDX, SDC2, SELP, TNFRSF11B, TNFRSF1B, VCAM1		no direction
Granzyme A Signaling	0	0	0.4	H1-0, H1-2		no direction
Granzyme B Signaling	0	0	0.3	APAF1, CASP3, DFFA		no direction
Gustation Pathway	0	0.186	0.46	ABCC8, ABCC9, ADCY5, ADCY8, CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, GABRA1, ITPR2, KCNN3, LIPA, LIPE, LIPG, LPAR6, LPL, P2RX1, P2RX6, PRKACA, PRKAR1A, PRKAR2B, SCN1B, SCN4A, SCN7A, SLC2A4, STIM1		positive
Gαi Signaling	0	0.209	0.435	ADCY5, ADCY8, CAV1, CNR1, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, HRAS, HTR1B, KRAS, MAPK3, MRAS, NPR3, NPY1R, NRAS, PRKACA, PRKAR1A, PRKAR2B, PTGER3, RALA, RRAS, S1PR1, S1PR3, STAT3		positive
Gαs Signaling	0	-0.426	0.45	ADCY5, ADCY8, ADD1, ADD2, ADD3, ADRB2, ATF4, CNR1, CREB3L2, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, MAP2K1, MAPK3, MC5R, MRAS, PRKACA, PRKAR1A, PRKAR2B, PTGER4, RAPGEF2, RGS2, RYR1, RYR3		negative
Histamine Degradation	0	0	0.429	ALDH1A1, ALDH3A2, Aldh3b2		no direction
Histidine Degradation VI	0	0	0.333	CYP11A1, CYP26B1, MICAL2		no direction
IL-4 Signaling	0	0	0.458	AKT1, AKT2, AKT3, HLA-A, HRAS, IL4R, INPP5K, INPPL1, IRS1, KRAS, MRAS, MTOR, NFAT5, NFATC1, NFATC2, NRAS, PIK3CB, PIK3R1, PIK3R3, RALA, RRAS, STAT6		no direction
Inflammasome pathway	0	0.447	0.455	MYD88, NEK7, NFKB1, PYCARD, TLR4		positive
Intrinsic Prothrombin Activation Pathway	0	1	0.333	COL1A2, COL3A1, COL5A3, F2, THBD		positive
Iron homeostasis signaling pathway	0	0	0.465	ATP6AP1, ATP6AP2, ATP6V0A1, ATP6V0C, ATP6V0D1, ATP6V0E2, ATP6V1A, ATP6V1C1, ATP6V1E1, BMP8A, BMPR1B, BMPR2, CD163, CIAO1, CIAO2A, CUL1, EGFR, ERFE, FECH, FTH1, FXN, GDF15, HFE, HP, IL6, IL6R, IREB2, LRP1, MAPK3, MCOLN1, PCBP1, PDGFA, PDGFB, PDGFRA, SLC11A2, SMAD3, SMAD4, STAT3, TF, TFRC		no direction
Ketogenesis	0	0	0.333	ACAA2, HADHA		no direction
Leucine Degradation I	0	0	0.286	ACADM, BCAT2		no direction
Leukocyte Extravasation Signaling	0	0.603	0.46	ACTA1, ACTA2, ACTB, ACTC1, ACTN2, ACTN4, AFDN, ARHGAP5, ARHGAP6, BCAR1, CD44, CDH5, CRK, CTNNA1, CTNNA3, CTNNB1, CTTN, DLC1, EZR, F11R, FER, GNAI2, ITGA3, ITGB1, MAPK12, MAPK14, MAPK8, MMP14, PIK3CB, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, PTK2, PTPN11, RASSF5, RDX, RHOA, ROCK1, TIMP2, TIMP3, VCAM1, VCL, Wasl, WIPF1		positive
Mechanisms of Viral Exit from Host Cells	0	0	0.464	ACTA1, ACTA2, ACTB, ACTC1, CHMP2B, PRKCE, PRKCI, PRKCQ, SH3GL1, SH3GLB1, VPS36, VPS4A, XPO1		no direction
Melanocyte Development and Pigmentation Signaling	0	-0.426	0.418	ADCY5, ADCY8, ATF4, CREB3L2, CRK, HRAS, KITLG, KRAS, MAP2K1, MAPK3, MRAS, NRAS, PIK3CB, PIK3R1, PIK3R3, PRKACA, PRKAR1A, PRKAR2B, PTPN11, RALA, RPS6KA2, RPS6KA5, RRAS		negative
Melatonin Degradation I	0	0	0.167	CYP2U1, LARGE1, POR		no direction
Melatonin Signaling	0	0.688	0.4	Calm1 (includes others), CAMK2D, CAMK2G, GNAI2, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK3, PDIA3, PLCD4, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, RORA, RORB, SLC2A4		positive
Mevalonate Pathway I	0	0	0.4	ACAA2, HADHA		no direction
Mineralocorticoid Biosynthesis	0	0	0.333	Gsta4		no direction
Mitochondrial Dysfunction	0	0	0.367	APH1B, APP, ATP5F1C, ATP5F1D, ATP5MC1, ATP5MG, ATPAF2, BACE1, CASP3, COX5A, COX6A1, COX7A2, COX7B, Cox8b, CPT1A, CYB5B, GPD2, LRRK2, MAOA, MAOB, MAPK12, MAPK8, MT-CO1, MT-CYB, MT-ND1, MT-ND2, MT-ND4, NCSTN, NDUFA10, NDUFA6, NDUFA9, NDUFAF1, NDUFB5, NDUFB7, NDUFS1, NDUFV1, NDUFV2, OGDH, PDHA1, PINK1, PRDX3, PRKN, PSEN1, RHOT2, SDHD, UCP2, UQCRC2		no direction
N-acetylglucosamine Degradation I	0	0	0.333	AMDHD2		no direction
N-acetylglucosamine Degradation II	0	0	0.333	AMDHD2		no direction
NAD Salvage Pathway II	0	0	0.25	NMRK2, NUDT12		no direction
NADH Repair	0	0	0.333	GAPDH		no direction
NRF2-mediated Oxidative Stress Response	0	0	0.463	ABCC4, ACTA1, ACTA2, ACTB, ACTC1, AKR7A2, AKT1, ATF4, BACH1, CCT7, CYP2U1, DNAJA4, DNAJB1, DNAJB2, DNAJB5, DNAJC12, DNAJC19, DNAJC21, DNAJC4, DNAJC7, DNAJC9, FKBP5, FMO1, FTH1, GSTM1, GSTM3, GSTM5, GSTO1, HACD3, HRAS, HSP90AA1, HSPB8, JUN, KEAP1, KRAS, MAF, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAP3K1, MAP3K5, MAPK14, MAPK3, MAPK7, MAPK8, MGST3, MRAS, NQO1, NRAS, PIK3CB, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, RALA, RRAS, SOD3, SQSTM1, TXNRD1, USP14		no direction
NUR77 Signaling in T Lymphocytes	0	0.853	0.453	APAF1, B2M, Calm1 (includes others), CASP3, CD3G, CD80, CHP1, HDAC2, HDAC9, HLA-A, MAP2K1, MAP3K2, MAPK3, MAPK7, MEF2D, NFATC1, PCNA, PDK1, PPP3CA, PPP3CB, PPP3R1, PRKCE, PRKCI, PRKCQ		positive
Necroptosis Signaling Pathway	0	-1.234	0.447	CAMK2D, CAMK2G, CAPN1, CAPN2, CAPN3, CAPN7, CAPNS1, CHP1, CYLD, DNM1L, EIF2AK2, FADD, FAS, GLUL, IKBKB, IKBKG, IRF3, MERTK, NGFR, PELI1, PGAM5, PLA2G3, PLA2G4A, PLA2G4E, PPP3CA, PPP3CB, PPP3R1, PYCARD, RBL2, RNF31, SLC25A3, TIMM10, TIMM13, TIMM22, TLR4, TNFRSF11B, TNFRSF1B, TOMM70, TP53, TRAF2, TSPO, UBC		negative
Neuropathic Pain Signaling In Dorsal Horn Neurons	0	0.894	0.417	BDNF, CAMK2D, CAMK2G, GRIN1, GRIN2A, GRINA, ITPR2, KCNN3, MAPK3, PDIA3, PIK3CB, PIK3R1, PIK3R3, PLCD4, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ		positive
Neuroprotective Role of THOP1 in Alzheimer's Disease	0	2.309	0.381	ACE, APP, HGFAC, HLA-A, HTRA1, HTRA3, IDE, LONP1, MAPT, PREP, PRKACA, PRKAR1A, PRKAR2B, PRSS23, PRSS36, TMPRSS9		positive
Neurovascular Coupling Signaling Pathway	0	-0.149	0.455	APP, BDKRB2, CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, Calm1 (includes others), GABRA1, GRIN1, GRIN2A, GRINA, ITPR2, KCNJ2, KCNMA1, KCNN3, MAPT, MPRIP, NPR3, P2RX1, PLA2G3, PLA2G4A, PLA2G4E, PLA2R1, PLAAT3, PLB1, PNPLA8, PRDX6, PRKACA, PRKAR1A, PRKAR2B, PRKG1, PTGER4, PTGS2, RHOA, ROCK1, RYR1, RYR3, SLC16A1, SLC1A3, SLCO2A1, STIM1, TRPC3		negative
Nicotine Degradation II	0	0	0.211	CYP2U1, FMO1, LARGE1, POR		no direction
Nicotine Degradation III	0	0	0.176	CYP2U1, LARGE1, POR		no direction
Nitric Oxide Signaling in the Cardiovascular System	0	0.378	0.457	AKT1, AKT2, AKT3, ATP2A1, ATP2A3, BDKRB2, CACNA1C, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, Calm1 (includes others), CAV1, HSP90AA1, ITPR2, MAP2K1, MAPK3, PDE1C, PDGFC, PIK3CB, PIK3R1, PIK3R3, PRKAA1, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, PRKG1, VEGFD		positive
Notch Signaling	0	1.342	0.45	APH1B, DTX4, HES1, MAML1, MAML3, NCSTN, NOTCH1, NOTCH3, PSEN1		positive
Nucleotide Excision Repair Pathway	0	0	0.364	CCNH, GTF2H2, GTF2H5, POLR2E, POLR2I, POLR2J, RAD23B, RPA1		no direction
Opioid Signaling Pathway	0	-0.378	0.435	ADCY5, ADCY8, AKT1, AKT2, AKT3, AP2A2, ARRB1, ATF4, CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, Calm1 (includes others), CAMK2D, CAMK2G, CREB3L2, CTNNB1, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, GRIN1, GRIN2A, GRINA, GRK4, GRK5, HRAS, ITPR2, KRAS, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK12, MAPK3, MAPK7, MRAS, NFKB1, NFKBIA, NRAS, PDE1C, PDK1, PENK, PPP3CA, PPP3CB, PPP3R1, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, RALA, RGS5, RGS8, RPS6KA2, RPS6KA5, RRAS, RYR1, RYR3, SCN7A, SRF		negative
Ovarian Cancer Signaling	0	-0.209	0.459	AKT1, AKT2, AKT3, ARRB1, CCND1, CD44, CTNNB1, E2F6, EDN1, EGFR, FZD7, HDAC11, HDAC2, HDAC4, HDAC5, HDAC6, HDAC9, HRAS, KRAS, MAP2K1, MAPK3, MRAS, MSH6, MTOR, NRAS, PDGFC, PIK3CB, PIK3R1, PIK3R3, PRKACA, PRKAR1A, PRKAR2B, PTGS2, RALA, RBL2, RRAS, TP53, VEGFD, WNT9A		negative
Oxidative Ethanol Degradation III	0	1.342	0.462	ACSL1, ACSS1, ALDH1A1, ALDH3A2, Aldh3b2, CYP2U1		positive
Oxidative Phosphorylation	0	-2.6	0.31	ATP5F1C, ATP5F1D, ATP5MC1, ATP5MG, ATPAF2, COX5A, COX6A1, COX7A2, COX7B, Cox8b, CYB5B, MT-CO1, MT-CYB, MT-ND1, MT-ND2, MT-ND4, NDUFA10, NDUFA6, NDUFA9, NDUFB5, NDUFB7, NDUFS1, NDUFV1, NDUFV2, SDHD, UQCRC2		negative
Oxytocin In Spinal Neurons Signaling Pathway	0	0	0.267	ABCC8, ABCC9, NPR3, PRKG1		no direction
PCP (Planar Cell Polarity) Pathway	0	-0.905	0.423	DAAM1, DVL3, EFNB1, FZD7, JUN, LGR4, MAPK12, MAPK8, RHOA, ROCK1, WNT9A		negative
Pentose Phosphate Pathway (Non-oxidative Branch)	0	0	0.333	TKT		no direction
Phagosome Formation	0	0.483	0.41	ADGRA3, ADGRG1, ADGRL3, ADRB2, AKT1, AKT2, AKT3, AP1S2, ARPC1B, ARPC3, ARPC4, BCAR1, BCL10, BDKRB2, C3, CD14, CFL2, CLIP1, CNR1, CRHR2, CYSLTR1, F2R, F2RL1, FZD7, GAB2, GPR155, GPR34, GPR37L1, GPRC5C, GPRC6A, HRAS, HTR1B, HTR2B, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, ITPR2, KRAS, LBP, LGR4, LPAR4, LPAR6, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MAPK12, MAPK3, MAPK7, MC5R, MRAS, MRC1, MTOR, MYD88, MYH1, MYH2, MYH3, MYH4, MYH8, MYH9, MYL1, MYL4, MYL9, MYLK, MYLK3, NPY1R, NRAS, PAK4, PIK3CB, PIK3R1, PIK3R3, PIKFYVE, PLA2G3, PLA2G4A, PLA2G4E, PLA2R1, PLAAT3, PLB1, PNPLA8, PRDX6, PRKCE, PRKCI, PRKCQ, PTGER3, PTGER4, PTK2, RALA, RAPGEF1, RHOA, ROCK1, RRAS, RXFP1, S1PR1, S1PR3, TLN2, TLR1, TLR4, TLR5, TLR6, TTN, WASF2, Wasl, WIPF1		positive
Phenylethylamine Degradation I	0	0	0.333	ALDH3A2		no direction
Phospholipases	0	0.905	0.394	LIPG, LPL, PDIA3, PLA1A, PLA2G3, PLA2G4A, PLA2G4E, PLA2R1, PLAAT3, PLB1, PLCD4, PNPLA8, PRDX6		positive
Phototransduction Pathway	0	0	0.267	GNB1, PRKACA, PRKAR1A, PRKAR2B		no direction
Pregnenolone Biosynthesis	0	0	0.364	CYP11A1, CYP26B1, CYP27A1, MICAL2		no direction
Primary Immunodeficiency Signaling	0	0	0.25	IKBKG, TAP1, TNFRSF13C		no direction
Pulmonary Healing Signaling Pathway	0	0.438	0.439	BMPR1B, BMPR2, CCND1, CFL2, CTNNB1, EGFR, ETV5, FGFR2, FZD7, HRAS, IDH2, KRAS, MAPK12, MAPK14, MAPK3, MAPK8, MMP14, MRAS, MYD88, NFATC1, NFKB1, NFKBIA, NGFR, NOTCH1, NOTCH3, NRAS, PDGFC, PRKAA1, PRKAB1, PRKAB2, PRKAG3, PRKCE, PRKCI, PRKCQ, RALA, RRAS, STAT3, TGFB1, TGFB2, TGFB3, TLR4, TNFRSF11B, TNFRSF1B, VEGFD, WNT9A, WWTR1, YAP1		positive
Purine Nucleotides De Novo Biosynthesis II	0	0	0.333	ADSS2, PAICS		no direction
Pyrimidine Deoxyribonucleotides De Novo Biosynthesis I	0	0	0.333	CMPK2, DTYMK, RRM1		no direction
Pyroptosis Signaling Pathway	0	0.816	0.453	BAX, CASP3, DHX9, GBP4, IL1R1, MAPK12, MAPK14, NEK7, NFKB1, NGFR, NOL3, PRKACA, PRKAR1A, PRKAR2B, PTGER4, PYCARD, RHOA, TLR1, TLR4, TLR5, TLR6, TNFRSF11B, TNFRSF1B, TRAF3		positive
RAN Signaling	0	-2	0.308	CSE1L, KPNA3, KPNB1, XPO1		negative
Rapoport-Luebering Glycolytic Shunt	0	0	0.25	BPGM		no direction
Regulation Of The Epithelial Mesenchymal Transition In Development Pathway	0	1.807	0.455	APH1B, CTNNB1, DVL3, FZD7, GLI3, MAML1, NCSTN, NFKB1, NOTCH1, PSEN1, RELA, SNAI2, SUFU, TWIST1, WNT9A		positive
Regulation of eIF4 and p70S6K Signaling	0	-0.408	0.462	AGO2, AGO4, AKT1, AKT2, AKT3, EIF2B2, EIF2B4, EIF3D, EIF3E, EIF3F, EIF3M, EIF4EBP1, EIF4EBP2, EIF4G3, HRAS, IRS1, ITGA10, ITGA11, ITGA3, ITGA6, ITGA7, ITGAV, ITGB1, KRAS, MAP2K1, MAPK12, MAPK14, MAPK3, MKNK1, MRAS, MTOR, NRAS, PAIP1, PAIP2, PDPK1, PIK3CB, PIK3R1, PIK3R3, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, RALA, RPS27L, RPS5, RPS7, RRAS		negative
Relaxin Signaling	0	-0.626	0.403	ADCY5, ADCY8, AKT1, AKT2, AKT3, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, JUN, MAP2K1, MAPK3, MRAS, NFKB1, NFKBIA, NFKBIB, NPR3, PDE1C, PDE7A, PDE7B, PDE8A, PIK3CB, PIK3R1, PIK3R3, PRKACA, PRKAR1A, PRKAR2B, RELA, RXFP1		negative
Retinoic acid Mediated Apoptosis Signaling	0	1.265	0.458	APAF1, CASP3, FADD, IRF1, PARP4, PARP9, RARA, RARG, RXRG, TIPARP, TNKS		positive
Role of BRCA1 in DNA Damage Response	0	-0.378	0.432	ACTB, ARID1A, ARID2, CDKN1A, E2F6, FANCD2, GADD45A, MSH6, RBL2, RPA1, SMARCA2, SMARCB1, SMARCD2, SMARCD3, TP53, UIMC1		negative
Role of Cytokines in Mediating Communication between Immune Cells	0	0	0.385	IL15, IL17F, IL33, IL6, TGFB1		no direction
Role of IL-17A in Psoriasis	0	0	0.4	IL17RA, IL17RC		no direction
Role of JAK1, JAK2 and TYK2 in Interferon Signaling	0	0	0.4	IFNAR2, NFKB1, RELA, STAT3		no direction
Role of Lipids/Lipid Rafts in the Pathogenesis of Influenza	0	0	0.333	RSAD2		no direction
Role of OCT4 in Mammalian Embryonic Stem Cell Pluripotency	0	-1	0.462	ETS2, JARID2, MEF2A, NR2F1, NR2F2, NR6A1, PHB, RARA, SH3GLB1, SPP1, TP53, WWP2		negative
Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses	0	1.46	0.456	C3, CCL5, DDX58, EIF2AK2, IL15, IL17F, IL33, IL6, IRF3, LTB, MAPK12, MAPK3, MAPK8, MYD88, NFKB1, PIK3CB, PIK3R1, PIK3R3, PRKCE, PRKCI, PRKCQ, RELA, TGFB1, TGFB2, TGFB3, TLR1, TLR4, TLR5, TLR6, TNFSF12, TRAF6		positive
Role of WNT/GSK-3β Signaling in the Pathogenesis of Influenza	0	0	0.292	CSNK1A1, CSNK1E, CTNNB1, DVL3, FZD7, NCOA1, WNT9A		no direction
SNARE Signaling Pathway	0	-2.121	0.427	ADCY5, ADCY8, CACNB1, CACNB4, Calm1 (includes others), CAMK2D, CAMK2G, GOSR2, GPAA1, MYH1, MYH2, MYH3, MYH4, MYH8, MYH9, MYL1, MYL4, MYL9, NAPB, NAPG, PRKACA, PRKAR1A, PRKAR2B, RAB1A, RAB6A, SNAP23, STX16, STXBP3, STXBP5, SYT11, SYT12, VTI1B		negative
SPINK1 Pancreatic Cancer Pathway	0	-0.378	0.438	CPD, CPE, CPQ, F2RL1, SMAD3, TGFB1, TGFBR2		negative
Serotonin Degradation	0	-0.707	0.4	ALDH1A1, ALDH3A2, Aldh3b2, DHRS4, LARGE1, MAOA, MAOB, SMOX		negative
Sirtuin Signaling Pathway	0	1.588	0.462	ABCA1, ADAM10, AKT1, APP, ARNTL, ATG13, ATG2A, ATG9A, ATG9B, ATP5F1C, ATP5F1D, ATP5MC1, BAX, BCL2L11, BPGM, CPT1A, DUSP6, FOXO1, FOXO4, GABPA, GADD45A, GADD45G, GLS, GOT2, GTF3C2, H1-0, H1-2, H3-3A/H3-3B, IDH2, JUN, LDHA, MAP1LC3A, MAP1LC3B, MAPK12, MAPK3, MAPK7, MT-CYB, MT-ND1, MT-ND2, MT-ND4, MTOR, NAMPT, NDRG1, NDUFA10, NDUFA6, NDUFA9, NDUFAF1, NDUFB5, NDUFB7, NDUFS1, NDUFV1, NDUFV2, NFKB1, NQO1, NR1H2, NR1H3, NR1H4, PDHA1, PDK1, PFKM, PPARA, PPARG, PPARGC1A, PRKAA1, RELA, RPTOR, SDHD, SF3A1, SIRT2, SIRT5, SIRT6, SLC2A1, SOD3, SREBF1, STAT3, TIMM10, TIMM13, TIMM22, TOMM70, TP53, TRIM28, TSPO, TUBA1A, UCP2, UQCRC2, ZBTB14		positive
Sonic Hedgehog Signaling	0	1.134	0.438	DYRK1B, GLI3, PRKACA, PRKAR1A, PRKAR2B, STK36, SUFU		positive
Sperm Motility	0	-0.655	0.412	AATK, CACNA1H, Calm1 (includes others), DSTYK, EGFR, EPHA3, EPHB2, EPHB3, ERBB2, ERBB3, ERBB4, FER, FGFR2, GNA13, GNAI2, GNAL, GNB1, GNB2, GNG2, INSR, ITPR2, LMTK2, MAP2K1, MAP2K3, MAP2K6, MAP2K7, MERTK, MET, MRAS, MUSK, PDE1C, PDGFRA, PDIA3, PLA2G3, PLA2G4A, PLA2G4E, PLA2R1, PLAAT3, PLB1, PLCD4, PNPLA8, PRDX6, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, PRKG1, PTK2, RET, ROS1, SLC12A2, TEK		negative
Sphingomyelin Metabolism	0	0	0.333	SGMS1, SGMS2		no direction
Sphingosine and Sphingosine-1-phosphate Metabolism	0	0	0.2	ASAH2		no direction
Stearate Biosynthesis I (Animals)	0	-0.333	0.429	ACSL1, ACSL3, ACSL5, ACSL6, AKR1B10, ELOVL1, LPGAT1, MBOAT7, PRXL2B, SLC27A1, TECR, THEM4		negative
Superoxide Radicals Degradation	0	0	0.286	NQO1, SOD3		no direction
Superpathway of Melatonin Degradation	0	-0.816	0.286	CYP2U1, LARGE1, MAOA, MAOB, POR, SMOX		negative
Synaptic Long Term Depression	0	0.949	0.423	CACNA1C, CACNA1H, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG6, GNA13, GNAI2, GNAL, HRAS, ITPR2, KRAS, MAP2K1, MAPK3, MRAS, NPR3, NRAS, PDIA3, PLA2G3, PLA2G4A, PLA2G4E, PLA2R1, PLAAT3, PLB1, PLCD4, PNPLA8, PPM1J, PPP2CA, PPP2R2B, PPP2R5B, PPP2R5D, PRDX6, PRKCE, PRKCI, PRKCQ, PRKG1, RALA, RRAS, RYR1, RYR3		positive
Synaptic Long Term Potentiation	0	-0.354	0.447	ADCY8, ATF4, CACNA1C, Calm1 (includes others), CAMK2D, CAMK2G, CHP1, CREB3L2, GRIN1, GRIN2A, GRINA, HRAS, ITPR2, KRAS, MAP2K1, MAPK3, MRAS, NRAS, PDIA3, PLCD4, PPP1R14C, PPP1R3A, PPP1R7, PPP3CA, PPP3CB, PPP3R1, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, RALA, RRAS		negative
T Helper Cell Differentiation	0	0	0.444	CD3G, CD80, HLA-A, IL12RB2, IL17F, IL4R, IL6, IL6R, IL6ST, NGFR, STAT3, STAT6, TGFB1, TGFBR2, TNFRSF11B, TNFRSF1B		no direction
TREM1 Signaling	0	-0.258	0.429	AKT1, AKT2, AKT3, IL6, IRAK1, ITGB1, MAPK3, MYD88, NFKB1, RELA, STAT3, TLR1, TLR4, TLR5, TLR6		negative
Telomere Extension by Telomerase	0	0	0.4	HNRNPA2B1, PINX1, TERF2IP, TNKS		no direction
Thioredoxin Pathway	0	0	0.333	TXNRD1		no direction
Thyroid Hormone Metabolism II (via Conjugation and/or Degradation)	0	0	0.222	DIO2, LARGE1		no direction
Tumoricidal Function of Hepatic Natural Killer Cells	0	1.633	0.333	APAF1, BAX, CASP3, DFFA, FADD, FAS		positive
UDP-N-acetyl-D-galactosamine Biosynthesis II	0	0	0.4	GPI, HK2		no direction
UVC-Induced MAPK Signaling	0	-0.728	0.425	EGFR, HRAS, JUN, KRAS, MAP2K1, MAPK12, MAPK14, MAPK3, MAPK8, MRAS, NRAS, PRKCE, PRKCI, PRKCQ, RALA, RRAS, TP53		negative
Ubiquinol-10 Biosynthesis (Eukaryotic)	0	1	0.364	COQ2, CYP11A1, CYP26B1, MICAL2		positive
VEGF Family Ligand-Receptor Interactions	0	0.218	0.434	AKT1, AKT2, AKT3, HRAS, KRAS, MAP2K1, MAPK3, MRAS, NRAS, NRP1, NRP2, PIK3CB, PIK3R1, PIK3R3, PLA2G3, PLA2G4A, PLA2G4E, PRKCE, PRKCI, PRKCQ, RALA, RRAS, VEGFD		positive
Valine Degradation I	0	0.447	0.462	BCAT2, DLD, HADHA, HIBADH, HIBCH, HSD17B4		positive
Vitamin-C Transport	0	-1	0.364	GSTO1, SLC2A1, SLC2A4, TXNRD1		negative
WNT/Ca+ pathway	0	0.302	0.429	ATF4, CREB3L2, DVL3, FZD7, NFAT5, NFATC1, NFATC2, NFKB1, PDIA3, PLCD4, PPP3CA, RELA		positive
Xenobiotic Metabolism AHR Signaling Pathway	0	-0.243	0.459	ABCG2, ALDH1A1, ALDH1L1, ALDH3A2, GSTM1, GSTM3, GSTM5, GSTO1, HDAC4, HDAC5, HSP90AA1, IL6, MGST3, NCOA1, NFKB1, NQO1, RELA		negative
Xenobiotic Metabolism PXR Signaling Pathway	0	-2.214	0.435	ABCB1, ABCC3, ALDH1A1, ALDH1L1, ALDH3A2, CAMK2D, CAMK2G, CHST10, CHST3, DNAJC7, GSTM1, GSTM3, GSTM5, GSTO1, HS2ST1, HS3ST3A1, HS3ST5, HS6ST1, HSP90AA1, MAOA, MAOB, MED1, MGST3, NCOA1, NDST1, NDST4, PPARGC1A, PPM1A, PPP1R14C, PPP1R3A, PPP1R7, PRKACA, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, SMOX, SNW1, SRA1		negative
Zymosterol Biosynthesis	0	0	0.333	NSDHL		no direction
cAMP-mediated signaling	0	0.667	0.385	ADCY5, ADCY8, ADRB2, AKAP1, AKAP11, AKAP13, AKAP6, ATF4, Calm1 (includes others), CAMK2D, CAMK2G, CNR1, CREB3L2, CREM, DUSP1, DUSP6, GNAI2, GNAL, GRK4, HTR1B, MAP2K1, MAPK3, MC5R, NPR3, NPY1R, PDE1C, PDE7A, PDE7B, PDE8A, PKIA, PPP3CA, PPP3CB, PPP3R1, PRKACA, PRKAR1A, PRKAR2B, PTGER3, PTGER4, RGS2, S1PR1, S1PR3, STAT3		positive
eNOS Signaling	0	-0.928	0.412	ADCY5, ADCY8, AKT1, AKT2, AKT3, BDKRB2, Calm1 (includes others), CASP3, CAV1, CHRNB1, CHRNE, ESR1, HSP90AA1, HSPA2, ITPR2, LPAR4, LPAR6, PDGFC, PDPK1, PIK3CB, PIK3R1, PIK3R3, PRKAA1, PRKAB1, PRKAB2, PRKACA, PRKAG3, PRKAR1A, PRKAR2B, PRKCE, PRKCI, PRKCQ, PRKG1, STUB1, VEGFD		negative
tRNA Splicing	0	-1	0.211	PDE1C, PDE7A, PDE7B, PDE8A		negative
